EP1095152A2 - Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch - Google Patents

Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch

Info

Publication number
EP1095152A2
EP1095152A2 EP99923557A EP99923557A EP1095152A2 EP 1095152 A2 EP1095152 A2 EP 1095152A2 EP 99923557 A EP99923557 A EP 99923557A EP 99923557 A EP99923557 A EP 99923557A EP 1095152 A2 EP1095152 A2 EP 1095152A2
Authority
EP
European Patent Office
Prior art keywords
nucleic acid
starch
plant
acid molecule
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99923557A
Other languages
German (de)
French (fr)
Inventor
Horst Lörz
Stephanie Lütticke
Martina Block
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Aventis CropScience GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis CropScience GmbH filed Critical Aventis CropScience GmbH
Publication of EP1095152A2 publication Critical patent/EP1095152A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14Organic oxygen compounds
    • A21D2/18Carbohydrates
    • A21D2/186Starches; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis

Definitions

  • the present invention relates to nucleic acid molecules that encode a wheat enzyme that is involved in starch synthesis in plants.
  • This enzyme is a soluble type I starch synthase.
  • the invention further relates to vectors, host cells, as well as plant cells and plants, which contain the nucleic acid molecules according to the invention.
  • polysaccharides are the most important renewable raw materials from plants.
  • Wheat is one of the most important crops, as it produces about 20% of the total starch production in the European Community.
  • the polysaccharide starch is a polymer made up of chemically uniform building blocks, the glucose molecules. However, it is a very complex mixture of different molecular forms, which differ in the degree of polymerization of the occurrence of branches of the glucose chains and their chain lengths, which can also be derivatized, for example phosphorylated. Starch is therefore not a uniform raw material.
  • amylose starch an essentially unbranched polymer composed of 1,4-glycosidically linked glucose molecules, and amylopectin starch, which in turn is a complex mixture of differently branched glucose chains.
  • the branches come about through the occurrence of additional -1, 6-glycosidic linkages.
  • about 1 1 to 37% of the synthesized starch consists of amylose starch.
  • the biochemical synthetic pathways that lead to the building of starch are in the essentially known.
  • the starch synthesis in plant cells takes place in the plastids.
  • starch synthases Important enzymes involved in starch synthase are starch synthases and branching enzymes. Various isoforms are described for starch synthase, all of which catalyze a polymerization reaction by transferring a glucosyl residue from ADP-glucose to ⁇ -1,4-glucans. Branching enzymes catalyze the introduction of ⁇ -2,6 branches into linear ⁇ -1,4-glucans.
  • Starch synthases can be divided into two classes: starch-bound starch synthases ("granule-bound starch synthases”; GBSS) and soluble starch synthases ("soluble starch synthases”; SSS). This distinction cannot be clearly made in every case, since some of the starch synthases are both bound to starch and in soluble form (Denyer et al., Plant J. 4 (1 993), 1 91-1 98; Mu et al., Plant J. 6 (1,994), 1 51-1 59). For different plant species, different isoforms are described within these classes, which differ in terms of their dependence on starter molecules (so-called “primer dependent” (type II) and “primer independent” (type I) starch synthases).
  • At least two isoforms of the starch-bound starch synthase (60 kDA and 100-105 kDA) and another isoform, which may be a soluble starch synthase (Denyer et al., Planta 1 96 (1 995), 256-265; Rahman et al., Aust. J. Plant Physiol. 22 (1 995), 793-803), was identified at the protein level.
  • the presence of several SSS isoforms has previously been demonstrated using chromatographic methods (Rijven, Plant Physiol. 81 (1 986), 448-453).
  • a cDNA encoding GBSS I from wheat has already been described (Ainsworth et al., Plant Mol. Biol. 22 (1 993), 67 to 82).
  • nucleic acid sequences which encode starch synthase isoforms from wheat or partial sequences of such nucleic acids have hitherto been known from WO 97/45545.
  • cDNA sequences coding for starch synthases other than GBSS I have so far only been used for pea (Dry et al., Plant J. 2 (1 992), 1 93-202), rice (Baba et al., Plant Physiol 103 (1 993), 565 to 573) and potato (Edwards et al., Plant J. 8 (1 995), 283 to 294).
  • soluble starch synthases have also been identified in a number of other plant species. Soluble starch synthases have been isolated, for example, to homogeneity from pea (Denyer and Smith, Planta 1 86 (1 992), 609 to 61 7) and potato (Edwards et al., Plant J. 8 (1 995), 283 to 294) .
  • any starch-storing plants preferably cereals, in particular wheat, in such a way that they synthesize a modified starch
  • the present invention is therefore based on the object of making available nucleic acid molecules, in particular those from wheat, which encode enzymes involved in starch biosynthesis and with the aid of which it is possible to produce genetically modified plants which are suitable for the production of chemical and / or or physical properties of modified vegetable starches.
  • the present invention therefore relates to nucleic acid molecules which proteins with the activity of a soluble starch synthase from wheat, wherein such molecules preferably encode proteins which essentially have the Seq ID no. Include 2 given amino acid sequence.
  • the invention relates to nucleic acid molecules which are listed under Seq ID No. 1 or a part thereof, preferably molecules which contain the nucleotide sequence specified in Seq ID No. 1 indicated coding region comprise, particularly preferably nucleotide No. 9 to 570 of Seq ID No. 1 as well as corresponding ribonucleotide sequences.
  • the present invention further relates to nucleic acid molecules which hybridized with one of the nucleic acid molecules according to the invention.
  • the invention also relates to nucleic acid molecules which encode a soluble starch synthase from wheat and whose sequence deviates from the nucleotide sequences of the molecules described above due to the degeneration of the genetic code.
  • the invention also relates to nucleic acid molecules which have a sequence which is complementary to all or part of one of the abovementioned sequences.
  • hybridization means hybridization under conventional hybridization conditions, preferably under stringent conditions, as described, for example, in Sambrook et al., Molecular Cloning, A Laboratory Manual, 2nd edition (1,989) Cold Spring Harbor Laboratory Press , Cold Spring Harbor, NY). Hybridization is particularly preferably carried out under the following
  • Hybridization buffer 2 x SSC; 1 0 x Denhardt's solution (Fikoll 400 + PEG +
  • Washing temperature T 40 to 75 ° C.
  • nucleic acid molecules which hybridize with the nucleic acid molecules according to the invention can encode starch synthases from any wheat plant which expresses such proteins.
  • Nucleic acid molecules that hybridize with the molecules of the invention can e.g. isolated from genomic or from cDNA libraries of wheat or wheat plant tissue. Alternatively, they can be produced by genetic engineering methods or by chemical synthesis.
  • nucleic acid molecules can be identified and isolated using the molecules according to the invention or parts of these molecules or the reverse complements of these molecules, e.g. by means of hybridization according to standard methods (see e.g. Sambrook et al., 1 989, Molecular Cloning, A Laboratory Manual, 2nd edition Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
  • nucleic acid molecules can be used as the hybridization sample that exactly or essentially the ones under Seq ID No. 1 indicated nucleotide sequence or parts of this sequence.
  • the fragments used for the hybridization sample can also be synthetic fragments which were produced with the aid of the usual synthetic techniques and whose sequence essentially corresponds to that of a nucleic acid molecule according to the invention.
  • the molecules hybridizing with the nucleic acid molecules according to the invention also include fragments, derivatives and allelic variants of the nucleic acid molecules described above, which encode a starch synthase according to the invention from wheat. Fragments are understood to mean parts of the nucleic acid molecules that are long enough to encode one of the proteins described.
  • the term derivative in this context means that the sequences of these molecules differ from the sequences of the nucleic acid molecules described above at one or more positions and have a high degree of homology to these sequences.
  • Homology means a sequence identity of at least 40%, in particular an identity of at least 60%, preferably over 80% and particularly preferably over 90%.
  • the deviations from the nucleic acid molecules described above may have resulted from deletion, substitution, insertion or recombination.
  • nucleic acid molecules in question or the proteins encoded by them are usually variations of these molecules which are modifications which have the same biological function. These can be both naturally occurring variations, for example sequences from other organisms, or mutations, wherein these mutations can have occurred naturally or have been introduced by targeted mutagenesis. Furthermore, the variations can be act synthetically produced sequences.
  • allelic variants can be both naturally occurring variants and also synthetically produced variants or those produced by recombinant DNA techniques.
  • the proteins encoded by the different variants of the nucleic acid molecules according to the invention have certain common characteristics. For this, e.g. Enzyme activity, molecular weight, immunological reactivity, conformation etc. belong as well as physical properties such as the running behavior in gel electrophoresis, chromatographic behavior, sedimentation coefficient, solubility, spectroscopic properties, charge properties, stability; pH optimum, temperature optimum etc.
  • a starch synthase Important characteristics of a starch synthase are: i) its localization in the stroma of plastids in plant cells; ii) their ability to synthesize linear - 1, 4-linked polyglucans. This activity can be determined as described in Denyer and Smith (Plante 1 86 (1 992), 606 to 61 7).
  • the protein encoded by the nucleic acid molecules according to the invention is a soluble type I starch synthase from wheat. These proteins have certain areas of homology with previously known soluble starch synthases from other plant species.
  • the nucleic acid molecules according to the invention can be DNA molecules, in particular cDNA or genomic molecules. Furthermore, the nucleic acid molecules according to the invention can be RNA molecules, which can result, for example, from transcription of a nucleic acid molecule according to the invention.
  • the nucleic acid molecules according to the invention can, for. B. obtained from natural sources or produced by recombinant techniques or synthetically.
  • the invention also relates to oligonucleotides which hybridize specifically with a nucleic acid molecule according to the invention. Such oligonucleotides preferably have a length of at least 10, in particular at least 15 and particularly preferably at least 50 nucleotides.
  • the oligonucleotides according to the invention are characterized in that they hybridize specifically with nucleic acid molecules according to the invention, ie not or only to a very small extent with nucleic acid sequences which code for other proteins, in particular other starch synthases.
  • the oligonucleotides according to the invention can be used, for example, as primers for a PCR reaction or as a hybridization sample for the isolation of related genes. They can also be components of antisense constructs or of DNA molecules which code for suitable ribozymes.
  • the invention further relates to vectors, in particular plasmids, cosmids, phagemids, viruses, bacteriophages and other vectors which are common in genetic engineering and which contain the nucleic acid molecules according to the invention described above.
  • vectors are suitable for the transformation of pro- or eukaryotic, preferably plant cells.
  • the vectors particularly preferably allow the nucleic acid molecules according to the invention, optionally together with flanking regulatory regions, to be integrated into the genome of the plant cell. Examples of this are binary vectors which can be used in gene transfer mediated by agrobacteria.
  • the integration of a nucleic acid molecule according to the invention in sense or anti-sense orientation preferably ensures the synthesis of a translatable or optionally non-translatable RNA in the transformed pro- or eukaryotic cells.
  • vector generally designates a suitable, the expert Known tool that enables the targeted transfer of a single- or double-stranded nucleic acid molecule into a host cell, for example a DNA or RNA virus, a virus fragment, a plasmid construct, which, in the presence or absence of regulatory elements, may be suitable for nucleic acid transfer in cells can, carrier materials such as glass fiber or metal particles such as can be used for example in the "particle gun” process, but it can also include a nucleic acid molecule that can be brought directly into a cell by chemical or physical methods.
  • the nucleic acid molecules contained in the vectors are linked to regulatory elements which ensure the transcription and synthesis of a translatable RNA in pro- or eukaryotic cells or, if desired, the synthesis of a non-translatable RNA.
  • nucleic acid molecules according to the invention in prokaryotic cells, for example in Escherichia coli, is important for a more precise characterization of the enzymatic activities of the enzymes for which these molecules code.
  • deletions at the 5 'end of the nucleotide sequence make it possible, for example, to identify amino acid sequences which are responsible for the translocation of the enzyme into the plastids (transit peptides). This allows targeted production of enzymes that are no longer localized in the plastids but in the cytosol by removing the corresponding sequences, or are localized in other compartments due to the addition of other signal sequences.
  • mutants can be produced which have a changed K m value or which are no longer subject to the regulatory mechanisms normally present in the cell via allosteric regulation or covalent modification.
  • mutants can be produced which have a modified substrate or product specificity of the protein according to the invention, for example by using ADP-glucose-6-phosphate instead of ADP-glucose. Furthermore, mutants can be produced which have a changed activity-temperature profile of the protein according to the invention.
  • the nucleic acid molecules according to the invention or parts of these molecules can be introduced into plasmids which permit mutagenesis or a sequence change by recombination of DNA sequences.
  • base changes can be made or natural or synthetic sequences added.
  • adapters or linkers can be attached to the fragments.
  • Manipulations which provide suitable restriction sites or which remove superfluous DNA or restriction sites can also be used. Where insertions, deletions or substitutions are possible, in vitro mutagenesis, "primer repair", restriction or ligation can be used. Sequence analysis, restriction analysis or other biochemical-molecular biological methods are generally used as the analysis method.
  • the invention relates to host cells, in particular pro- or eukaryotic cells which are transformed with a nucleic acid molecule according to the invention or a vector according to the invention described above, and cells which are derived from cells transformed in this way and contain a nucleic acid molecule according to the invention or a vector.
  • host cells in particular pro- or eukaryotic cells which are transformed with a nucleic acid molecule according to the invention or a vector according to the invention described above, and cells which are derived from cells transformed in this way and contain a nucleic acid molecule according to the invention or a vector.
  • the invention further relates to recombinantly producible proteins with the activity of a starch synthase, which are encoded by the nucleic acid molecules according to the invention, and methods for their production, in which a host cell according to the invention is cultivated under suitable conditions known to the person skilled in the art, which allow the synthesis of the protein according to the invention, and then it from the
  • Host cells and / or the culture medium is isolated.
  • nucleic acid molecules according to the invention By providing the nucleic acid molecules according to the invention, it is now possible to use genetic engineering methods to specifically intervene in the starch metabolism of plants and to change it in such a way that a modified starch is synthesized, which in its physico-chemical form Properties, for example the amylose / amylopectin ratio, the degree of branching, the average chain length, the phosphate content, the gelatinization behavior, the gel or film formation properties, the starch grain size and / or the starch grain shape is changed compared to known starch.
  • a modified starch which in its physico-chemical form Properties, for example the amylose / amylopectin ratio, the degree of branching, the average chain length, the phosphate content, the gelatinization behavior, the gel or film formation properties, the starch grain size and / or the starch grain shape is changed compared to known starch.
  • nucleic acid molecules according to the invention in plant cells in order to increase the activity of the corresponding starch synthase, or to introduce them into cells which naturally do not express this enzyme. Furthermore, it is possible to modify the nucleic acid molecules according to the invention by methods known to the person skilled in the art in order to obtain starch synthases according to the invention which are no longer subject to the natural cellular regulation mechanisms or which have changed temperature-activity profiles or substrate or product specificities.
  • the synthesized protein can be localized in any compartment of the plant cell.
  • the sequence ensuring localization in plastids must be deleted and the remaining coding region may have to be linked to DNA sequences which ensure localization in the respective compartment.
  • Such sequences are known (see for example Braun et al., EMBO J. 1 1 (1 992), 321 9-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1 988), 846-850 ; Sonnewald et al., Plant J. 1 (1,991), 95-106).
  • the present invention thus also relates to a method for producing transgenic plant cells which are transformed with a nucleic acid molecule or vector according to the invention, in which a nucleic acid molecule according to the invention or a vector according to the invention in the genome of a plant cell is integrated, the transgenic plant cells which were transformed by means of a nucleic acid molecule or vector according to the invention and transgenic plant cells which are derived from cells transformed in this way.
  • the cells according to the invention contain one or more nucleic acid molecules or vectors according to the invention, these being preferably linked to regulatory DNA elements which ensure transcription in plant cells, in particular with a suitable promoter.
  • Such cells can be distinguished from naturally occurring plant cells, inter alia, in that they contain a nucleic acid molecule according to the invention which does not naturally occur in these cells or in that such a molecule is integrated at a location in the genome of the cell where it does not otherwise occur , ie in a different genomic environment.
  • transgenic plant cells according to the invention can be distinguished from naturally occurring plant cells in that they contain at least one copy of a nucleic acid molecule according to the invention stably integrated into their genome, optionally in addition to copies of such a molecule that occur naturally in the cells.
  • the plant cells according to the invention can be distinguished from naturally occurring cells in particular in that these additional copy (s) ) is localized in locations in the genome where it does not naturally occur. This can be easily checked, for example, with the aid of a Southern blot analysis according to methods known to the person skilled in the art.
  • the transgenic plant cells have transcripts of the nucleic acid molecules according to the invention, which are e.g. B. simply by Northern blot analysis according to methods known to those skilled in the art. If the introduced nucleic acid molecule according to the invention is homologous with respect to the plant cell, the cells according to the invention can be distinguished from naturally occurring cells, for example on the basis of the additional expression of nucleic acid molecules according to the invention.
  • the transgenic plant cells preferably contain more transcripts of the nucleic acid molecules according to the invention. This can e.g. B. can be detected by Northern blot analysis.
  • “More” preferably means at least 10% more, preferably at least 20% more and particularly preferably at least 50% more transcripts than corresponding, non-transformed cells.
  • the cells preferably also have a corresponding (at least 10%, 20% or 50%) increase in activity or, if appropriate, a reduction in activity of the protein according to the invention.
  • the transgenic plant cells can be regenerated into whole plants using techniques known to those skilled in the art.
  • the present invention also relates to a method for producing transgenic plants, in which one or more nucleic acid molecules or vectors according to the invention are integrated into the genome of a plant cell and a complete plant is regenerated from said plant cell.
  • the plants obtainable by regeneration of the transgenic plant cells according to the invention are also the subject of the present invention.
  • the invention furthermore relates to plants which contain the transgenic plant cells described above.
  • the transgenic plants can in principle be plants of any plant species, ie both monocot and dicot plants.
  • the invention also relates to propagation material of the plants according to the invention, for example fruits, seeds, tubers, rhizomes, seedlings, cuttings, calli, protoplasts, cell cultures etc.
  • the present invention further relates to a method for producing a modified starch comprising the step of extracting the starch from a plant according to the invention described above and / or from starch-storing parts of such a plant.
  • the transgenic plant cells and plants according to the invention synthesize a starch which has its physicochemical properties, for example the amylose / amylopectin ratio, the degree of branching, the average chain length, the phosphate content, the gelatinization behavior, the starch grain size and / or the starch grain shape compared to wild type Plants synthesized starch is changed.
  • a starch can be changed with regard to the viscosity and / or the film or gel formation properties of pastes of this starch compared to known starches.
  • the present invention furthermore relates to a starch which can be obtained from the plant cells, plants and their propagation material according to the invention and starch which can be obtained by the process according to the invention described above.
  • nucleic acid molecules according to the invention it is also possible to use the nucleic acid molecules according to the invention to produce plant cells and plants in which the activity of a protein according to the invention is reduced. This also leads to the synthesis of a starch with changed chemical and / or physical properties compared to starch from wild-type plant cells.
  • Another object of the invention is thus also a transgenic plant cell containing a nucleic acid molecule according to the invention, in which the activity of a starch synthase is reduced compared to a non-transformed cell.
  • the production of plant cells with a reduced activity of a starch synthase can be achieved, for example, by the expression of a corresponding antisense-RNA, a sense-RNA to achieve a cosuppression effect or the expression of a correspondingly constructed ribozyme which specifically cleaves transcripts which code for a starch synthase , using the nucleic acid molecules according to the invention by methods known to the person skilled in the art, cf. Jorgensen (Trends Biotechnol. 8 (1 990), 340-344), Niebel et al., (Curr. Top. Microbiol. Immunol. 1 97 (1 995), 91-103), Flavell et al. (Curr. Top.
  • the number of transcripts encoding it is reduced, e.g. by expression of an antisense RNA.
  • a DNA molecule can be used which comprises the entire sequence coding for a protein according to the invention including any flanking sequences which may be present, and also DNA molecules which only comprise parts of the coding sequence, these parts having to be long enough to to cause an antisense effect in the cells.
  • sequences up to a minimum length of 15 bp, preferably a length of 100-500 bp can be used for efficient antisense inhibition, in particular sequences with a length of more than 500 bp.
  • DNA molecules are used that are shorter than 5000 bp, preferably sequences that are shorter than 2500 bp.
  • DNA sequences which have a high degree of homology to the sequences of the DNA molecules according to the invention, but which are not completely identical.
  • the minimum homology should be greater than approximately 65%.
  • sequences with homologies between 95 and 100% is preferred.
  • the invention also relates to a method for producing a modified starch, comprising the step of extracting the starch from a cell or plant according to the invention and / or from starch-storing parts of such a plant.
  • the invention furthermore relates to starch which can be obtained from the cells, plants and propagation material or parts thereof according to the invention and starch which can be obtained by a process according to the invention.
  • starches according to the invention can be modified by processes known to those skilled in the art and are suitable in unmodified or modified form for various uses in the food or non-food sector.
  • the possible uses of the starches according to the invention can be divided into two large areas.
  • One area comprises the hydrolysis products of starch, mainly glucose and glucan building blocks, which are obtained via enzymatic or chemical processes. They serve as the starting material for further chemical modifications and processes, such as fermentation.
  • the simplicity and cost-effective execution of a hydrolysis process can be important for reducing the costs.
  • it is essentially enzymatic using amyloglucosidase. It would be conceivable to save costs by using fewer enzymes.
  • a structural change in strength, e.g. Surface enlargement of the grain, easier digestibility through e.g. A lower degree of branching or a steric structure that limits the accessibility for the enzymes used could cause this.
  • Starch is a classic additive for many foods, where it essentially takes on the function of binding aqueous additives or increases the viscosity or increases gel formation.
  • the important properties are the flow and Sorption behavior, the swelling and gelatinization temperature, the viscosity and thickening performance, the solubility of the starch, the transparency and paste structure, the heat, shear and acid stability, the tendency to retrogradation, the ability to form films, the freeze / thaw stability, the viscosity stability in Salt solutions, digestibility and the ability to form complexes with, for example, inorganic or organic ions.
  • starch can be used as an additive for different manufacturing processes or as an additive in technical products.
  • starch When using starch as an auxiliary, the paper and cardboard industry should be mentioned in particular.
  • the starch primarily serves for retardation (retention of solids), the setting of filler and fine particles, as a strengthening agent and for drainage.
  • the favorable properties of the starch in terms of rigidity, hardness, sound, grip, gloss, smoothness, splitting resistance and surfaces are exploited.
  • the requirements for the starch in relation to the surface treatment are essentially a high degree of whiteness, an adapted viscosity, high viscosity stability, good film formation and low dust formation.
  • the solids content, an adapted viscosity, a high binding capacity and high pigment affinity play an important role.
  • rapid, even, loss-free distribution, high mechanical stability and complete restraint in the paper flow are important.
  • At the Use of the starch in the spray area is also of importance to an adapted solids content, high viscosity and high binding capacity.
  • starches A large area of use of the starches is in the adhesive industry, where the possible uses are divided into four areas: use as pure starch glue, use with starch glues prepared with special chemicals, use of starch as an additive to synthetic resins and polymer dispersions, and use of starches as an extender for synthetic adhesives.
  • 90% of the starch-based adhesives are used in the fields of corrugated cardboard, paper bags, bags and pouches, composite materials for paper and aluminum, cardboard packaging and rewetting glue for envelopes, stamps, etc.
  • starch as a sizing agent, i.e. as an auxiliary for smoothing and strengthening the hook-and-loop behavior to protect against the tensile forces that occur during weaving and to increase the abrasion resistance during weaving, starch as a means of textile upgrading after poor-quality pre-treatments such as bleaching, dyeing, etc., starch as a thickening agent in the manufacture of color pastes to prevent dye diffusion and starch as an additive to chaining agents for sewing threads.
  • the fourth area of application is the use of starches as an additive in building materials.
  • One example is the production of gypsum plasterboard, in which the starch mixed in the gypsum slurry pastes with the water, diffuses to the surface of the gypsum board and binds the cardboard to the board there.
  • Other areas of application are admixing to plaster and mineral fibers.
  • starch products are used to delay setting.
  • starch Another market for starch is in the manufacture of soil stabilizers that are used to temporarily protect soil particles from water during artificial earthmoving. Combined products made of starch and polymer emulsions are, according to current knowledge, to be equated with the previously used products in terms of their erosion and incrustation-reducing effects, but are significantly less expensive than these.
  • starch in crop protection agents to change the specific properties of the preparations.
  • the starch can be used to improve the wetting of crop protection agents and fertilizers, to release the active ingredients in a dosed manner, to convert liquid, volatile and / or malodorous active ingredients into microcrystalline, stable, moldable substances, to mix incompatible compounds and to extend the duration of action by reducing the Decomposition can be used.
  • starch can be considered Binder for tablets or for binder dilution in capsules can be used.
  • the starch can furthermore serve as a tablet disintegrant, since after swallowing it absorbs liquid and swells to such an extent after a short time that the active substance is released.
  • Medical lubricant and wound powders are based on starch for qualitative reasons.
  • starches are used, for example, as carriers for powder additives such as fragrances and salicylic acid.
  • a relatively large area of application for starch is toothpaste.
  • Starch is used as an additive to coal and briquette. Coal can be agglomerated or briquetted with a high-quality addition of starch, which prevents the briquettes from breaking down prematurely.
  • the added starch is between 4 and 6% for barbecued coal and between 0, 1 and 0.5% for calorized coal. Furthermore, starches are becoming increasingly important as binders, since their addition to coal and briquette can significantly reduce the emissions of harmful substances.
  • the starch can also be used as a flocculant in ore and coal sludge processing.
  • Another area of application is as an additive to foundry additives.
  • Various casting processes require cores that are made from binder-mixed sands. Bentonite, which is mixed with modified starches, mostly swelling starches, is predominantly used today as a binder.
  • starch addition is to increase the flow resistance and to improve the binding strength.
  • source strengths have other production-related requirements, such as dispersibility in cold water, rehydration, good miscibility in sand and high water retention.
  • the starch can be used to improve the technical and optical quality.
  • the reasons for this are the improvement of the surface gloss, the improvement of the handle and the appearance, for this reason starch is sprinkled on the sticky rubberized surfaces of rubber materials before the cold vulcanization, and the improvement of the printability of the rubber.
  • Another way of selling the modified starches is in the production of leather substitutes.
  • starch secondary products in the processing process (starch is only a filler, there is no direct link between synthetic polymer and starch) or, alternatively, the integration of starch secondary products in the production of polymers (starch and polymer are one firm bond).
  • starch as a pure filler is not competitive compared to other substances such as talc. It is different if the specific starch properties come into play and this significantly changes the property profile of the end products.
  • An example of this is the use of starch products in the processing of thermoplastics, such as polyethylene.
  • the starch and the synthetic polymer are co-expressed in a 1: 1 ratio to form a 'master batch' combined, from which various products are made with granulated polyethylene using conventional processing techniques.
  • starch in polyurethane foams.
  • starch derivatives By adapting the starch derivatives and by optimizing the process, it is possible to control the reaction between synthetic polymers and the hydroxyl groups of the starches.
  • the result is polyurethane foils that get the following property profiles through the use of starch: a reduction in the coefficient of thermal expansion, a reduction in shrinkage behavior, an improvement in pressure / stress behavior, an increase in water vapor permeability without changing the water absorption, a reduction in flammability and tear density, no dripping of flammable parts, Halogen free and reduced aging.
  • Disadvantages that are currently still present are reduced compressive strength and reduced impact resistance.
  • Solid plastic products such as pots, plates and bowls can also be manufactured with a starch content of over 50%.
  • starch / polymer mixtures can be assessed favorably because they have a much higher biodegradability.
  • starch graft polymers Because of their extreme water-binding capacity, starch graft polymers have also become extremely important. These are Products with a backbone made of starch and a side grid of a synthetic monomer grafted on according to the principle of the radical chain mechanism.
  • the starch graft polymers available today are characterized by better binding and retention properties of up to 1000 g of water per g of starch with high viscosity.
  • the areas of application for these superabsorbents have expanded considerably in recent years and are in the hygiene sector with products such as diapers and pads as well as in the agricultural sector, for example in seed pilling.
  • Decisive for the use of the new, genetically modified starches are on the one hand the structure, water content, protein content, lipid content, fiber content, ash / phosphate content, amylose / amylopectin ratio, molar mass distribution, degree of branching, grain size and shape as well as crystallinity, and on the other hand also the properties flow into the following characteristics: flow and sorption behavior, gelatinization temperature, viscosity, viscosity stability in salt solutions, thickening performance, solubility, paste structure and transparency, heat, shear and acid stability, tendency to retrogradation, gel formation, freeze / thaw stability, complex formation, iodine binding, film formation, adhesive strength , Enzyme stability, digestibility and reactivity.
  • modified starches by means of genetic engineering methods can, on the one hand, change the properties of the starch obtained from the plant in such a way that further modifications by means of chemical or physical methods no longer appear necessary.
  • the starches modified by genetic engineering processes can be subjected to further chemical modifications, which leads to further improvements in quality for certain of the fields of application described above.
  • These chemical modifications are generally known. In particular, these are modifications by heat treatment, treatment with organic or inorganic acids, oxidation and esterifications, which, for example, lead to the formation of phosphate, nitrate, sulfate, xanthate, acetate and Lead citrate starches.
  • monohydric or polyhydric alcohols can be used in the presence of strong acids to produce starch ethers, so that starch alkyl ether, O-allyl ether, hydroxyl alkyl ether, O-carboxylmethyl ether, N-containing starch ether, P-containing starch ether), S-containing starch ether, cross-linked starches or starch graft polymers result.
  • a preferred use of the starches according to the invention is in the production of packaging material and disposable articles on the one hand and as food or intermediate food product on the other hand.
  • nucleic acid molecules according to the invention are linked to regulatory DNA elements which ensure transcription in plant cells. These include in particular promoters, enhancers and terminators. In general, any promoter active in plant cells can be used for the expression.
  • the promoter can be selected so that the expression is constitutive or only in a certain tissue, at a certain time in plant development or at a time determined by external influences.
  • the promoter can be homologous or heterologous to the plant. Suitable promoters are, for example, the 35S RNA promoter of the Cauliflower Mosaic Virus and the ubiquitin promoter from maize for constitutive expression, the patatin promoter B33 (Rocha-Sosa et al., EMBO J. 8 (1 989), 23-29 ) for a tuber-specific expression or a promoter which ensures expression only in photosynthetically active tissues, for example the ST-LS1 promoter (Stockhaus et al., Proc. Natl. Acad.
  • the present invention provides nucleic acid molecules that encode a protein with the function of a soluble starch synthase from wheat.
  • the nucleic acid molecules according to the invention allow the production of this enzyme, its functional identification within the starch biosynthesis, the production of genetically modified plants in which the activity of this enzyme is changed and thus enables the synthesis of a starch with a modified structure and changed physicochemical properties in such modified plants .
  • nucleic acid molecules according to the invention can also be used to produce plants in which the activity of the starch synthase according to the invention is increased or decreased and at the same time the activities of other enzymes involved in starch synthesis are changed.
  • the change in the activities of a starch synthase in plants leads to the synthesis of a starch with a different structure.
  • nucleic acid molecules which encode a starch synthase or corresponding antisense constructs can be introduced into plant cells in which the synthesis of endogenous GBSS I, SSS or GBSS II proteins is already inhibited due to an antisense effect or a mutation or the synthesis of the Branching enzyme is inhibited (such as in WO 92/14827 or Shannon and Garwood, 1,984, in Whistler, BeMiller and Paschall, Starch: Chemistry and Technology, Academic Press, London, 2nd Edition: 25-86).
  • DNA molecules can be used for the transformation which simultaneously contain several regions coding for the corresponding enzymes in antisense orientation under the control of a suitable promoter.
  • each sequence can be under the control of its own promoter, or the sequences can be transcribed as a fusion from a common promoter or under the control of a common promoter. The latter alternative will generally be preferable since in this case the synthesis of the corresponding proteins should be inhibited to approximately the same extent.
  • the resulting transcript should preferably not exceed a length of 10 kb and in particular a length of 5 kb.
  • Coding regions which are located in such DNA molecules in combination with other coding regions in antisense orientation behind a suitable promoter, can originate from DNA sequences which code for the following proteins: starch-bound (GBSS I and II) and soluble Starch synthases (SSS I and II), branching enzymes (isoamylases, pullulanases, R enzymes, "branching” enzymes, “debranching” enzymes), starch phosphorylases and disproportionation enzymes.
  • GBSS I and II starch-bound
  • SSS I and II soluble Starch synthases
  • branching enzymes isoamylases, pullulanases, R enzymes, "branching” enzymes, "debranching” enzymes
  • starch phosphorylases starch phosphorylases and disproportionation enzymes.
  • constructs can be introduced into plant mutants which are defective for one or more genes of starch biosynthesis (Shannon and Garwood, 1,984, in Whistler, BeMiller and Paschall, Starch: Chemistry and Technology, Academic Press, London, 2nd Edition: 25 -86). These defects can relate to the following proteins: starch-bound (GBSS I and II) and soluble starch synthases (SSS I and II), branching enzymes (BE I and II), "debranching" enzymes (R-enzymes), disproportionation enzymes and starch phosphorylases . This is only an example.
  • a large number of cloning vectors are available to prepare the introduction of foreign genes into higher plants, which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells.
  • examples of such vectors are pBR322, pUC series, M 1 3mp series, pACYC1 84 etc.
  • the desired sequence can be introduced into the vector at a suitable restriction site.
  • the plasmid obtained is used for the transformation of E. coli cells.
  • Transformed E.coli cells are grown in a suitable medium, then harvested and lysed.
  • the plasmid is recovered. Restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are generally used as the analysis method for characterizing the plasmid DNA obtained.
  • the plasmid DNA can be cleaved and DNA fragments obtained can be linked to other DNA sequences.
  • Each plasmid DNA sequence can be cloned into the same or different plasmids.
  • a variety of techniques are available for introducing DNA into a plant host cell. These techniques include transformation plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agents, the fusion of protoplasts, the injection, the electroporation of DNA, the introduction of DNA using the biolistic method and other possibilities.
  • plasmids When injecting and electroporation of DNA into plant cells, there are no special requirements for the plasmids used. Simple plasmids such as e.g. pUC derivatives can be used. However, if whole plants are to be regenerated from such transformed cells, the presence of a selectable marker gene is generally necessary.
  • the Ti or Ri plasmid is used for the transformation of the plant cell, at least the right boundary, but frequently the right and left boundary of the Ti and Ri plasmid T-DNA as the flank region, must be linked to the genes to be introduced.
  • the DNA to be introduced must be cloned into special plasmids, either in an intermediate vector or in a binary vector.
  • the intermediate vectors can be integrated into the Ti or Ri plasmid of the agrobacteria on the basis of sequences which are homologous to sequences in the T-DNA by homologous recombination. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria. Using a helper plasmid, the intermediate vector can be transferred to Agrobacterium tumefaciens (conjugation). Binary vectors can replicate in both E. coli and agrobacteria.
  • the agrobacterium serving as the host cell is said to contain a plasmid which carries a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present.
  • the agrobacterium transformed in this way can be used to transform plant cells.
  • T-DNA for the transformation of plant cells has been intensively investigated and is sufficient in EP 1 20 51 6; Hoekema, In: The Binary Plant Vector System Offsetdrukkerij Kanters B.V., Alblasserdam (1 985), Chapter V; Fraley et al., Crit. Rev. Plant. Sci., 4, 1-46 and An et al. EMBO J. 4 (1 985), 277-287.
  • plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes.
  • the infected plant material e.g. leaf pieces, stem segments, roots, but also protoplasts or suspension-cultivated plant cells
  • a suitable medium which, among other things. certain sugars, amino acids, antibiotics or biocides for the selection of transformed cells can contain, whole plants can be regenerated again.
  • the plants thus obtained can then be examined for the presence of the introduced DNA.
  • Other possibilities of introducing foreign DNA using the biolistic method or by protoplast transformation are known (cf. for example Willmitzer, L., 1 993 Transgenic plants.
  • the first transgenic, fertile wheat plant which after bombardment with microprojectile bound DNA could be regenerated by Vasil et al. (Bio / Technology 10 (1,992), 667-674).
  • the target tissue for the bombardment was an embryogenic callus culture (type C callus).
  • the bar gene which encodes a phosphinothricin acetyltransferase and thus imparts resistance to the herbicide phosphinothricin was used as the selection marker.
  • Weeks et al. Plant Physiol. 102 (1,993), 1077-1084
  • Becker et al. Plant J. 5 (2) (1 994), 299-307.
  • the target tissue for DNA transformation here is the scutellum of immature embryos, which was stimulated in an introductory in vitro phase to induce somatic embryos.
  • the efficiency of the transformation lies with that of Becker et al. (loc cit.) developed system with 1 transgenic plant per 83 embryos of the "Florida" variety significantly higher than that of Weeks et al. established system with 1 to 2 transgenic plants per 1000 "Bohwhite” embryos.
  • the introduced DNA is integrated in the genome of the plant cell, it is generally stable there and is also retained in the progeny of the originally transformed cell. It normally contains one of the selection markers mentioned above, which e.g. Resistance to a biocide such as phosphinothricin or an antibiotic such as Kanamycin, G 41 8, bleomycin or hygromycin mediated or the selection of the presence or absence of certain sugars or amino acids allowed.
  • the individually selected marker should therefore allow the selection of transformed cells over cells that lack the inserted DNA.
  • the transformed cells grow within the plant in the usual way (see also McCormick et al., Plant Cell Reports 5 (1 986), 81-84).
  • the resulting plants can be grown normally and with plants that have the same transformed genetic makeup or other genetic makeup, are crossed.
  • the resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plant cells.
  • Two or more generations should be grown to ensure that the phenotypic trait is stably maintained and inherited. Seeds should also be harvested to ensure that the appropriate phenotype or other characteristics have been preserved.
  • the vector pBluescript II SK (Stratagene) was used for cloning in E. coli.
  • the E. coli strain DH5 ⁇ (Bethesda Research Laboratories, Gaithersburg, USA) was used for the Bluescript vector and for the antisense constructs.
  • the E. coli strain XL1-Blue was used for the in vivo excision.
  • the specified media were adjusted to pH 5.6 with KOH and solidified with 0.3% Gelrite.
  • ears with caryopses of developmental level 1 are harvested 2 to 14 days after anthesis and surface sterilized.
  • the isolated scutella are plated with the embryo axis facing the medium on induction medium # 30.
  • the target DNA is added to the precipitation mixture in a ratio of 1: 1, consisting of the target gene and a resistance marker gene (bar gene).
  • DNA fragments that were used as screening probes were labeled using a specific PCR with the incorporation of DIG-labeled dUTP (Boehringer Mannheim, Germany).
  • the plasmid pTaSSI 8/1 was deposited at the DSMZ in Braunschweig, Federal Republic of Germany in accordance with the Budapest Treaty under number DSM 1 2794.
  • Example 1 Identification, isolation and characterization of a cDNA encoding a soluble starch synthase (SS I) from wheat (Triticum aestivum L., cv. Florida)
  • SS I soluble Starch synthase
  • the wheat cDNA bank was synthesized from poly (A) + RNA from approx. 20 day old caryopses (endosperm) in a Lambda Zap II vector analogous to the manufacturer's instructions (Lambda ZAP 11-cDNA Synthesis Kit, Stratagene GmbH, Heidelberg, Germany ). After determining the titer of the cDNA bank, a primary titer of 1.26 ⁇ 10 6 pfu / ml could be determined.
  • poly (A) + RNA of approximately 20 days old caryopses was transcribed into single-stranded cDNA and used in a tailing reaction.
  • the resulting cDNA provided in the 5 'region with the oligo (dA) anchor # 9 (kit) was amplified in a first reaction with the primers oligo (dT) # 8 (kit) and B2F5 according to a modified protocol as follows: 5 ⁇ l of thawed cDNA, 5 ⁇ l of 10 ⁇ reaction buffer (Life Technologies), 0.25 ⁇ M B2F5 primer, 0.75 ⁇ M oligo (dT) # 8, 0.2 mM dNTP's and 5U Taq polymerase (recombinant , Life Technologies).
  • the PCR profile was: 94 ° C 3794 ° C 45 "/ 56 ° C 1 772 ° C 1 '30", 29 cycles / 72 ° C 5'. This was followed by a further PCR with the primers Oligo (dT) # 8 (kit),
  • B2F5 primer 0.25 ⁇ M B2F6 primer, 0.75 ⁇ M oligo (dT) # 8, 0.2mM dNTP's and
  • 5U Taq polymerase (recombinant, Life Technologies) used.
  • the PCR profile was:
  • B2F5 5'CCTCCCAATTCAAGGATTAGTG 3 '(Seq ID No. 3)
  • B2F6 5'CCTCGCATGCAGCATAGCAA 3 '(Seq. ID No. 4)
  • PCR products obtained by the above methods were separated in an agarose gel and the DNA fragments with a size greater than 800 bp were isolated.
  • the PCR fragments were cloned using the pCR-Script SK (+) cloning kit from Stratagene (Heidelberg). Sequence analysis of the cloned subfragments identified approximately 1 50 bp previously unknown sequence of the SS I clone.
  • the oligonucleotides B2R00 and B2F6.2 were selected for the amplification of a DNA fragment (SS I probe), which was then labeled with digoxygenin-1 1 -UTP as described and as a probe for screening the wheat cDNA bank was used.
  • the SS I probe was labeled by means of a PCR reaction with the primers B2R00 and B2F6.2 analogously to the information in "The DIG System Users Guide for Filter Hybridization" (Boehringer Mannheim).
  • the clone TaSSI 8/1 was further analyzed.
  • the plasmid DNA was isolated from the clone TaSSI 8/1 and the sequence of the cDNA insertions was determined using the dideoxynucleotide method (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1 977), 5463-5467).
  • the insertion of the clone TaSSI 8/1 is 2805 bp long and represents a complete cDNA.
  • the nucleotide sequence is shown under Seq ID No. 1 specified.
  • the corresponding amino acid sequence can be found under Seq ID No. 2 specified.
  • a comparison with previously published sequences showed that the under Seq ID No. 1 sequence is new and includes a complete coding region.
  • Example 3 Preparation of the plant transformation vector pTa-gamma-SSI-8/1
  • the expression of the cDNA isolated under Example 1 was based on constructed from pUC1 9 as the base plasmid the plant transformation vector pTa-gamma-SSI-8/1.
  • the cDNA insertion of the plasmid TaSSI 8/1 is connected completely in sense orientation to the 3 'end of the ubiquitin promoter.
  • This promoter consists of the first untranslated exon and the first intron of the ubiquitinl gene from maize (Christensen AH et al., Plant Molecular Biology 1 8 (1 992), 675-689).
  • Parts of the polylinker and the NOS terminator originate from the plasmid pACT1 .cas (CAMBIA, TG 0063; Cambia, GPO Box 3200, Canberra ACT 2601, Australia). Vector constructs with this terminator and constructions based on pActl .cas are described in MCElroy et al. (Molecular Breeding 1 (1 995), 27-37). The resulting vector was called pUbi.cas.
  • the expression vector was cloned by restricting a fragment from the clone TaSSI 8/1 with the restriction enzymes Xba I and Ssp. I. The fragment was filled in at the ends using a Klenow reaction and then ligated into the Sma I cloning site of the expression vector pUbi.cas. The resulting expression vector was called pTA-gamma-SSI 8/1.
  • the 5'-untranslated leader of the clone TaSSI-8/1 was first removed by treatment with exonnuclease. The cloning into the expression vector pUbi.cas was then carried out. This construct was called Ta-gamma-SSI-8/1 -2.
  • microorganism referred to under I has been received by this international depository on (date of first deposit) and an application for conversion of this first deposit into a deposit under the Budapest Treaty has been received on (date of receipt of the application for conversion)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to nucleic acid molecules which code for enzymes and which are involved in the synthesis of starch in plants. These enzymes concern soluble starch synthases derived from wheat. The invention also relates to vectors and host cells which contain the described nucleic acid molecules, especially transformed plant cells and plants which can be regenerated therefrom, which exhibit an increased or reduced activity of the inventive starch synthases.

Description

Nucleinsäuremoleküle codierend Enzyme aus Weizen, die an der Stärkesynthese beteiligt sindNucleic acid molecules encoding wheat enzymes that are involved in starch synthesis
Die vorliegende Erfindung betrifft Nucleinsäuremoleküle, die ein Enzym aus Weizen codieren, das an der Stärkesynthese in Pflanzen beteiligt ist. Bei diesem Enzym handelt es sich um eine lösliche Stärkesynthase vom Typ I.The present invention relates to nucleic acid molecules that encode a wheat enzyme that is involved in starch synthesis in plants. This enzyme is a soluble type I starch synthase.
Weiterhin betrifft die Erfindung Vektoren, Wirtszellen, sowie Pflanzenzellen und Pflanzen, die die erfindungsgemäßen Nucleinsäuremolekülen enthalten.The invention further relates to vectors, host cells, as well as plant cells and plants, which contain the nucleic acid molecules according to the invention.
Ferner werden Verfahren zur Herstellung transgener Pflanzen beschrieben, die aufgrund der Einführung von erfindungsgemäßen Nucleinsäuremolekülen eine in ihren Eigenschaften veränderte Stärke synthetisieren.Furthermore, processes for the production of transgenic plants are described which synthesize a starch whose properties have been modified due to the introduction of nucleic acid molecules according to the invention.
Im Hinblick auf die zunehmende Bedeutung, die pflanzlichen Inhaltsstoffen als erneuerbaren Rohstoffquellen in letzter Zeit beigemessen wird, ist es eine der Aufgaben der biotechnologischen Forschung, sich um eine Anpassung dieser pflanzlichen Rohstoffe an die Anforderungen der verarbeitenden Industrie zu bemühen. Um eine Anwendung von nachwachsenden Rohstoffen in möglichst vielen Einsatzgebieten zu ermöglichen, ist es darüber hinaus erforderlich, eine große St off Vielfalt zu erreichen.In view of the increasing importance that vegetable ingredients have recently been given as renewable raw material sources, one of the tasks of biotechnological research is to try to adapt these vegetable raw materials to the requirements of the manufacturing industry. In order to enable the use of renewable raw materials in as many areas as possible, it is also necessary to achieve a wide variety of st offs.
Neben Ölen, Fetten und Proteinen stellen Polysaccharide die wesentlichen nachwachsenden Rohstoffe aus Pflanzen dar. Eine zentrale Stellung bei den Polysacchariden nimmt neben Cellulose die Stärke ein, die einer der wichtigsten Speicherstoffe in höheren Pflanzen ist. Hierbei ist Weizen eine der wichtigsten Kulturpflanzen, da ca. 20 % der Gesamtstärkeproduktion der Europäischen Gemeinschaft aus ihr gewonnen werden.In addition to oils, fats and proteins, polysaccharides are the most important renewable raw materials from plants. A central position among polysaccharides, along with cellulose, is starch, which is one of the most important storage substances in higher plants. Wheat is one of the most important crops, as it produces about 20% of the total starch production in the European Community.
Das Polysaccharid Stärke ist ein Polymer aus chemisch einheitlichen Grundbausteinen, den Glucosemolekülen. Es handelt sich dabei jedoch um ein sehr komplexes Gemisch aus unterschiedlichen Molekülformen, die sich hinsichtlich ihres Polymerisationsgrades des Auftretens von Verzweigungen der Glucoseketten und deren Kettenlängen unterscheiden, die darüber hinaus derivatisiert, z.B. phosphoryliert sein können. Daher stellt Stärke keinen einheitlichen Rohstoff dar. Man unterscheidet insbesondere die Amylose-Stärke, ein im wesentlichen unverzweigtes Polymer aus -1 ,4-glycosidisch verknüpften Glucosemolekülen, von der Amylopektin-Stärke, die ihrerseits ein komplexes Gemisch aus unterschiedlich verzweigten Glucoseketten darstellt. Die Verzweigungen kommen dabei durch das Auftreten von zusätzlichen -1 ,6- glycosidischen Verknüpfungen zustande. In Weizen besteht die synthetisierte Stärke zu ca. 1 1 bis 37 % aus Amylose-Stärke.The polysaccharide starch is a polymer made up of chemically uniform building blocks, the glucose molecules. However, it is a very complex mixture of different molecular forms, which differ in the degree of polymerization of the occurrence of branches of the glucose chains and their chain lengths, which can also be derivatized, for example phosphorylated. Starch is therefore not a uniform raw material. A distinction is made in particular between amylose starch, an essentially unbranched polymer composed of 1,4-glycosidically linked glucose molecules, and amylopectin starch, which in turn is a complex mixture of differently branched glucose chains. The branches come about through the occurrence of additional -1, 6-glycosidic linkages. In wheat, about 1 1 to 37% of the synthesized starch consists of amylose starch.
Um eine möglichst vielfältige Anwendung von geeigneten Stärken für unterschiedlichste industrielle Bedürfnisse zu ermöglichen, ist es wünschenswert, Pflanzen zur Verfügung zu stellen, die in der Lage sind, modifizierte Stärken zu synthetisieren, die für verschiedene Verwendungszwecke besonders gut geeignet sind. Eine Möglichkeit, derartige Pflanzen bereitzustellen, besteht in züchterischen Maßnahmen. Die züchterischen Einflußnahme erweist sich beim Weizen aufgrund seines polyploiden Charakters (tetra- und hexaploid) jedoch sehr schwer. Erst kürzlich gelang durch Kreuzung natürlich auftretender Mutanten die Herstellung eines "waxy" (Amylose-freien) Weizens (Nakamura et al., Mol. Gen. Genet. 248 (1 995), 253-259).In order to enable the most varied possible use of suitable starches for a wide variety of industrial needs, it is desirable to provide plants which are able to synthesize modified starches which are particularly well suited for various uses. One way to provide such plants is through breeding measures. However, it is very difficult to influence breeding in wheat due to its polyploid character (tetra- and hexaploid). Only recently by crossing naturally occurring mutants has it been possible to produce a "waxy" (amylose-free) wheat (Nakamura et al., Mol. Gen. Genet. 248 (1 995), 253-259).
Eine Alternative zu züchterischen Verfahren besteht in der gezielten Modifikation stärkeproduzierender Pflanzen durch gentechnologische Methoden. Voraussetzung hierfür ist jedoch die Identifizierung und Charakterisierung der an der Stärkesynthese und/oder Stärkemodifikation beteiligten Enzyme sowie die Isolierung der diese Enzyme codierenden Nucleinsäuremoleküle.An alternative to breeding methods is the targeted modification of starch-producing plants using genetic engineering methods. The prerequisite for this, however, is the identification and characterization of the enzymes involved in starch synthesis and / or starch modification, and the isolation of the nucleic acid molecules encoding these enzymes.
Die biochemischen Synthesewege, die zum Aufbau von Stärke führen, sind im wesentlichen bekannt. Die Stärkesynthese in pflanzlichen Zellen findet in den Piastiden statt. In photosynthetisch aktiven Geweben sind dies die Chloroplasten, in photosynthetisch inaktiven, stärkespeichernden Geweben die Amyloplasten.The biochemical synthetic pathways that lead to the building of starch are in the essentially known. The starch synthesis in plant cells takes place in the plastids. In photosynthetically active tissues, these are the chloroplasts, in photosynthetically inactive, starch-storing tissues, the amyloplasts.
Wichtige an der Stärkesynthase beteiligte Enzyme sind die Starkesynthasen sowie die Verzweigungsenzyme. Bei den Stärkesynthase sind verschiedene Isoformen beschrieben, die alle eine Polymerisierungsreaktion durch Übertragung eines Glucosylrestes von ADP-Glucose auf α-1 ,4-Glucane katalysieren. Verzweigungsenzyme katalysieren die Einführung von α-2,6-Verzweigungen in lineare α-1 ,4-Glucane.Important enzymes involved in starch synthase are starch synthases and branching enzymes. Various isoforms are described for starch synthase, all of which catalyze a polymerization reaction by transferring a glucosyl residue from ADP-glucose to α-1,4-glucans. Branching enzymes catalyze the introduction of α-2,6 branches into linear α-1,4-glucans.
Starkesynthasen können in zwei Klassen eingeteilt werden: die Stärkekorn- gebundenen Starkesynthasen ("granule-bound starch synthases"; GBSS) und die löslichen Starkesynthasen ("soluble starch synthases"; SSS). Diese Unterscheidung ist nicht in jedem Fall eindeutig zu treffen, da einige der Starkesynthasen sowohl stärkekorngebunden als auch in löslicher Form vorliegen (Denyer et al., Plant J. 4 (1 993), 1 91 -1 98; Mu et al., Plant J. 6 (1 994), 1 51 - 1 59). Für verschiedene Pflanzenspezies werden innerhalb dieser Klassen wiederum verschiedene Isoformen beschrieben, die sich hinsichtlich ihrer Abhängigkeit von Startermolekülen unterscheiden (sogenannte "primer dependent" (Typ II) und "primer independent" (Typ I) starch synthases).Starch synthases can be divided into two classes: starch-bound starch synthases ("granule-bound starch synthases"; GBSS) and soluble starch synthases ("soluble starch synthases"; SSS). This distinction cannot be clearly made in every case, since some of the starch synthases are both bound to starch and in soluble form (Denyer et al., Plant J. 4 (1 993), 1 91-1 98; Mu et al., Plant J. 6 (1,994), 1 51-1 59). For different plant species, different isoforms are described within these classes, which differ in terms of their dependence on starter molecules (so-called "primer dependent" (type II) and "primer independent" (type I) starch synthases).
Lediglich für die Isoform GBSS I gelang es bisher, die genaue Funktion bei der Stärkesynthese zu ermitteln, in denen diese Enzymaktivität stark oder vollkommen reduziert ist, synthetisieren eine amylosefreie (sogenannte "waxy") Stärke (Shure et al., Cell 35 (1 983), 225-233; Visser et al., Mol. Gen- Genet. 225 (1 991 ), 289-296; WO 92/1 1 376), so daß diesem Enzym eine entscheidende Rolle bei der Synthese der Amylose-Stärke zugesprochen wird. Dieses Phänomen wird ebenfalls in Zellen der Grünalge Chlamydomonas reinhardtii beobachtet (Delrue et al., J. Bacteriol. 1 74 (1 992), 361 2-3620). Bei Chlamydomonas konnte darüber hinaus gezeigt werden, daß GBSS I nicht nur an der Synthese der Amylose beteiligt ist, sondern auch einen Einfluß auf die Amylopektinsynthese besitzt. In Mutanten, die keine GBSS I-Aktivität aufweisen, fehlt eine bestimmte Fraktion des normalerweise snythetisieren Amylopektins, die längerkettige Glucane aufweist.Only the isoform GBSS I has so far been able to determine the exact function in starch synthesis, in which this enzyme activity is greatly or completely reduced, and synthesize an amylose-free (so-called "waxy") starch (Shure et al., Cell 35 (1,983 ), 225-233; Visser et al., Mol. Gen-Genet. 225 (1 991), 289-296; WO 92/1 1 376), so that this enzyme has been assigned a decisive role in the synthesis of the amylose starch becomes. This phenomenon is also observed in cells of the green algae Chlamydomonas reinhardtii (Delrue et al., J. Bacteriol. 1 74 (1 992), 361 2-3620). at Chlamydomonas could also be shown that GBSS I is not only involved in the synthesis of amylose, but also has an influence on amylopectin synthesis. Mutants lacking GBSS I activity lack a certain fraction of the normally snythetic amylopectin that has longer chain glucans.
Die Funktionen der anderen Isoformen der Stärkekorn-gebundenen Starkesynthasen, insbesondere der GBSS II, und der löslichen Starkesynthasen sind bisher unklar. Es wird angenommen, daß die löslichen Starkesynthasen zusammen mit Verzweigungsenzymen an der Synthese des Amylopektins beteiligt sind (siehe z.B. Ponstein et al., Plant Physiol. 29 (1 990), 234-241 ) und daß sie eine wichtige Funktion bei der Regulation der Stärkesyntheserate spielen.The functions of the other isoforms of the starch-bound starch synthases, in particular GBSS II, and the soluble starch synthases have so far been unclear. It is believed that the soluble starch synthases, along with branching enzymes, are involved in the synthesis of the amylopectin (see, for example, Ponstein et al., Plant Physiol. 29 (1 990), 234-241) and that they have an important function in regulating the starch synthesis rate play.
Bei Weizen wurden mindestens zwei Isoformen der Stärkekorn-gebundenen Stärkesynthase (60 kDA und 100 - 105 kDA) und eine weitere Isoform, die möglicherweise eine lösliche Stärkesynthase (Denyer et al., Planta 1 96 (1 995), 256-265; Rahman et al., Aust. J. Plant Physiol. 22 (1 995), 793 - 803) repräsentiert, auf der Proteinebene identifiziert. Das Vorhandensein mehrerer SSS-lsoformen wurde schon früher mit Hilfe chromatographischer Methoden nachgewiesen (Rijven, Plant Physiol. 81 (1 986), 448 - 453) . Eine GBSS I aus Weizen codierende cDNA ist bereits beschrieben (Ainsworth et al., Plant Mol. Biol. 22 (1 993), 67 bis 82).In wheat, at least two isoforms of the starch-bound starch synthase (60 kDA and 100-105 kDA) and another isoform, which may be a soluble starch synthase (Denyer et al., Planta 1 96 (1 995), 256-265; Rahman et al., Aust. J. Plant Physiol. 22 (1 995), 793-803), was identified at the protein level. The presence of several SSS isoforms has previously been demonstrated using chromatographic methods (Rijven, Plant Physiol. 81 (1 986), 448-453). A cDNA encoding GBSS I from wheat has already been described (Ainsworth et al., Plant Mol. Biol. 22 (1 993), 67 to 82).
Nucleinsäuresequenzen, die Stärkesynthase-Isoformen aus Weizen codieren bzw. Teilsequenzen solcher Nucleinsäuren sind bisher aus der WO 97/45545 bekannt.Nucleic acid sequences which encode starch synthase isoforms from wheat or partial sequences of such nucleic acids have hitherto been known from WO 97/45545.
cDNA-Sequenzen, die für andere Starkesynthasen als für die GBSS I codieren, wurden bisher lediglich für Erbse (Dry et al., Plant J. 2 (1 992), 1 93 - 202), Reis (Baba et al., Plant Physiol. 103 (1 993), 565 bis 573) und Kartoffel (Edwards et al., Plant J. 8 (1 995), 283 bis 294) beschrieben. Außer beim Weizen wurden lösliche Starkesynthasen auch in einer Reihe weiterer Pflanzenarten identifiziert. Lösliche Starkesynthasen sind beispielsweise bis zur Homogenität aus Erbse (Denyer und Smith, Planta 1 86 (1 992), 609 bis 61 7) und Kartoffel (Edwards et al., Plant J. 8 (1 995), 283 bis 294) isoliert worden.cDNA sequences coding for starch synthases other than GBSS I have so far only been used for pea (Dry et al., Plant J. 2 (1 992), 1 93-202), rice (Baba et al., Plant Physiol 103 (1 993), 565 to 573) and potato (Edwards et al., Plant J. 8 (1 995), 283 to 294). In addition to wheat, soluble starch synthases have also been identified in a number of other plant species. Soluble starch synthases have been isolated, for example, to homogeneity from pea (Denyer and Smith, Planta 1 86 (1 992), 609 to 61 7) and potato (Edwards et al., Plant J. 8 (1 995), 283 to 294) .
In diesen Fällen stellte sich heraus, daß die als SSS III identifizierte Isoform der löslichen Stärkesynthase identisch ist mit der Stärkekorn-gebundenen Stärkesynthase GBSS II (Denyer et al., Plant J. 4 (1 993), 1 91 bis 1 98; Edwards et al., Plant J. 8 (1 995), 283 bis 294). Für einige weitere Pflanzenspezies wurde das Vorhandensein mehrerer SSS-lsoformen mit Hilfe chromatographischer Methoden beschrieben, beispielswiese bei Gerste (Tyynelä und Schulman, Physiologica Plantarum 89 (1 993) 835-841 ; Kreis, Planta 148 (1 980), 41 2 bis 41 6). DNA-Sequenzen, die diese Proteine codieren, wurden jedoch bisher nicht beschrieben.In these cases, it was found that the isoform of the soluble starch synthase identified as SSS III is identical to the starch-bound starch synthase GBSS II (Denyer et al., Plant J. 4 (1 993), 1 91 to 1 98; Edwards et al., Plant J. 8 (1,995), 283-294). For several other plant species, the presence of several SSS isoforms has been described using chromatographic methods, for example in the case of barley (Tyynelä and Schulman, Physiologica Plantarum 89 (1 993) 835-841; Kreis, Planta 148 (1 980), 41 2 to 41 6 ). However, DNA sequences encoding these proteins have not been described.
Um weitere Möglichkeiten bereitzustellen, beliebige stärke-speichemde Pflanzen, vorzugsweise Getreide, insbesondere Weizen, dahingehend zu verändern, daß sie eine modifizierte Stärke synthesieren, ist es erforderlich, jeweils DNA- Sequenzen zu identifizieren, die weitere Isoformen der Starkesynthasen codieren.In order to provide further possibilities for modifying any starch-storing plants, preferably cereals, in particular wheat, in such a way that they synthesize a modified starch, it is necessary in each case to identify DNA sequences which code further isoforms of the starch synthases.
Der vorliegenden Erfindung liegt somit die Aufgabe zugrunde, Nucleinsäuremoleküle, insbesondere solche aus Weizen, zur Verfügung zu stellen, die an der Stärkebiosynthese beteiligte Enzyme codieren und mit deren Hilfe es möglich ist, gentechnisch modifizierte Pflanzen herzustellen, die die Herstellung von in ihren chemischen und/oder physikalischen Eigenschaften veränderten pflanzlichen Stärken ermöglichen.The present invention is therefore based on the object of making available nucleic acid molecules, in particular those from wheat, which encode enzymes involved in starch biosynthesis and with the aid of which it is possible to produce genetically modified plants which are suitable for the production of chemical and / or or physical properties of modified vegetable starches.
Diese Aufgabe wird durch die Bereitstellung der in den Patentansprüchen bezeichneten Ausführungsformen gelöst.This task is accomplished by the provision of the claims designated embodiments solved.
Die vorliegende Erfindung betrifft daher Nucleinsäuremoleküle, die Proteine mit der Aktivität einer löslichen Stärkesynthase aus Weizen, wobei derartige Moleküle vorzugsweise Proteine codieren, die im wesentlichen die unter Seq ID No. 2 angegebene Aminosäuresequenz umfassen. Insbesondere betrifft die Erfindung Nucleinsäuremoleküle, die die unter Seq ID No. 1 angegebene Nucleotidsequenz oder einen Teil davon enthalten, bevorzugt Moleküle, die die in Seq ID No. 1 angegebene codierende Region umfassen, besonders bevorzugt Nucleotid Nr. 9 bis 570 von Seq ID Nr. 1 sowie entsprechende Ribo- nucleotidsequenzen .The present invention therefore relates to nucleic acid molecules which proteins with the activity of a soluble starch synthase from wheat, wherein such molecules preferably encode proteins which essentially have the Seq ID no. Include 2 given amino acid sequence. In particular, the invention relates to nucleic acid molecules which are listed under Seq ID No. 1 or a part thereof, preferably molecules which contain the nucleotide sequence specified in Seq ID No. 1 indicated coding region comprise, particularly preferably nucleotide No. 9 to 570 of Seq ID No. 1 as well as corresponding ribonucleotide sequences.
Ferner betrifft die vorliegende Erfindung Nucleinsäuremoleküle, die mit einem der erfindungsgemäßen Nukleinsäuremoleküle hybridisierten.The present invention further relates to nucleic acid molecules which hybridized with one of the nucleic acid molecules according to the invention.
Gegenstand der Erfindung sind ebenfalls Nucleinsäuremoleküle, die eine lösliche Stärkesynthase aus Weizen codieren und deren Sequenz aufgrund der Degeneration des genetischen Codes von den Nucleotidsequenzen der oben beschriebenen Moleküle abweicht.The invention also relates to nucleic acid molecules which encode a soluble starch synthase from wheat and whose sequence deviates from the nucleotide sequences of the molecules described above due to the degeneration of the genetic code.
Die Erfindung betrifft auch Nucleinsäuremoleküle, die eine Sequenz aufweisen, die zu der gesamten oder einem Teil einer der obengenannten Sequenzen komplementär ist.The invention also relates to nucleic acid molecules which have a sequence which is complementary to all or part of one of the abovementioned sequences.
Der Begriff "Hybridisierung" bedeutet im Rahmen dieser Erfindung eine Hybridisierung unter konventionellen Hybridisierungsbedingungen, vorzugsweise unter stringenten Bedingungen, wie sie beispielsweise in Sambrook et al., Molecular Cloning, A Laboratory Manual, 2. Aufl. (1 989) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) beschrieben sind. Besonders bevorzugt erfolgt eine "Hybridisierung" unter den folgendenIn the context of this invention, the term “hybridization” means hybridization under conventional hybridization conditions, preferably under stringent conditions, as described, for example, in Sambrook et al., Molecular Cloning, A Laboratory Manual, 2nd edition (1,989) Cold Spring Harbor Laboratory Press , Cold Spring Harbor, NY). Hybridization is particularly preferably carried out under the following
Bedingungen:Conditions:
Hybridisierungspuffer: 2 x SSC; 1 0 x Denhardt-Lösung (Fikoll 400 + PEG +Hybridization buffer: 2 x SSC; 1 0 x Denhardt's solution (Fikoll 400 + PEG +
BSA; Verhältnis 1 : 1 : 1 ); 0, 1 % SDS; 5 mM EDTA;BSA; Ratio 1: 1: 1); 0.1% SDS; 5mM EDTA;
50 mM Na2HPO4; 250 μg/ml Heringssperma-DNA;50 mM Na 2 HPO 4 ; 250 µg / ml herring sperm DNA;
50 μg/ml tRNA; oder50 µg / ml tRNA; or
0,25 M Natriumphosphatpuffer pH 7,2;0.25 M sodium phosphate buffer pH 7.2;
1 mM EDTA; 7% SDS Hybridisierungstemperatur T = 65 bis 70°C1mM EDTA; 7% SDS hybridization temperature T = 65 to 70 ° C
Waschpuffer: 0,2 x SSC; 0, 1 % SDSWash buffer: 0.2 x SSC; 0.1% SDS
Waschtemperatur T = 40 bis 75 °C.Washing temperature T = 40 to 75 ° C.
Nucleinsäuremoleküle, die mit den erfindungsgemäßen Nucleinsäuremolekülen hybridisieren, können prinzipiell Starkesynthasen aus jeder beliebigen Weizenpflanze codieren, die derartige Proteine exprimiert.In principle, nucleic acid molecules which hybridize with the nucleic acid molecules according to the invention can encode starch synthases from any wheat plant which expresses such proteins.
Nucleinsäuremoleküle, die mit den erfindungsgemäßen Molekülen hybridisieren, können z.B. aus genomischen oder aus cDNA-Bibliotheken von Weizen oder Weizenpflanzengewebe isoliert werden. Alternativ können sie durch gentechnische Methoden oder durch chemische Synthese hergestellt werden.Nucleic acid molecules that hybridize with the molecules of the invention can e.g. isolated from genomic or from cDNA libraries of wheat or wheat plant tissue. Alternatively, they can be produced by genetic engineering methods or by chemical synthesis.
Die Identifizierung und Isolierung derartiger Nucleinsäuremoleküle kann dabei unter Verwendung der erfindungsgemäßen Moleküle oder Teile dieser Moleküle bzw. der reversen Komplemente dieser Moleküle erfolgen, z.B. mittels Hybridisierung nach Standardverfahren (siehe z.B. Sambrook et al., 1 989, Molecular Cloning, A Laboratory Manual, 2. Aufl. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).Such nucleic acid molecules can be identified and isolated using the molecules according to the invention or parts of these molecules or the reverse complements of these molecules, e.g. by means of hybridization according to standard methods (see e.g. Sambrook et al., 1 989, Molecular Cloning, A Laboratory Manual, 2nd edition Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
Als Hybridisierungsprobe können z.B. Nucleinsäuremoleküle verwendet werden, die exakt die oder im wesentlichen die unter Seq ID No. 1 angegebene Nucleotidsequenz oder Teile dieser Sequenz aufweisen. Bei den als Hybridisierungsprobe verwendeten Fragmenten kann es sich auch um synthetische Fragmente handeln, die mit Hilfe der gängigen Synthesetechniken hergestellt wurden und deren Sequenz im wesentlichen mit der eines erfindungsgemäßen Nucleinsäuremoleküls übereinstimmt.For example, nucleic acid molecules can be used as the hybridization sample that exactly or essentially the ones under Seq ID No. 1 indicated nucleotide sequence or parts of this sequence. With the as The fragments used for the hybridization sample can also be synthetic fragments which were produced with the aid of the usual synthetic techniques and whose sequence essentially corresponds to that of a nucleic acid molecule according to the invention.
Die mit den erfindungsgemäßen Nucleinsäuremolekülen hybridisierenden Moleküle umfassen auch Fragmente, Derivate und allelische Varianten der oben beschriebenen Nucleinsäuremoleküle, die eine erfindungsgemäße Stärkesynthase aus Weizen codieren. Unter Fragmenten werden dabei Teile der Nucleinsäuremoleküle verstanden, die lang genug sind, um eines der beschriebenen Proteine zu codieren. Der Ausdruck Derivat bedeutet in diesem Zusammenhang, daß die Sequenzen dieser Moleküle sich von den Sequenzen der oben beschriebenen Nucleinsäuremoleküle an einer oder mehreren Positionen unterscheiden und einen hohen Grad an Homologie zu diesen Sequenzen aufweisen. Homologie bedeutet dabei eine Sequenzidentität von mindestens 40 %, insbesondere eine Identität von mindestens 60 %, vorzugsweise über 80 % und besonders bevorzugt über 90 % . Die Abweichungen zu den oben beschriebenen Nucleinsäuremolekülen können dabei durch Deletion, Substitution, Insertion oder Rekombination entstanden sein.The molecules hybridizing with the nucleic acid molecules according to the invention also include fragments, derivatives and allelic variants of the nucleic acid molecules described above, which encode a starch synthase according to the invention from wheat. Fragments are understood to mean parts of the nucleic acid molecules that are long enough to encode one of the proteins described. The term derivative in this context means that the sequences of these molecules differ from the sequences of the nucleic acid molecules described above at one or more positions and have a high degree of homology to these sequences. Homology means a sequence identity of at least 40%, in particular an identity of at least 60%, preferably over 80% and particularly preferably over 90%. The deviations from the nucleic acid molecules described above may have resulted from deletion, substitution, insertion or recombination.
Homologie bedeutet ferner, daß funktioneile und/oder strukturelle Äquivalenz zwischen den betreffenden Nucleinsäuremolekülen oder den durch sie codierten Proteinen, besteht. Bei den Nucleinsäuremolekülen, die homolog zu den oben beschriebenen Molekülen sind und Derivate dieser Moleküle darstellen, handelt es sich in der Regel um Variationen dieser Moleküle, die Modifikationen darstellen, die dieselbe biologische Funktion ausüben. Es kann sich dabei sowohl um natürlicherweise auftretende Variationen handeln, beispielsweise um Sequenzen aus anderen Organismen, oder um Mutationen, wobei diese Mutationen auf natürliche Weise aufgetreten sein können oder durch gezielte Mutagenese eingeführt wurden. Ferner kann es sich bei den Variationen um synthetisch hergestellte Sequenzen handeln. Bei den allelischen Varianten kann es sich sowohl um natürlich auftretende Varianten handeln, als auch um synthetisch hergestellte oder durch rekombinante DNA-Techniken erzeugte Varianten.Homology also means that there is functional and / or structural equivalence between the nucleic acid molecules in question or the proteins encoded by them. The nucleic acid molecules which are homologous to the molecules described above and which are derivatives of these molecules are usually variations of these molecules which are modifications which have the same biological function. These can be both naturally occurring variations, for example sequences from other organisms, or mutations, wherein these mutations can have occurred naturally or have been introduced by targeted mutagenesis. Furthermore, the variations can be act synthetically produced sequences. The allelic variants can be both naturally occurring variants and also synthetically produced variants or those produced by recombinant DNA techniques.
Die von den verschiedenen Varianten der erfindungsgemäßen Nucleinsäuremoleküle codierten Proteine weisen bestimmte gemeinsame Charakteristika auf. Dazu können z.B. Enzymaktivität, Molekulargewicht, immunologische Reaktivität, Konformation etc. gehören sowie physikalische Eigenschaften wie z.B. das Laufverhalten in Gelelektrophoresen, chromatographisches Verhalten, Sedimentationskoeffizienten, Löslichkeit, spektroskopische Eigenschaften, Ladungseigenschaften, Stabilität; pH-Optimum, Temperatur-Optimum etc.The proteins encoded by the different variants of the nucleic acid molecules according to the invention have certain common characteristics. For this, e.g. Enzyme activity, molecular weight, immunological reactivity, conformation etc. belong as well as physical properties such as the running behavior in gel electrophoresis, chromatographic behavior, sedimentation coefficient, solubility, spectroscopic properties, charge properties, stability; pH optimum, temperature optimum etc.
Wichtige Charakteristika einer Stärkesynthase sind: i) ihre Lokalisation im Stroma der Piastiden pflanzlicher Zellen; ii) ihre Fähigkeit zur Synthese linearer - 1 ,4-verknüpfter Polyglucane. Diese Aktivität kann wie in Denyer und Smith (Plante 1 86 (1 992), 606 bis 61 7) beschrieben bestimmt werden. Bei dem durch die erfindungsgemäßen Nucleinsäuremoleküle codierten Protein handelt es sich um eine lösliche Stärkesynthase vom Typ I aus Weizen. Diese Proteine weisen gewisse Homologiebereiche zu bisher bekannten löslichen Starkesynthasen aus anderen Pflanzenarten auf.Important characteristics of a starch synthase are: i) its localization in the stroma of plastids in plant cells; ii) their ability to synthesize linear - 1, 4-linked polyglucans. This activity can be determined as described in Denyer and Smith (Plante 1 86 (1 992), 606 to 61 7). The protein encoded by the nucleic acid molecules according to the invention is a soluble type I starch synthase from wheat. These proteins have certain areas of homology with previously known soluble starch synthases from other plant species.
Bei den erfindungsgemäßen Nucleinsäuremolekülen kann es sich um DNA- Moleküle handeln, insbesondere um cDNA- oder genomische Moleküle. Ferner können die erfindungsgemäßen Nucleinsäuremoleküle RNA-Moleküiesein, die z.B. durch Transkription eines erfindungsgemäßen Nucleinsäuremoleküls resultieren können. Die erfindungsgemäßen Nucleinsäuremoleküle können z. B. aus natürlichen Quellen gewonnen sein oder durch rekombinante Techniken oder synthetisch hergestellt sein. Gegenstand der Erfindung sind auch Oligonucleotide, die spezifisch mit einem erfindungsgemäßen Nucleinsäuremolekül hybridisieren. Derartige Oligonucleotide haben vorzugsweise eine Länge von mindestens 10, insbesondere von mindestens 1 5 und besonders bevorzugt von mindestens 50 Nucleotiden. Die erfindungsgemäßen Oligonukleotide sind dadurch gekennzeichnet, daß sie spezifisch mit erfindungsgemäßen Nucleinsäuremolekülen hybridisieren, d.h. nicht oder nur in sehr geringem Ausmaß mit Nucleinsäuresequenzen, die andere Proteine, insbesondere andere Starkesynthasen codieren. Die erfindungsgemäßen Oligonucleotide können beispielsweise als Primer für eine PCR-Reaktion verwendet werden oder als Hybridisierungsprobe für die Isolierung verwandter Gene. Ebenso können sie Bestandteile von antisense-Konstrukten sein oder von DNA-Molekülen, die für geeignete Ribozyme codieren.The nucleic acid molecules according to the invention can be DNA molecules, in particular cDNA or genomic molecules. Furthermore, the nucleic acid molecules according to the invention can be RNA molecules, which can result, for example, from transcription of a nucleic acid molecule according to the invention. The nucleic acid molecules according to the invention can, for. B. obtained from natural sources or produced by recombinant techniques or synthetically. The invention also relates to oligonucleotides which hybridize specifically with a nucleic acid molecule according to the invention. Such oligonucleotides preferably have a length of at least 10, in particular at least 15 and particularly preferably at least 50 nucleotides. The oligonucleotides according to the invention are characterized in that they hybridize specifically with nucleic acid molecules according to the invention, ie not or only to a very small extent with nucleic acid sequences which code for other proteins, in particular other starch synthases. The oligonucleotides according to the invention can be used, for example, as primers for a PCR reaction or as a hybridization sample for the isolation of related genes. They can also be components of antisense constructs or of DNA molecules which code for suitable ribozymes.
Ferner betrifft die Erfindung Vektoren, insbesondere Plasmide, Cosmide,Phagemide, Viren, Bacteriophagen und andere in der Gentechnik gängige Vektoren, die die oben beschriebenen erfindungsgemäßen Nucleinsäuremoleküle enthalten. Derartige Vektoren sind zur Transformation pro- oder eukaryontischer, vorzugsweise pflanzlicher Zellen geeignet.The invention further relates to vectors, in particular plasmids, cosmids, phagemids, viruses, bacteriophages and other vectors which are common in genetic engineering and which contain the nucleic acid molecules according to the invention described above. Such vectors are suitable for the transformation of pro- or eukaryotic, preferably plant cells.
Besonders bevorzugt erlauben die Vektoren die Integration der erfindungsgemäßen Nucleinsäuremoleküle, gegebenenfalls zusammen mit flankierenden regulatorischen Regionen, in das Genom der Pflanzenzelle. Beispiele hierfür sind binäre Vektoren, die bei dem Agrobakterien-vermittelten Gentransfer eingesetzt werden können. Vorzugsweise ist durch die Integration eines erfindungsgemäßen Nucleinsäuremoleküls in sense- oder anti-sense- Orientierung die Synthese einer translatierbaren oder gegebenenfalls nicht- translatierbaren RNA in den transformierten pro- oder eukaryontischen Zellen gewährleistet.The vectors particularly preferably allow the nucleic acid molecules according to the invention, optionally together with flanking regulatory regions, to be integrated into the genome of the plant cell. Examples of this are binary vectors which can be used in gene transfer mediated by agrobacteria. The integration of a nucleic acid molecule according to the invention in sense or anti-sense orientation preferably ensures the synthesis of a translatable or optionally non-translatable RNA in the transformed pro- or eukaryotic cells.
Der Begriff "Vektor" bezeichnet im allgemeinen ein geeignetes, dem Fachmann bekanntes Hilfsmittel, das den gezielten Transfer eines ein- oder doppelsträngigen Nukleinsäuremoleküls in eine Wirtszelle ermöglicht, beispielsweise einen DNA- oder RNA-Virus, ein Virusfragment, ein Plasmidkonstrukt, das in An- oder Abwesenheit von regulatorischen Elementen zum Nukleinsäure-Transfer in Zellen geeignet sein kann, Trägermaterialien wie Glasfaser oder auch Metallpartikel wie sie z.B. beim "particle gun "-Verfahren eingesetzt werden können, er kann aber auch ein Nukleinsäuremolekül umfassen, das durch chemische oder physikalische Verfahren direkt in eine Zelle gebracht werden kann.The term "vector" generally designates a suitable, the expert Known tool that enables the targeted transfer of a single- or double-stranded nucleic acid molecule into a host cell, for example a DNA or RNA virus, a virus fragment, a plasmid construct, which, in the presence or absence of regulatory elements, may be suitable for nucleic acid transfer in cells can, carrier materials such as glass fiber or metal particles such as can be used for example in the "particle gun" process, but it can also include a nucleic acid molecule that can be brought directly into a cell by chemical or physical methods.
In einer bevorzugten Ausführungsform sind die in den Vektoren enthaltenen Nucleinsäuremoleküle verknüpft mit regulatorischen Elementen, die die Transkription und Synthese einer translatierbaren RNA in pro- oder eukaryontischen Zellengewährleisten oder - sofern gewünscht - dieSynthese einer nicht-translatierbaren RNA gewährleisten.In a preferred embodiment, the nucleic acid molecules contained in the vectors are linked to regulatory elements which ensure the transcription and synthesis of a translatable RNA in pro- or eukaryotic cells or, if desired, the synthesis of a non-translatable RNA.
Die Expression der erfindungsgemäßen Nucleinsäuremoleküle in prokaryontischen Zellen, beispielsweise in Escherichia coli, ist für eine genauere Charakterisierung der enzymatischen Aktivitäten der Enzyme, für die diese Moleküle codieren, von Bedeutung. Es ist insbesondere möglich, das Produkt, das von den entsprechenden Enzymen in Abwesenheit anderer, in der pflanzlichen Zelle an der Stärkesynthese beteiligter Enzyme synthetisiert wird, zu charakterisieren. Dies läßt Rückschlüsse zu auf die Funktion, die das entsprechende Protein bei der Stärkesynthese in der Pflanzenzelle ausübt.The expression of the nucleic acid molecules according to the invention in prokaryotic cells, for example in Escherichia coli, is important for a more precise characterization of the enzymatic activities of the enzymes for which these molecules code. In particular, it is possible to characterize the product which is synthesized by the corresponding enzymes in the absence of other enzymes which are involved in the starch synthesis in the plant cell. This allows conclusions to be drawn about the function that the corresponding protein performs in the starch synthesis in the plant cell.
Darüber hinaus ist es möglich, mittels gängiger molekularbiologischer Techniken (siehe z.B. Sambrook et al., 1 989, Molecular Cloning, A Laboratory Manual, 2. Aufl. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) verschiedenartige Mutationen in die erfindungsgemäßen Nucleinsäuremoleküle einzuführen, wodurch es zur Synthese von Proteinen mit eventuell veränderten biologischen Eigenschaften kommt. Hierbei ist zum einen die Erzeugung von Deletionsmutanten möglich, bei denen durch fortschreitende Deletionen vom 5'- oder vom 3'-Ende der codierenden DNA-Sequenz Nucleinsäuremoleküle erzeugt werden, die zur Synthese entsprechend verkürzter Proteine führen. Durch derartige Deletionen am 5'-Ende der Nucleotidsequenz ist es beispielsweise möglich, Aminosäuresequenzen zu identifizieren, die für die Translokation des Enzyms in die Piastiden verantwortlich sind (Transitpeptide). Dies erlaubt es, gezielt Enzyme herzustellen, die durch Entfernen der entsprechenden Sequenzen nicht mehr in den Piastiden, sondern im Cytosol lokalisiert sind, oder aufgrund der Addition von anderen Signalsequenzen in anderen Kompartimenten lokalisiert sind.In addition, it is possible using conventional molecular biological techniques (see, for example, Sambrook et al., 1,989, Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) to make various mutations in the nucleic acid molecules according to the invention introduce, which leads to the synthesis of proteins with possibly changed biological properties. The first is the generation of Deletion mutants possible, in which progressive deletions from the 5 'or from the 3' end of the coding DNA sequence generate nucleic acid molecules which lead to the synthesis of correspondingly shortened proteins. Such deletions at the 5 'end of the nucleotide sequence make it possible, for example, to identify amino acid sequences which are responsible for the translocation of the enzyme into the plastids (transit peptides). This allows targeted production of enzymes that are no longer localized in the plastids but in the cytosol by removing the corresponding sequences, or are localized in other compartments due to the addition of other signal sequences.
Andererseits ist auch die Einführung von Punktmutationen denkbar an Positionen, bei denen eine Veränderung der Aminosäuresequenz einen Einfluß beispielweise auf die Enzymaktivität oder die Regulierung des Enzyms hat. Auf diese Weise können z.B. Mutanten hergestellt werden, die einen veränderten Km- Wert besitzen oder nicht mehr den normalerweise in der Zelle vorliegenden Regulationsmechanismen über allosterische Regulation oder kovalente Modifizierung unterliegen.On the other hand, the introduction of point mutations is also conceivable at positions in which a change in the amino acid sequence has an influence, for example on the enzyme activity or the regulation of the enzyme. In this way, for example, mutants can be produced which have a changed K m value or which are no longer subject to the regulatory mechanisms normally present in the cell via allosteric regulation or covalent modification.
Des weiteren können Mutanten hergestellt werden, die eine veränderte Substratoder Produktspezifität des erfindungsgemäßen Proteins aufweisen, indem sie beispielsweise ADP-Glucose-6-Phosphat anstelle von ADP-Glucose verwerten. Weiterhin können Mutanten hergestellt werden, die ein verändertes Aktivitäts- Temperatur-Profil des erfindungsgemäßen Proteins aufweisen.Furthermore, mutants can be produced which have a modified substrate or product specificity of the protein according to the invention, for example by using ADP-glucose-6-phosphate instead of ADP-glucose. Furthermore, mutants can be produced which have a changed activity-temperature profile of the protein according to the invention.
Für die gentechnische Modififikation prokaryontischer Zellen können die erfindungsgemäßen Nucleinsäuremoleküle oder Teile dieser Moleküle in Plasmide eingebracht werden, die eine Mutagenese oder eine Sequenzveränderung durch Rekombination von DNA-Sequenzen erlauben. Mit Hilfe von Standardverfahren (vgl. Sambrook et al., 1 989, Molecular Cloning: A laboratory manual, 2. Aufl., Cold Spring Harbor Laboratory Press, NY, USA) können Basenaustausche vorgenommen oder natürliche oder synthetische Sequenzen hinzugefügt werden. Für die Verbindung der DNA-Fragmente untereinander können an die Fragmente Adaptoren oder Linker angesetzt werden. Ferner können Manipulationen, die passende Restriktionsschnittstellen zur Verfügung stellen oder die überflüssige DNA oder Restriktionsschnittstellen entfernen, eingesetzt werden. Wo Insertionen, Deletionen oder Substitutionen in Frage kommen, können in vitro- Mutagenese, "primer repair", Restriktion oder Ligation verwendet werden. Als Analysemethode werden im allgemeinen Sequenzanalyse, Restriktionsanalyse oder weitere biochemisch-molekularbiologische Methoden durchgeführt.For the genetic modification of prokaryotic cells, the nucleic acid molecules according to the invention or parts of these molecules can be introduced into plasmids which permit mutagenesis or a sequence change by recombination of DNA sequences. With the help of standard methods (cf. Sambrook et al., 1 989, Molecular Cloning: A laboratory manual, 2nd ed., Cold Spring Harbor Laboratory Press, NY, USA), base changes can be made or natural or synthetic sequences added. To connect the DNA fragments to one another, adapters or linkers can be attached to the fragments. Manipulations which provide suitable restriction sites or which remove superfluous DNA or restriction sites can also be used. Where insertions, deletions or substitutions are possible, in vitro mutagenesis, "primer repair", restriction or ligation can be used. Sequence analysis, restriction analysis or other biochemical-molecular biological methods are generally used as the analysis method.
In einer weiteren Ausführungsform betrifft die Erfindung Wirtszellen, insbesondere pro- oder eukaryontische Zellen, die mit einem oben beschriebenen erfindungsgemäßen Nucleinsäuremolekül oder einem erfindungsgemäßen Vektor transformiert sind, sowie Zellen, die von derart transformierten Zellen abstammen und ein erfindungsgemäßes Nucleinsäuremolekül oder einen Vektor enthalten. Dabei handelt es sich vorzugsweise um pro- oder eukaryontiache, insbesondere um pflanzliche Zellen.In a further embodiment, the invention relates to host cells, in particular pro- or eukaryotic cells which are transformed with a nucleic acid molecule according to the invention or a vector according to the invention described above, and cells which are derived from cells transformed in this way and contain a nucleic acid molecule according to the invention or a vector. These are preferably pro- or eukaryotic, in particular plant cells.
Gegenstand der Erfindung sind ferner rekombinant herstellbare Proteine mit der Aktivität einer Stärkesynthase, die durch die erfindungsgemäßen Nucleinsäuremoleküle codiert werden, sowie Verfahren zu deren Herstellung, worin eine erfindungsgemäße Wirtszelle unter dem Fachmann bekannten, geeigneten Bedingungen kultiviert wird, die die Synthese des erfindungsgemäßen Proteins erlauben, und es anschließend aus denThe invention further relates to recombinantly producible proteins with the activity of a starch synthase, which are encoded by the nucleic acid molecules according to the invention, and methods for their production, in which a host cell according to the invention is cultivated under suitable conditions known to the person skilled in the art, which allow the synthesis of the protein according to the invention, and then it from the
Wirtszellen und/oder dem Kulturmedium isoliert wird.Host cells and / or the culture medium is isolated.
Durch die Bereitstellung der erfindungsgemäßen Nucleinsäuremoleküle ist es nun möglich, mit Hilfe gentechnischer Methoden in den Stärkemetabolismus von Pflanzen gezielt einzugreifen und ihn dahingehend zu verändern, daß es zur Synthese einer modifizierten Stärke kommt, die in ihren physikalisch-chemischen Eigenschaften, beispielsweise dem Amylose/Amylopektin-Verhältnis, dem Verzweigungsgrad, der durchschnittlichen Kettenlänge, dem Phosphatgehalt, dem Verkleisterungsverhalten, den Gel- oder Filmbildungseigenschaften, der Stärkekorngröße und/oder der Stärkekornform im Vergleich zu bekannter Stärke verändert ist.By providing the nucleic acid molecules according to the invention, it is now possible to use genetic engineering methods to specifically intervene in the starch metabolism of plants and to change it in such a way that a modified starch is synthesized, which in its physico-chemical form Properties, for example the amylose / amylopectin ratio, the degree of branching, the average chain length, the phosphate content, the gelatinization behavior, the gel or film formation properties, the starch grain size and / or the starch grain shape is changed compared to known starch.
Möglich ist somit die Expression der erfindungsgemäßen Nucleinsäuremoleküle in pflanzlichen Zellen, um die Aktivität der entsprechenden Stärkesynthase zu erhöhen, oder die Einführung in Zellen, die dieses Enzym natürlicherweise nicht exprimieren. Ferner ist es möglich, die erfindungsgemäßen Nucleinsäuremoleküle nach dem Fachmann bekannten Methoden zu modifizieren, um erfindungsgemäße Starkesynthasen zu erhalten, die nicht mehr den natürlichen zelleigenen Regulationsmechanismen unterliegen, bzw. veränderte Temperatur- Aktivitätsprofile oder Substrat- bzw. Produktspezifitäten aufweisen.It is thus possible to express the nucleic acid molecules according to the invention in plant cells in order to increase the activity of the corresponding starch synthase, or to introduce them into cells which naturally do not express this enzyme. Furthermore, it is possible to modify the nucleic acid molecules according to the invention by methods known to the person skilled in the art in order to obtain starch synthases according to the invention which are no longer subject to the natural cellular regulation mechanisms or which have changed temperature-activity profiles or substrate or product specificities.
Bei der Expression der erfindungsgemäßen Nucleinsäuremoleküle in Pflanzen besteht grundsätzlich die Möglichkeit, daß das synthetisierte Protein in jedem beliebigen Kompartiment der pflanzlichen Zelle lokalisiert sein kann. Um die Lokaiisation in einem bestimmten Kompartiment zu erreichen, muß die die Lokalisation in Piastiden gewährleistende Sequenz deletiert werden und die verbleibende codierende Region gegebenenfalls mit DNA-Sequenzen verknüpft werden, die die Lokalisierung in dem jeweiligen Kompartiment gewährleisten. Derartige Sequenzen sind bekannt (siehe beispielsweise Braun et al., EMBO J. 1 1 (1 992), 321 9-3227; Wolter et al., Proc. Natl. Acad. Sei. USA 85 (1 988), 846-850; Sonnewald et al., Plant J. 1 (1 991 ), 95-106).When the nucleic acid molecules according to the invention are expressed in plants, there is in principle the possibility that the synthesized protein can be localized in any compartment of the plant cell. In order to achieve localization in a particular compartment, the sequence ensuring localization in plastids must be deleted and the remaining coding region may have to be linked to DNA sequences which ensure localization in the respective compartment. Such sequences are known (see for example Braun et al., EMBO J. 1 1 (1 992), 321 9-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1 988), 846-850 ; Sonnewald et al., Plant J. 1 (1,991), 95-106).
Die vorliegende Erfindung betrifft somit auch ein Verfahren zur Herstellung transgener Pflanzenzellen, die mit einem erfindungsgemäßen Nucleinsäuremolekül oder Vektor transformiertwerden, worin ein erfindungsgemäßes Nucleinsäuremolekül oder ein erfindungsgemäßer Vektor in das Genom einer pflanzlichen Zelle integriert wird, die transgenen Pflanzenzellen, die mittels eines erfindungsgemäßen Nucleinsäuremoleküls oder Vektors transformiert wurden sowie transgene Pflanzenzellen, die von derartig transformierten Zellen abstammen. Die erfindungsgemäßen Zellen enthalten ein oder mehrere erfindungsgemäße Nucleinsäuremoleküle oder Vektoren, wobei diese vorzugsweise mit regulatorischen DNA-Elementen verknüpft sind, die die Transkription in pflanzlichen Zellen gewährleisten, insbesondere mit einem geeigneten Promotor. Derartige Zellen lassen sich von natürlicherweise vorkommenden Pflanzenzellen unter anderem dadurch unterscheiden, daß sie ein erfindungsgemäßes Nucleinsäuremolekül enthalten, das natürlicherweise in diesen Zellen nicht vorkommt oder dadurch, daß ein solches Molekül an einem Ort im Genom der Zelle integriert vorliegt, an dem es sonst nicht vorkommt, d.h. in einer anderen genomischen Umgebung. Ferner lassen sich derartige erfindungsgemäße transgene Pflanzenzellen von natürlicherweise vorkommenden Pflanzenzellen dadurch unterscheiden, daß sie mindestens eine Kopie eines erfindungsgemäßen Nucleinsäuremoleküls stabil integriert in ihr Genom enthalten, gegebenenfalls zusätzlich zu natürlicherweise in den Zellen vorkommenden Kopien eines solchen Moleküls. Handelt es sich bei dem (den) in die Zellen eingeführten Nucleinesäuremolekül(en) um zusätzliche Kopien zu bereits natürlicherweise in den Zellen vorkommenden Molekülen, so lassen sich die erfindungsgemäßen Pflanzenzellen von natürlicherweise vorkommenden insbesondere dadurch unterscheiden, daß diese zusätzliche(n) Kopie(n) an Orten im Genom lokalisiert ist/sind an denen sie natürlicherweise nicht vorkommt (vorkommen). Dies läßt sich beispielsweise mit Hilfe einer Southern Blot-Analyse nach dem Fachmann bekannten Verfahren einfach überprüfen.The present invention thus also relates to a method for producing transgenic plant cells which are transformed with a nucleic acid molecule or vector according to the invention, in which a nucleic acid molecule according to the invention or a vector according to the invention in the genome of a plant cell is integrated, the transgenic plant cells which were transformed by means of a nucleic acid molecule or vector according to the invention and transgenic plant cells which are derived from cells transformed in this way. The cells according to the invention contain one or more nucleic acid molecules or vectors according to the invention, these being preferably linked to regulatory DNA elements which ensure transcription in plant cells, in particular with a suitable promoter. Such cells can be distinguished from naturally occurring plant cells, inter alia, in that they contain a nucleic acid molecule according to the invention which does not naturally occur in these cells or in that such a molecule is integrated at a location in the genome of the cell where it does not otherwise occur , ie in a different genomic environment. Furthermore, such transgenic plant cells according to the invention can be distinguished from naturally occurring plant cells in that they contain at least one copy of a nucleic acid molecule according to the invention stably integrated into their genome, optionally in addition to copies of such a molecule that occur naturally in the cells. If the nucleic acid molecule (s) introduced into the cells are additional copies of molecules already naturally occurring in the cells, the plant cells according to the invention can be distinguished from naturally occurring cells in particular in that these additional copy (s) ) is localized in locations in the genome where it does not naturally occur. This can be easily checked, for example, with the aid of a Southern blot analysis according to methods known to the person skilled in the art.
Ist das in das pflanzliche Genom eingeführte erfindungsgemäße Nucleinsäuremolekül heterolog in Bezug auf die Pflanzenzelle, so weisen die transgenen Pflanzenzellen Transkripte der erfindungsgemäßen Nucleinsäuremoleküle auf, die sich z. B. durch Northern-Blot-Analyse nach dem Fachmann bekannten Verfahren einfach nachweisen lassen. Ist das eingeführte erfindungsgemäße Nucleinsäuremolekül homolog in Bezug auf die Pflanzenzelle, können die erfindungsgemäßen Zellen von natürlicherweise auftretenden beispielsweise aufgrund der zusätzlichen Expression erfindungsgemäßer Nucleinsäuremoleküle unterschieden werden. Die transgenen Pflanzenzellen enthalten vorzugsweise mehr Transkripte der erfindungsgemäßen Nucleinsäuremoleküle. Dies kann z. B. durch Northern-Blot-Analyse nachgewiesen werden. "Mehr" bedeutet dabei vorzugweise mindestens 1 0% mehr, bevorzugt mindestens 20% mehr und besonders bevorzugt mindestens 50% mehr Transkripte als entsprechende, nicht-transformierte Zellen. Vorzugsweise weisen die Zellen ferner eine entsprechende (mindestens 1 0%, 20% bzw. 50%ige) Aktivitätsteigerung oder ggf. eine Aktivitätsreduzierung des erfindungsgemäßen Proteins auf. Die transgenen Pflanzenzellen können nach dem Fachmann bekannten Techniken zu ganzen Pflanzen regeneriert werden.If the nucleic acid molecule according to the invention introduced into the plant genome is heterologous with respect to the plant cell, then the transgenic plant cells have transcripts of the nucleic acid molecules according to the invention, which are e.g. B. simply by Northern blot analysis according to methods known to those skilled in the art. If the introduced nucleic acid molecule according to the invention is homologous with respect to the plant cell, the cells according to the invention can be distinguished from naturally occurring cells, for example on the basis of the additional expression of nucleic acid molecules according to the invention. The transgenic plant cells preferably contain more transcripts of the nucleic acid molecules according to the invention. This can e.g. B. can be detected by Northern blot analysis. "More" preferably means at least 10% more, preferably at least 20% more and particularly preferably at least 50% more transcripts than corresponding, non-transformed cells. The cells preferably also have a corresponding (at least 10%, 20% or 50%) increase in activity or, if appropriate, a reduction in activity of the protein according to the invention. The transgenic plant cells can be regenerated into whole plants using techniques known to those skilled in the art.
Ebenfalls ist ein Gegenstand der vorliegenden Erfindung ein Verfahren zur Herstellung transgener Pflanzen, worin ein oder mehrere erfindungsgemäße Nucleinsäuremoleküle oder Vektoren in das Genom einer pflanzlichen Zelle integriert werden und eine vollständige Pflanze aus besagter Pflanzenzelle regeneriert wird. Die durch Regeneration der erfindungsgemäßen transgenen Pflanzenzellen erhältlichen Pflanzen sind ebenfalls Gegenstand der vorliegenden Erfindung. Ferner sind Gegenstand der Erfindung Pflanzen, die die oben beschriebenen transgenen Pflanzenzellen enthalten. Bei den transgenen Pflanzen kann es sich prinzipiell um Pflanzen jeder beliebigen Pflanzenspezies handeln, d.h. sowohl monokotyle als auch dikotyle Pflanzen. Bevorzugt handelt es sich um Nutzpflanzen, vorzugsweise stärkesynthetisierende bzw. stärkespeichernde Pflanzen, besonders bevorzugt Roggen, Gerste Hafer, Weizen, Hirse, Sago, Mais, Reis, Erbse, Markerbse, Maniok, Kartoffel, Tomate, Raps, Sojabohne, Hanf, Flachs, Sonnenblume, Kuherbse oder Arrowroot, insbesondere Weizen, Mais, Reis und Kartoffel. Die Erfindung betrifft ebenfalls Vermehrungsmaterial der erfindungsgemäßen Pflanzen, beispielsweise Früchte, Samen, Knollen, Wurzelstöcke, Sämlinge, Stecklinge, Calli, Protoplasten, Zellkulturen etc..The present invention also relates to a method for producing transgenic plants, in which one or more nucleic acid molecules or vectors according to the invention are integrated into the genome of a plant cell and a complete plant is regenerated from said plant cell. The plants obtainable by regeneration of the transgenic plant cells according to the invention are also the subject of the present invention. The invention furthermore relates to plants which contain the transgenic plant cells described above. The transgenic plants can in principle be plants of any plant species, ie both monocot and dicot plants. They are preferably useful plants, preferably starch-synthesizing or starch-storing plants, particularly preferably rye, barley, oats, wheat, millet, sago, maize, rice, pea, pea, cassava, potato, tomato, rapeseed, soybean, hemp, flax, sunflower , Cow pea or arrowroot, especially wheat, corn, rice and potato. The invention also relates to propagation material of the plants according to the invention, for example fruits, seeds, tubers, rhizomes, seedlings, cuttings, calli, protoplasts, cell cultures etc.
Die vorliegende Erfindung betrifft ferner ein Verfahren zur Herstellung einer modifizierten Stärke umfassend den Schritt der Extraktion der Stärke aus einer oben beschriebenen erfindungsgemäßen Pflanze und/oder aus stärkespeichernden Teilen einer solchen Pflanze.The present invention further relates to a method for producing a modified starch comprising the step of extracting the starch from a plant according to the invention described above and / or from starch-storing parts of such a plant.
Verfahren zur Extraktion der Stärke von Pflanzen oder von stärkespeichernden Teilen von Pflanzen, insbesondere aus Weizen, sind dem Fachmann bekannt, vgl. z.B. Eckhoff et al. (Cereal Chem. 73 (1 996) 54-57) "Starch: Chemistry and Technology (Hrsg.: Whistler, BeMiller und Paschall (1 994), 2. Ausgabe, Academic Press Inc. London Ltd; ISBN 0-1 2-746270-8; siehe z. B. Kapitel XII, Seite 41 2-468: Mais und Sorghum-Stärken: Herstellung; von Watson; Kapitel XIII, Seite 469-479: Tapioca-, Arrowroot- und Sagostärken: Herstellung; von Corbishley und Miller; Kapitel XIV, Seite 479-490: Kartoffelstärke: Herstellung und Verwendungen; von Mitch; Kapitel XV, Seite 491 bis 506: Weizenstärke: Herstellung, Modifizierung und Verwendungen; von Knight und Oson; und Kapitel XVI, Seite 507 bis 528: Reisstärke: Herstellung und Verwendungen; von Rohmer und Klem). Vorrichtungen, die für gewöhnlich bei Verfahren zur Extraktion von Stärke von Pflanzenmaterial verwendet werden, sind Separatoren, Dekanter, Hydrocyclone, Sprühtrockner und Wirbelschichttrockner.Methods for extracting the starch from plants or from starch-storing parts of plants, in particular from wheat, are known to the person skilled in the art, cf. e.g. Eckhoff et al. (Cereal Chem. 73 (1 996) 54-57) "Starch: Chemistry and Technology (Ed .: Whistler, BeMiller and Paschall (1 994), 2nd edition, Academic Press Inc. London Ltd; ISBN 0-1 2- 746270-8; see e.g. Chapter XII, page 41 2-468: Maize and sorghum starches: manufacture; by Watson; Chapter XIII, pages 469-479: tapioca, arrowroot and sago starches: manufacture; by Corbishley and Miller; Chapter XIV, pages 479-490: Potato Starch: Manufacture and Uses; by Mitch; Chapter XV, Pages 491 to 506: Wheat Starch: Manufacture, Modification and Uses; by Knight and Oson; and Chapter XVI, Pages 507 to 528: Rice Starch : Manufacture and Uses; by Rohmer and Klem) Devices commonly used in processes for extracting starch from plant material are separators, decanters, hydrocyclones, spray dryers and fluidized bed dryers.
Die erfindungsgemäßen transgenen Pflanzenzellen und Pflanzen synthetisieren aufgrund der Expression eines erfindungsgemäßen Nucleinsäuremoleküls eine Stärke, die in ihren physikalisch-chemischen Eigenschaften, z.B. dem Amylose/Amylopektin-Verhältnis, dem Verzweigungsgrad, der durchschnittlichen Kettenlänge, dem Phosphatgehalt, dem Verkleisterungsverhalten, der Stärkekorngröße und/oder der Stärkekornform im Vergleich zu in Wildtyp- Pflanzen synthetisierter Stärke verändert ist. Insbesondere kann eine solche Stärke im Hinblick auf die Viskosität und/oder die Film- oder Gelbildungseigenschaften von Kleistern dieser Stärke im Vergleich zu bekannten Stärken verändert sein.Based on the expression of a nucleic acid molecule according to the invention, the transgenic plant cells and plants according to the invention synthesize a starch which has its physicochemical properties, for example the amylose / amylopectin ratio, the degree of branching, the average chain length, the phosphate content, the gelatinization behavior, the starch grain size and / or the starch grain shape compared to wild type Plants synthesized starch is changed. In particular, such a starch can be changed with regard to the viscosity and / or the film or gel formation properties of pastes of this starch compared to known starches.
Gegenstand der vorliegenden Erfindung ist femer eine Stärke, die aus den erfindungsgemäßen Pflanzenzellen, Pflanzen sowie deren Vermehrungsmaterial erhältlich ist und Stärke, die durch das oben beschriebene erfindungsgemäße Verfahren erhältlich ist.The present invention furthermore relates to a starch which can be obtained from the plant cells, plants and their propagation material according to the invention and starch which can be obtained by the process according to the invention described above.
Ferner ist es möglich, mit Hilfe der erfindungsgemäßen Nucleinsäuremoleküle Pflanzenzellen und Pflanzen zu erzeugen, bei denen die Aktivität eines erfindungsgemäßen Proteins verringert ist. Dies führt ebenfalls zur Synthese einer Stärke mit veränderten chemischen und/oder physikalischen Eigenschaften verglichen mit Stärke aus Wildtyp-Pflanzenzellen.It is also possible to use the nucleic acid molecules according to the invention to produce plant cells and plants in which the activity of a protein according to the invention is reduced. This also leads to the synthesis of a starch with changed chemical and / or physical properties compared to starch from wild-type plant cells.
Ein weiterer Gegenstand der Erfindung ist somit auch ein transgene Pflanzenzelle, enthaltend ein erfindungsgemäßes Nukleinsäuremolekül, in der die Aktivität einer Stärkesynthase im Vergleich zu einer nichttransformierten Zellen reduziert ist.Another object of the invention is thus also a transgenic plant cell containing a nucleic acid molecule according to the invention, in which the activity of a starch synthase is reduced compared to a non-transformed cell.
Die Herstellung von Pflanzenzellen mit einer verringerten Aktivität einer Stärkesynthase kann beispielsweise erzielt werden durch die Expression einer entsprechenden antisense-RNA, einer sense-RNA zur Erzielung eines Cosuppres- sionseffektes oder die Expression eines entsprechend konstruierten Ribozyms, das spezifisch Transkripte spaltet, die eine Stärkesynthase codieren, unter Verwendung der erfindungsgemäßen Nucleinsäuremoleküle nach dem Fachmann bekannten Verfahren, vgl. Jorgensen (Trends Biotechnol. 8 (1 990), 340-344), Niebel et al., (Curr. Top. Microbiol. Immunol. 1 97 (1 995), 91 -103), Flavell et al. (Curr. Top. Microbiol. Immunol. 197 (1995), 43-46), Palaqui und Vaucheret (Plant. Mol. Biol. 29 (1 995), 149-1 59), Vaucheret et al., (Mol. Gen. Genet. 248 (1 995), 31 1 -31 7), de Borne et al. (Mol. Gen. Genet. 243 (1 994), 61 3-621 ).The production of plant cells with a reduced activity of a starch synthase can be achieved, for example, by the expression of a corresponding antisense-RNA, a sense-RNA to achieve a cosuppression effect or the expression of a correspondingly constructed ribozyme which specifically cleaves transcripts which code for a starch synthase , using the nucleic acid molecules according to the invention by methods known to the person skilled in the art, cf. Jorgensen (Trends Biotechnol. 8 (1 990), 340-344), Niebel et al., (Curr. Top. Microbiol. Immunol. 1 97 (1 995), 91-103), Flavell et al. (Curr. Top. Microbiol. Immunol. 197 (1995), 43-46), Palaqui and Vaucheret (Plant. Mol. Biol. 29 (1 995), 149-1 59), Vaucheret et al., (Mol. Gen. Genet. 248 (1 995), 31 1 -31 7), de Borne et al. (Mol. Gen. Genet. 243 (1,994), 61 3-621).
Vorzugsweise wird zur Reduzierung der Aktivität einer erfindungsgemäßen Stärkesynthase in den pflanzlichen Zellen die Anzahl der sie codierenden Transkripte reduziert, z.B. durch Expression einer antisense-RNA.Preferably, to reduce the activity of a starch synthase according to the invention in the plant cells, the number of transcripts encoding it is reduced, e.g. by expression of an antisense RNA.
Hierzu kann zum einen ein DNA-Molekül verwendet werden, das die gesamte für ein erfindungsgemäßes Protein codierende Sequenz einschließlich eventuell vorhandener flankierender Sequenzen umfaßt, als auch DNA-Moleküle, die nur Teile der codierenden Sequenz umfassen, wobei diese Teile lang genug sein müssen, um in den Zellen einen antisense-Effekt zu bewirken. Es können im allgemeinen Sequenzen bis zu einer Mindestlänge von 1 5 bp, vorzugsweise einer Länge von 100-500 bp, für eine effiziente antisense-lnhibition insbesondere Sequenzen mit einer Länge über 500 bp verwendet werden. In der Regel werden DNA-Moleküle verwendet, die kürzer als 5000 bp, vorzugsweise Sequenzen, die kürzer als 2500 bp sind.For this purpose, a DNA molecule can be used which comprises the entire sequence coding for a protein according to the invention including any flanking sequences which may be present, and also DNA molecules which only comprise parts of the coding sequence, these parts having to be long enough to to cause an antisense effect in the cells. In general, sequences up to a minimum length of 15 bp, preferably a length of 100-500 bp, can be used for efficient antisense inhibition, in particular sequences with a length of more than 500 bp. As a rule, DNA molecules are used that are shorter than 5000 bp, preferably sequences that are shorter than 2500 bp.
Möglich ist auch die Verwendung von DNA-Sequenzen, die einen hohen Grad an Homologie zu den Sequenzen der erfindungsgemäßen DNA-Moleküle aufweisen, aber nicht vollkommen identisch sind. Die minimale Homologie sollte größer als ca. 65 % sein. Die Verwendung von Sequenzen mit Homologien zwischen 95 und 1 00 % ist zu bevorzugen.It is also possible to use DNA sequences which have a high degree of homology to the sequences of the DNA molecules according to the invention, but which are not completely identical. The minimum homology should be greater than approximately 65%. The use of sequences with homologies between 95 and 100% is preferred.
Gegenstand der Erfindung ist auch ein Verfahren zur Herstellung einer modifizierten Stärke umfassend den Schritt der Extraktion der Stärke aus einer erfindungsgemäßen Zelle oder Pflanze und/oder aus stärkespeichernden Teilen einer solchen Pflanze.The invention also relates to a method for producing a modified starch, comprising the step of extracting the starch from a cell or plant according to the invention and / or from starch-storing parts of such a plant.
Gegenstand der Erfindung ist ferner Stärke, die aus den erfindungsgemäßen Zellen, Pflanzen sowie Vermehrungsmaterial oder deren Teilen erhältlich ist sowie Stärke, die durch ein erfindungsgemäßes Verfahren erhältlich ist.The invention furthermore relates to starch which can be obtained from the cells, plants and propagation material or parts thereof according to the invention and starch which can be obtained by a process according to the invention.
Die erfindungsgemäßen Stärken können nach dem Fachmann bekannten Verfahren modifiziert werden und eignen sich in unmodifizierter oder modifizierter Form für verschiedene Verwendungen im Nahrungsmittel- oder Nicht-Nahrungsmittelbereich.The starches according to the invention can be modified by processes known to those skilled in the art and are suitable in unmodified or modified form for various uses in the food or non-food sector.
Grundsätzlich lassen sich die Einsatzmöglichkeiten der erfindungsgemäßen Stärken in zwei große Bereiche unterteilen. Der eine Bereich umfaßt die Hydrolyseprodukte der Stärke, hauptsächlich Glucose und Glucanbausteine, die über enzymatische oder chemische Verfahren erhalten werden. Sie dienen als Ausgangsstoff für weitere chemische Modifikationen und Prozesse, wie Fermentation. Für eine Reduktion der Kosten kann hierbei die Einfachheit und kostengünstige Ausführung eines Hydrolyseverfahrens von Bedeutung sein. Gegenwärtig verläuft es im wesentlichen enzymatisch unter Verwendung von Amyloglucosidase. Vorstellbar wäre eine Kosteneinsparung durch einen geringeren Einsatz von Enzymen. Eine Strukturveränderung der Stärke, z.B. Oberflächenvergrößerung des Korns, leichtere Verdaulichkeit durch z.B. geringeren Verzweigungsgrad oder eine sterische Struktur, die die Zugänglichkeit für die eingesetzten Enzyme begrenzt, könnte dies bewirken.Basically, the possible uses of the starches according to the invention can be divided into two large areas. One area comprises the hydrolysis products of starch, mainly glucose and glucan building blocks, which are obtained via enzymatic or chemical processes. They serve as the starting material for further chemical modifications and processes, such as fermentation. The simplicity and cost-effective execution of a hydrolysis process can be important for reducing the costs. Currently, it is essentially enzymatic using amyloglucosidase. It would be conceivable to save costs by using fewer enzymes. A structural change in strength, e.g. Surface enlargement of the grain, easier digestibility through e.g. A lower degree of branching or a steric structure that limits the accessibility for the enzymes used could cause this.
Der andere Bereich, in dem die erfindungsgemäßen Stärken wegen ihrer polymeren Struktur als sogenannte native Stärke verwendet wird, gliedert sich in zwei weitere Einsatzgebiete:The other area, in which the starches according to the invention are used as so-called native starches because of their polymer structure, is divided into two further areas of application:
1 . Nahrungsmittelindustrie1 . Food industry
Stärke ist ein klassischer Zusatzstoff für viele Nahrungsmittel, bei denen sie im wesentlichen die Funktion des Bindens von wäßrigen Zusatzstoffen übernimmt bzw. eine Erhöhung der Viskosität oder aber eine erhöhte Gelbildung hervorruft. Wichtige Eigenschaftsmerkmale sind das Fließ- und Sorptionsverhalten, die Quell- und Verkleisterungstemperatur, die Viskosität und Dickungsleistung, die Löslichkeit der Stärke, die Transparenz und Kleisterstruktur, die Hitze-, Scher- und Säurestabilität, die Neigung zur Retrogradation, die Fähigkeit zur Filmbildung, die Gefrier/Taustabilität, die Viskositätsstabilität in Salzlösungen, die Verdaulichkeit sowie die Fähigkeit zur Komplexbildung mit z.B. anorganischen oder organischen Ionen.Starch is a classic additive for many foods, where it essentially takes on the function of binding aqueous additives or increases the viscosity or increases gel formation. The important properties are the flow and Sorption behavior, the swelling and gelatinization temperature, the viscosity and thickening performance, the solubility of the starch, the transparency and paste structure, the heat, shear and acid stability, the tendency to retrogradation, the ability to form films, the freeze / thaw stability, the viscosity stability in Salt solutions, digestibility and the ability to form complexes with, for example, inorganic or organic ions.
2. Nicht-Nahrungmittelindustrie2. Non-food industry
In diesem großen Bereich kann die Stärke als Hilfsstoff für unterschiedliche Herstellungsprozesse bzw. als Zusatzstoff in technischen Produkten eingesetzt werden. Bei der Verwendung der Stärke als Hilfsstoff ist hier insbesondere die Papier- und Pappeindustrie zu nennen. Die Stärke dient dabei in erster Linie zur Retardation (Zurückhaltung von Feststoffen), der Abbindung von Füllstoff- und Feinstoffteilchen, als Festigungsstoff und zur Entwässerung. Darüber hinaus werden die günstigen Eigenschaften der Stärke in bezug auf die Steifigkeit, die Härte, den Klang, den Griff, den Glanz, die Glätte, die Spaltfestigkeit sowie die Oberflächen ausgenutzt.In this large area, starch can be used as an additive for different manufacturing processes or as an additive in technical products. When using starch as an auxiliary, the paper and cardboard industry should be mentioned in particular. The starch primarily serves for retardation (retention of solids), the setting of filler and fine particles, as a strengthening agent and for drainage. In addition, the favorable properties of the starch in terms of rigidity, hardness, sound, grip, gloss, smoothness, splitting resistance and surfaces are exploited.
2.1 Papier- und Pappeindustrie2.1 Paper and cardboard industry
Innerhalb des Papierherstellungsprozesses sind vier Anwendungsbereiche, nämlich Oberfläche, Strich, Masse und Sprühen, zu unterscheiden. Die Anforderungen an die Stärke in bezug auf die Oberflächenbehandlung sind im wesentlichen ein hoher Weißegrad, eine angepaßte Viskosität, eine hohe Viskositätsstabilität, eine gute Filmbildung sowie eine geringe Staubbildung. Bei der Verwendung im Strich spielt der Feststoffgehalt, eine angepaßte Viskosität, ein hohes Bindevermögen sowie eine hohe Pigmentaffinität eine wichtige Rolle. Als Zusatz zur Masse ist eine rasche, gleichmäßige, verlustfreie Verteilung, eine hohe mechanische Stabilität und eine vollständige Zurückhaltung im Papierfließ von Bedeutung. Beim Einsatz der Stärke im Sprühbereich sind ebenfalls ein angepaßter Feststoffgehalt, hohe Viskosität sowie ein hohes Bindevermögen von Bedeutung.There are four areas of application within the paper manufacturing process, namely surface, line, mass and spraying. The requirements for the starch in relation to the surface treatment are essentially a high degree of whiteness, an adapted viscosity, high viscosity stability, good film formation and low dust formation. When used in the coating, the solids content, an adapted viscosity, a high binding capacity and high pigment affinity play an important role. As an addition to the mass, rapid, even, loss-free distribution, high mechanical stability and complete restraint in the paper flow are important. At the Use of the starch in the spray area is also of importance to an adapted solids content, high viscosity and high binding capacity.
2.2 Klebstoffindustrie2.2 Adhesives industry
Ein großer Einsatzbereich der Stärken besteht in der Klebstoffindustrie, wo man die Einsatzmöglichkeiten in vier Teilbereiche gliedert: die Verwendung als reinem Stärkeleim, die Verwendung bei mit speziellen Chemikalien aufbereiteten Stärkeleimen, die Verwendung von Stärke als Zusatz zu synthetischen Harzen und Polymerdispersionen sowie die Verwendung von Stärken als Streckmittel für synthetische Klebstoffe. 90 % der Klebstoffe auf Stärkebasis werden in den Bereichen Wellpappenherstellung, Herstellung von Papiersäcken, Beuteln und Tüten, Herstellung von Verbundmaterialien für Papier und Aluminium, Herstellung von Kartonagen und Wiederbefeuchtungsleim für Briefumschläge, Briefmarken usw. eingesetzt.A large area of use of the starches is in the adhesive industry, where the possible uses are divided into four areas: use as pure starch glue, use with starch glues prepared with special chemicals, use of starch as an additive to synthetic resins and polymer dispersions, and use of starches as an extender for synthetic adhesives. 90% of the starch-based adhesives are used in the fields of corrugated cardboard, paper bags, bags and pouches, composite materials for paper and aluminum, cardboard packaging and rewetting glue for envelopes, stamps, etc.
2.3 Textil- und Textilpflegemittelindustrie2.3 Textile and textile care products industry
Ein großes Einsatzfeld für die Stärken als Hilfsmittel und Zusatzstoff ist der Bereich Herstellung von Textilien und Textilpflegemitteln. Innerhalb der Textilindustrie sind die folgenden vier Einsatzbereiche zu unterscheiden: Der Einsatz der Stärke als Schlichtmittel, d.h. als Hiifsstoff zur Glättung und Stärkung des Klettverhaltens zum Schutz gegen die beim Weben angreifenden Zugkräfte sowie zur Erhöhung der Abriebfestigkeit beim Weben, Stärke als Mittel zur Textilaufrüstung vor allem nach qualitätsverschlechtemden Vorbehandlungen, wie Bleichen, Färben usw., Stärke als Verdickungsmittel bei der Herstellung von Farbpasten zur Verhinderung von Farbstoffdiffusionen sowie Stärke als Zusatz zu Kettungsmitteln für Nähgarne. 2.4 BaustoffindustrieA large field of application for the starches as an auxiliary and additive is the area of manufacture of textiles and textile care products. The following four areas of application can be distinguished within the textile industry: The use of starch as a sizing agent, i.e. as an auxiliary for smoothing and strengthening the hook-and-loop behavior to protect against the tensile forces that occur during weaving and to increase the abrasion resistance during weaving, starch as a means of textile upgrading after poor-quality pre-treatments such as bleaching, dyeing, etc., starch as a thickening agent in the manufacture of color pastes to prevent dye diffusion and starch as an additive to chaining agents for sewing threads. 2.4 Building materials industry
Der vierte Einsatzbereich ist die Verwendung der Stärken als Zusatz bei Baustoffen. Ein Beispiel ist die Herstellung von Gipskartonplatten, bei der die im Gipsbrei vermischte Stärke mit dem Wasser verkleistert, an die Oberfläche der Gipsplatte diffundiert und dort den Karton an die Platte bindet. Weitere Einsatzbereiche sind die Beimischung zu Putz- und Mineralfasern. Bei Transportbeton werden Stärkeprodukte zur Verzögerung der Abbindung eingesetzt.The fourth area of application is the use of starches as an additive in building materials. One example is the production of gypsum plasterboard, in which the starch mixed in the gypsum slurry pastes with the water, diffuses to the surface of the gypsum board and binds the cardboard to the board there. Other areas of application are admixing to plaster and mineral fibers. In ready-mixed concrete, starch products are used to delay setting.
2.5 Bodenstabilisation2.5 Soil stabilization
Ein weiterer Markt für die Stärke bietet sich bei der Herstellung von Mitteln zur Bodenstabilisation an, die bei künstlichen Erdbewegungen zum temporären Schutz der Bodenpartikel gegenüber Wasser eingesetzt werden. Kombinationsprodukte aus der Stärke und Polymeremulsionen sind nach heutiger Kenntnis in ihrer Erosions- und ver- krustungsmindernden Wirkung den bisher eingesetzten Produkten gleichzusetzen, liegen preislich aber deutlich unter diesen.Another market for starch is in the manufacture of soil stabilizers that are used to temporarily protect soil particles from water during artificial earthmoving. Combined products made of starch and polymer emulsions are, according to current knowledge, to be equated with the previously used products in terms of their erosion and incrustation-reducing effects, but are significantly less expensive than these.
2.6 Einsatz in Pflanzenschutz- und Düngemitteln2.6 Use in crop protection and fertilizers
Ein Einsatzbereich liegt in der Verwendung der Stärke in Pflanzenschutzmitteln zur Veränderung der spezifischen Eigenschaften der Präparate. So kann die Stärke zur Verbesserung der Benetzung von Pflanzenschutz- und Düngemitteln, zur dosierten Freigabe der Wirkstoffe, zur Umwandlung flüssiger, flüchtiger und/oder übelriechender Wirkstoffe in mikrokristalline, stabile, formbare Substanzen, zur Mischung inkompatibler Verbindungen und zur Verlängerung der Wirkdauer durch Verminderung der Zersetzung eingesetzt werden.One area of application is the use of starch in crop protection agents to change the specific properties of the preparations. The starch can be used to improve the wetting of crop protection agents and fertilizers, to release the active ingredients in a dosed manner, to convert liquid, volatile and / or malodorous active ingredients into microcrystalline, stable, moldable substances, to mix incompatible compounds and to extend the duration of action by reducing the Decomposition can be used.
2.7 Pharmaka, Medizin und Kosmetikindustrie2.7 Pharmaceuticals, medicine and cosmetics industry
Ein weiteres Einsatzgebiet besteht im Bereich der Pharmaka, Medizin und Kosmetikindustrie. In der pharmazeutischen Industrie kann die Stärke als Bindemittel für Tabletten oder zur Bindemittelverdünnung in Kapseln eingesetzt werden. Weiterhin kann die Stärke als Tablettensprengmittel dienen, da sie nach dem Schlucken Flüssigkeit absorbieren und nach kurzer Zeit soweit quellen, daß der Wirkstoff freigesetzt wird. Medizinische Gleit- und Wundpuder basieren aus qualitativen Gründen auf Stärke. Im Bereich der Kosmetik werden Stärken beispielsweise als Träger von Puderzusatzstoffen, wie Düften und Salicylsäure eingesetzt. Ein relativ großer Anwendungsbereich für die Stärke liegt bei Zahnpasta.Another area of application is in the pharmaceutical, medical and cosmetic industries. In the pharmaceutical industry, starch can be considered Binder for tablets or for binder dilution in capsules can be used. The starch can furthermore serve as a tablet disintegrant, since after swallowing it absorbs liquid and swells to such an extent after a short time that the active substance is released. Medical lubricant and wound powders are based on starch for qualitative reasons. In the field of cosmetics, starches are used, for example, as carriers for powder additives such as fragrances and salicylic acid. A relatively large area of application for starch is toothpaste.
2.8 Stärkezusatz zu Kohlen und Briketts2.8 Starch addition to coals and briquettes
Einen Einsatzbereich bietet die Stärke als Zusatzstoff zu Kohle und Brikett. Kohle kann mit einem Stärkezusatz quantitativ hochwertig agglomeriert bzw. brikettiert werden, wodurch ein frühzeitiges Zerfallen der Briketts verhindert wird. Der Stärkezusatz liegt bei Grillkohle zwischen 4 und 6 %, bei kalorierter Kohle zwischen 0, 1 und 0,5 %. Des weiteren gewinnen Stärken als Bindemittel an Bedeutung, da durch ihren Zusatz zu Kohle und Brikett der Ausstoß schädlicher Stoffe deutlich vermindert werden kann.Starch is used as an additive to coal and briquette. Coal can be agglomerated or briquetted with a high-quality addition of starch, which prevents the briquettes from breaking down prematurely. The added starch is between 4 and 6% for barbecued coal and between 0, 1 and 0.5% for calorized coal. Furthermore, starches are becoming increasingly important as binders, since their addition to coal and briquette can significantly reduce the emissions of harmful substances.
2.9 Erz- und Kohleschlammaufbereitung2.9 Ore and coal sludge processing
Die Stärke kann ferner bei der Erz- und Kohleschlammaufbereitung als Flockungsmittel eingesetzt werden.The starch can also be used as a flocculant in ore and coal sludge processing.
2.10 Gießereihilfsstoff2.10 Foundry auxiliary
Ein weiterer Einsatzbereich besteht als Zusatz zu Gießereihilfsstoffen. Bei verschiedenen Gußverfahren werden Kerne benötigt, die aus Bindemittelversetzten Sänden hergestellt werden. Als Bindemittel wird heute überwiegend Bentonit eingesetzt, das mit modifizierten Stärken, meist Quellstärken, versetzt ist.Another area of application is as an additive to foundry additives. Various casting processes require cores that are made from binder-mixed sands. Bentonite, which is mixed with modified starches, mostly swelling starches, is predominantly used today as a binder.
Zweck des Stärkezusatzes ist die Erhöhung der Fließfestigkeit sowie die Verbesserung der Bindefestigkeit. Darüber hinaus können die Quellstärken weitere produktionstechnische Anforderungen, wie im kalten Wasser dispergierbar, rehydratisierbar, gut in Sand mischbar und hohes Wasserbindungsvermögen, aufweisen.The purpose of the starch addition is to increase the flow resistance and to improve the binding strength. In addition, the source strengths have other production-related requirements, such as dispersibility in cold water, rehydration, good miscibility in sand and high water retention.
2.1 1 Einsatz in der Kautschukindustrie2.1 1 Use in the rubber industry
In der Kautschukindustrie kann die Stärke zur Verbesserung der technischen und optischen Qualität eingesetzt werden. Gründe sind dabei die Verbesserung des Oberflächenglanzes, die Verbesserung des Griffs und des Aussehens, dafür wird Stärke vor der Kaltvulkanisation auf die klebrigen gummierten Flächen von Kautschukstoffen gestreut, sowie die Verbesserung der Bedruckbarkeit des Kautschuks.In the rubber industry, the starch can be used to improve the technical and optical quality. The reasons for this are the improvement of the surface gloss, the improvement of the handle and the appearance, for this reason starch is sprinkled on the sticky rubberized surfaces of rubber materials before the cold vulcanization, and the improvement of the printability of the rubber.
2.1 2 Herstellung von Lederersatzstoffen2.1 2 Manufacture of leather substitutes
Eine weitere Absatzmöglichkeit der modifizierten Stärken besteht bei der Herstellung von Lederersatzstoffen.Another way of selling the modified starches is in the production of leather substitutes.
2.13 Stärke in synthetischen Polymeren2.13 Starch in synthetic polymers
Auf dem Kunststoffsektor zeichnen sich folgende Einsatzgebiete ab: die Einbindung von Stärkefolgeprodukten in den Verarbeitungsprozeß (Stärke ist nur Füllstoff, es besteht keine direkte Bindung zwischen synthetischem Polymer und Stärke) oder alternativ die Einbindung von Stärkefolgeprodukten in die Herstellung von Polymeren (Stärke und Polymer gehen eine feste Bindung ein).The following areas of application are emerging in the plastics sector: the integration of starch secondary products in the processing process (starch is only a filler, there is no direct link between synthetic polymer and starch) or, alternatively, the integration of starch secondary products in the production of polymers (starch and polymer are one firm bond).
Die Verwendung der Stärke als reinem Füllstoff ist verglichen mit den anderen Stoffen wie Talkum nicht wettbewerbsfähig. Anders sieht es aus, wenn die spezifischen Stärkeeigenschaften zum Tragen kommen und hierdurch das Eigenschaftsprofil der Endprodukte deutlich verändert wird. Ein Beispiel hierfür ist die Anwendung von Stärkeprodukten bei der Verarbeitung von Thermoplasten, wie Polyethylen. Hierbei werden die Stärke und das synthetische Polymer durch Koexpression im Verhältnis von 1 : 1 zu einem 'master batch' kombiniert, aus dem mit granuliertem Polyethylen unter Anwendung herkömmlicher Verfahrenstechniken diverse Produkte hergestellt werden. Durch die Einbindung von Stärke in Polyethylenfolien kann eine erhöhte Stoffdurchlässigkeit bei Hohlkörpern, eine verbesserte Wasserdampfdurchlässigkeit, ein verbessertes Antistatikverhalten, ein verbessertes Antiblockverhalten sowie eine verbesserte Bedruckbarkeit mit wäßrigen Farben erreicht werden.The use of starch as a pure filler is not competitive compared to other substances such as talc. It is different if the specific starch properties come into play and this significantly changes the property profile of the end products. An example of this is the use of starch products in the processing of thermoplastics, such as polyethylene. The starch and the synthetic polymer are co-expressed in a 1: 1 ratio to form a 'master batch' combined, from which various products are made with granulated polyethylene using conventional processing techniques. By incorporating starch in polyethylene films, an increased material permeability for hollow bodies, an improved water vapor permeability, an improved antistatic behavior, an improved antiblocking behavior and improved printability with aqueous inks can be achieved.
Eine andere Möglichkeit ist die Anwendung der Stärke in Polyurethanschäumen. Mit der Adaption der Stärkederivate sowie durch die verfahrenstechnische Optimierung ist es möglich, die Reaktion zwischen synthetischen Polymeren und den Hydroxygruppen der Stärken gezielt zu steuern. Das Ergebnis sind Polyurethanfolien, die durch die Anwendung von Stärke folgende Eigenschaftsprofile erhalten: eine Verringerung des Wärmeausdehnungskoeffizienten, Verringerung des Schrumpfverhaltens, Verbesserung des Druck/Spannungsverhaltens, Zunahme der Wasserdampfdurchlässigkeit ohne Veränderung der Wasseraufnahme, Verringerung der Entflammbarkeit und der Aufrißdichte, kein Abtropfen brennbarer Teile, Halogenfreiheit und verminderte Alterung. Nachteile, die gegenwärtig noch vorhanden sind, sind verringerte Druckfestigkeit sowie eine verringerte Schlagfestigkeit.Another option is to use the starch in polyurethane foams. By adapting the starch derivatives and by optimizing the process, it is possible to control the reaction between synthetic polymers and the hydroxyl groups of the starches. The result is polyurethane foils that get the following property profiles through the use of starch: a reduction in the coefficient of thermal expansion, a reduction in shrinkage behavior, an improvement in pressure / stress behavior, an increase in water vapor permeability without changing the water absorption, a reduction in flammability and tear density, no dripping of flammable parts, Halogen free and reduced aging. Disadvantages that are currently still present are reduced compressive strength and reduced impact resistance.
Die Produktentwicklung beschränkt sich inzwischen nicht mehr nur auf Folien. Auch feste Kunststoffprodukte, wie Töpfe, Platten und Schalen, sind mit einem Stärkegehalt von über 50 % herzustellen. Des weiteren sind Stärke/ Polymermischungen günstig zu beurteilen, da sie eine sehr viel höhere biologische Abbaubarkeit aufweisen.Product development is no longer limited to foils. Solid plastic products such as pots, plates and bowls can also be manufactured with a starch content of over 50%. Furthermore, starch / polymer mixtures can be assessed favorably because they have a much higher biodegradability.
Außerordentliche Bedeutung haben weiterhin auf Grund ihres extremen Wasserbindungsvermögen Stärkepfropfpolymerisate gewonnen. Dies sind Produkte mit einem Rückgrat aus Stärke und einer nach dem Prinzip des Radikalkettenmechanismus aufgepfropften Seitengitters eines synthetischen Monomers. Die heute verfügbaren Stärkepfropfpolymerisate zeichnen sich durch ein besseres Binde- und Rückhaltevermögen von bis zu 1000 g Wasser pro g Stärke bei hoher Viskosität aus. Die Anwendungsbereiche für diese Superabsorber haben sich in den letzten Jahren stark ausgeweitet und liegen im Hygienebereich mit Produkten wie Windeln und Unterlagen sowie im landwirtschaftlichen Sektor, z.B. bei Saatgutpillierungen.Because of their extreme water-binding capacity, starch graft polymers have also become extremely important. these are Products with a backbone made of starch and a side grid of a synthetic monomer grafted on according to the principle of the radical chain mechanism. The starch graft polymers available today are characterized by better binding and retention properties of up to 1000 g of water per g of starch with high viscosity. The areas of application for these superabsorbents have expanded considerably in recent years and are in the hygiene sector with products such as diapers and pads as well as in the agricultural sector, for example in seed pilling.
Entscheidend für den Einsatz der neuen, gentechnisch veränderten Stärken sind zum einen die Struktur, Wassergehalt, Proteingehalt, Lipidgehalt, Fasergehalt, Asche/Phosphatgehalt, Amylose/Amylopektinverhältnis, Molmassenverteilung, Verzweigungsgrad, Korngröße und -form sowie Kristallinität, zum anderen auch die Eigenschaften, die in folgende Merkmale münden: Fließ- und Sorptionsverhalten, Verkleisterungstemperatur, Viskosität, Viskositätsstabilität in Salzlösungen, Dickungsleistung, Löslichkeit, Kleisterstruktur und -transparenz, Hitze-, Scher- und Säurestabilität, Retrogradationsneigung, Gelbildung, Gefrier/Taustabilität, Komplexbildung, Jodbindung, Filmbildung, Klebekraft, Enzymstabilität, Verdaulichkeit und Reaktivität.Decisive for the use of the new, genetically modified starches are on the one hand the structure, water content, protein content, lipid content, fiber content, ash / phosphate content, amylose / amylopectin ratio, molar mass distribution, degree of branching, grain size and shape as well as crystallinity, and on the other hand also the properties flow into the following characteristics: flow and sorption behavior, gelatinization temperature, viscosity, viscosity stability in salt solutions, thickening performance, solubility, paste structure and transparency, heat, shear and acid stability, tendency to retrogradation, gel formation, freeze / thaw stability, complex formation, iodine binding, film formation, adhesive strength , Enzyme stability, digestibility and reactivity.
Die Erzeugung modifizierter Stärken mittels gentechnischer Verfahren kann zum einen die Eigenschaften der aus der Pflanze gewonnenen Stärke dahingehend verändern, daß weitere Modifikationen mittels chemischer oder physikalischer Verfahren nicht mehr notwendig erscheinen. Zum anderen können die durch gentechnische Verfahren veränderte Stärken weiteren chemischen Modifikationen unterworfen werden, was zu weiteren Verbesserungen der Qualität für bestimmte der oben beschriebenen Einsatzgebiete führt. Diese chemischen Modifikationen sind grundsätzlich bekannt. Insbesondere handelt es sich dabei um Modifikationen durch Hitzebehandlung, Behandlung mit organischen oder anorganischen Säuren, Oxidation und Veresterungen, welche z.B. zur Entstehung von Phosphat-, Nitrat-, Sulfat-, Xanthat-, Acetat- und Citratstärken führen. Desweiteren können ein- oder mehrwertige Alkohole in Gegenwart starker Säuren zur Erzeugung von Stärkeethern eingesetzt werden, so daß Stärke-Alkylether, O-Allylether, Hydroxylalkylether, O- Carboxylmethylether, N-haltige Stärkeether, P-haltige Stärkeether), S-haltige Stärkeether, vernetzte Stärken oder Stärke-Pfropf-Polymerisate resultieren.The generation of modified starches by means of genetic engineering methods can, on the one hand, change the properties of the starch obtained from the plant in such a way that further modifications by means of chemical or physical methods no longer appear necessary. On the other hand, the starches modified by genetic engineering processes can be subjected to further chemical modifications, which leads to further improvements in quality for certain of the fields of application described above. These chemical modifications are generally known. In particular, these are modifications by heat treatment, treatment with organic or inorganic acids, oxidation and esterifications, which, for example, lead to the formation of phosphate, nitrate, sulfate, xanthate, acetate and Lead citrate starches. Furthermore, monohydric or polyhydric alcohols can be used in the presence of strong acids to produce starch ethers, so that starch alkyl ether, O-allyl ether, hydroxyl alkyl ether, O-carboxylmethyl ether, N-containing starch ether, P-containing starch ether), S-containing starch ether, cross-linked starches or starch graft polymers result.
Eine bevorzugte Verwendung der erfindungsgemäße Stärken liegt in der Herstellung von Verpackungsmaterial und Einwegartikeln einerseits sowie als Lebensmittel oder Lebensmittelvorprodukt andererseits.A preferred use of the starches according to the invention is in the production of packaging material and disposable articles on the one hand and as food or intermediate food product on the other hand.
Zur Expression der erfindungsgemäßen Nucleinsäuremoleküle in sense- oder antisense-Orientierung in pflanzlichen Zellen werden diese mit regulatorischen DNA-Elementen verknüpft, die die Transkription in pflanzlichen Zellen gewährleisten. Hierzu zählen insbesonderePromotoren, Enhancer und Terminatoren. Generell kommt für die Expression jeder in pflanzlichen Zellen aktive Promotor in Frage.To express the nucleic acid molecules according to the invention in sense or antisense orientation in plant cells, these are linked to regulatory DNA elements which ensure transcription in plant cells. These include in particular promoters, enhancers and terminators. In general, any promoter active in plant cells can be used for the expression.
Der Promotor kann dabei so gewählt sein, daß die Expression konstitutiv erfolgt oder nur in einem bestimmten Gewebe, zu einem bestimmten Zeitpunkt der Pflanzenentwicklung oder zu einem durch äußere Einflüsse determinierten Zeitpunkt. In Bezug auf die Pflanze kann der Promotor homolog oder heterolog sein. Geeignete Promotoren sind z.B. der Promotor der 35S RNA des Cauliflower Mosaic Virus und der Ubiquitin-Promotor aus Mais für eine konstitutive Expression, der Patatin-Promotor B33 (Rocha-Sosa et al., EMBO J. 8 (1 989), 23-29) für eine knollenspezifische Expression oder ein Promotor, der eine Expression lediglich in photosynthetisch aktiven Geweben sicherstellt, z.B. der ST-LS1 -Promotor (Stockhaus et al., Proc. Natl. Acad. Sei. USA 84 (1 987), 7943-7947; Stockhaus et al., EMBO J. 8 (1 989), 2445-2451 ) oder für eine en- dosperm-spezifische Expression der HMG-Promotor aus Weizen, der USP- Promotor, der Phaseolinpromotor oder Promotoren von Zein-Genen aus Mais. Ferner kann eine Terminationssequenz vorhanden sein, die der korrekten Beendigung der Transkription dient sowie der Addition eines Poiy-A-Schwanzes an das Transkript, dem eine Funktion bei der Stabilisierung der Transkripte beigemessen wird. Derartige Elemente sind in der Literatur beschrieben (vgl. Gielen et al., EMBO J. 8 (1 989), 23-29) und sind beliebig austauschbar.The promoter can be selected so that the expression is constitutive or only in a certain tissue, at a certain time in plant development or at a time determined by external influences. The promoter can be homologous or heterologous to the plant. Suitable promoters are, for example, the 35S RNA promoter of the Cauliflower Mosaic Virus and the ubiquitin promoter from maize for constitutive expression, the patatin promoter B33 (Rocha-Sosa et al., EMBO J. 8 (1 989), 23-29 ) for a tuber-specific expression or a promoter which ensures expression only in photosynthetically active tissues, for example the ST-LS1 promoter (Stockhaus et al., Proc. Natl. Acad. Sci. USA 84 (1 987), 7943-7947 ; Stockhaus et al., EMBO J. 8 (1 989), 2445-2451) or, for an endosperm-specific expression, the HMG promoter from wheat, the USP promoter, the phaseolin promoter or promoters from zein genes from maize . There may also be a termination sequence which serves to correctly terminate the transcription and to add a Poiy-A tail to the transcript, which is assigned a function in stabilizing the transcripts. Such elements are described in the literature (cf. Gielen et al., EMBO J. 8 (1 989), 23-29) and are interchangeable.
Die vorliegende Erfindung stellt Nucleinsäuremoleküle zur Verfügung, die ein Protein mit der Funktion einer lösliche Stärkesynthase aus Weizen codieren. Die erfindungsgemäßen Nucleinsäuremoleküle erlauben die Herstellung dieses Enzyms, dessen funktionale Identifizierung innerhalb der Stärkebiosynthese, die Herstellung gentechnisch veränderter Pflanzen, bei denen die Aktivität dieses Enzyms verändert ist und ermöglicht somit die Synthese einer Stärke mit veränderter Struktur und veränderten physikalisch-chemischen Eigenschaften in derartig modifizierten Pflanzen.The present invention provides nucleic acid molecules that encode a protein with the function of a soluble starch synthase from wheat. The nucleic acid molecules according to the invention allow the production of this enzyme, its functional identification within the starch biosynthesis, the production of genetically modified plants in which the activity of this enzyme is changed and thus enables the synthesis of a starch with a modified structure and changed physicochemical properties in such modified plants .
Die erfindungsgemäßen Nucleinsäuremoleküle können prinzipiell auch dazu verwendet werden, Pflanzen herzustellen, in denen die Aktivität der erfindungsgemäßen Stärkesynthase erhöht oder verringert ist und gleichzeitig die Aktivitäten anderer, an der Stärkesynthese beteiligter Enyzme verändert sind. Durch die Veränderung der Aktivitäten einer Stärkesynthase in Pflanzen kommt es zur Synthese einer in ihrer Struktur veränderten Stärke. Ferner können Nucleinsäuremoleküle, die eine Stärkesynthase codieren oder entsprechende antisense-Konstrukte, in Pflanzenzellen eingebracht werden, bei denen bereits die Synthese endogener GBSS I-, SSS- oder GBSS Il-Proteine aufgrund eines antisense-Effektes oder einer Mutation inhibiert ist oder die Synthese des Verzweigungsenzyms inhibiert ist (wie z.B. in WO 92/14827 oder Shannon und Garwood, 1 984, in Whistler, BeMiller und Paschall, Starch:Chemistry and Technology, Academic Press, London, 2nd Edition: 25-86).In principle, the nucleic acid molecules according to the invention can also be used to produce plants in which the activity of the starch synthase according to the invention is increased or decreased and at the same time the activities of other enzymes involved in starch synthesis are changed. The change in the activities of a starch synthase in plants leads to the synthesis of a starch with a different structure. Furthermore, nucleic acid molecules which encode a starch synthase or corresponding antisense constructs can be introduced into plant cells in which the synthesis of endogenous GBSS I, SSS or GBSS II proteins is already inhibited due to an antisense effect or a mutation or the synthesis of the Branching enzyme is inhibited (such as in WO 92/14827 or Shannon and Garwood, 1,984, in Whistler, BeMiller and Paschall, Starch: Chemistry and Technology, Academic Press, London, 2nd Edition: 25-86).
Soll die Inhibierung der Synthese mehrerer an der Stärkebiosynthese beteiligter Enzyme in transformierten Pflanzen erreicht werden, so können DNA-Moleküle zur Transformation verwendet werden, die gleichzeitig mehrere, die entsprechenden Enzyme codierenden Regionen in antisense-Orientierung unter der Kontrolle eines geeigneten Promotors enthalten. Hierbei kann alternativ jede Sequenz unter der Kontrolle eines eigenen Promotors stehen, oder die Sequenzen können als Fusion von einem gemeinsamen Promotor transkribiert werden bzw. unter der Kontrolle eines gemeinsamen Promoters stehen. Letztere Alternative wird in der Regel vorzuziehen sein, da in diesem Fall die Synthese der entsprechenden Proteine in etwa gleichem Maße inhibiert werden sollte. Für die Länge der einzelnen codierenden Regionen, die in einem derartigen Konstrukt verwendet werden, gilt das, was oben bereits für die Herstellung von antisense- Konstrukten ausgeführt wurde. Eine obere Grenze für die Anzahl der in einem derartigen DNA-Molekül von einem Promotor aus transkribierten antisense- Fragmente gibt es prinzipiell nicht. Das entstehende Transkript sollte aber vorzugsweise eine Länge von 10 kb und insbesondere eine Länge von 5 kb nicht überschreiten.Is the inhibition of the synthesis of several involved in the starch biosynthesis Enzymes are achieved in transformed plants, DNA molecules can be used for the transformation which simultaneously contain several regions coding for the corresponding enzymes in antisense orientation under the control of a suitable promoter. Alternatively, each sequence can be under the control of its own promoter, or the sequences can be transcribed as a fusion from a common promoter or under the control of a common promoter. The latter alternative will generally be preferable since in this case the synthesis of the corresponding proteins should be inhibited to approximately the same extent. For the length of the individual coding regions which are used in such a construct, that which has already been stated above for the production of antisense constructs applies. In principle, there is no upper limit for the number of antisense fragments transcribed from a promoter in such a DNA molecule. However, the resulting transcript should preferably not exceed a length of 10 kb and in particular a length of 5 kb.
Codierende Regionen, die in derartigen DNA-Molekülen in Kombination mit anderen codierenden Regionen in antisense-Orientierung hinter einem geeigneten Promotor lokalisiert sind, können aus DNA-Sequenzen stammen, die für folgende Proteine codieren: Stärkekorn-gebundene (GBSS I und II) und lösliche Starkesynthasen (SSS I und II), Verzweigungsenzyme (Isoamylasen, Pullulanasen, R-Enzyme, "Branching"-Enzyme, "Debranching"-Enzyme), Stärkephosphorylasen und Disproportionierungsenzyme. Dies ist nur eine beispielhafte Aufzählung. Auch die Verwendung anderer DNA-Sequenzen im Rahmen einer derartigen Kombination ist denkbar.Coding regions, which are located in such DNA molecules in combination with other coding regions in antisense orientation behind a suitable promoter, can originate from DNA sequences which code for the following proteins: starch-bound (GBSS I and II) and soluble Starch synthases (SSS I and II), branching enzymes (isoamylases, pullulanases, R enzymes, "branching" enzymes, "debranching" enzymes), starch phosphorylases and disproportionation enzymes. This is only an example. The use of other DNA sequences in the context of such a combination is also conceivable.
Mit Hilfe derartiger Konstrukte ist es möglich, in Pflanzenzellen, die mit diesen transformiert wurden, die Synthese mehrerer Enzyme gleichzeitig zu inhibieren. Weiterhin können die Konstrukte in pflanzliche Mutanten eingebracht werden, die für ein oder mehrere Gene der Stärkebiosynthese defekt sind (Shannon und Garwood, 1 984, in Whistler, BeMiller und Paschall, Starch:Chemistry and Technology, Academic Press, London, 2nd Edition: 25-86). Diese Defekte können sich auf folgende Proteine beziehen: Stärkekorn-gebundene (GBSS I und II) und lösliche Starkesynthasen (SSS I und II), Verzweigungsenzyme (BE I und II), "Debranching"-Enzyme (R-Enzyme), Disproportionierungsenzyme und Stärkephosphorylasen. Dies ist nur eine beispielhafte Aufzählung.With the help of such constructs, it is possible to inhibit the synthesis of several enzymes simultaneously in plant cells which have been transformed with them. Furthermore, the constructs can be introduced into plant mutants which are defective for one or more genes of starch biosynthesis (Shannon and Garwood, 1,984, in Whistler, BeMiller and Paschall, Starch: Chemistry and Technology, Academic Press, London, 2nd Edition: 25 -86). These defects can relate to the following proteins: starch-bound (GBSS I and II) and soluble starch synthases (SSS I and II), branching enzymes (BE I and II), "debranching" enzymes (R-enzymes), disproportionation enzymes and starch phosphorylases . This is only an example.
Mit Hilfe einer derartigen Vorgehensweise ist es weiterhin möglich, in Pflanzenzellen, die mit diesen transformiert wurden, die Synthese mehrerer Enzyme gleichzeitig zu inhibieren.With the help of such a procedure it is also possible to inhibit the synthesis of several enzymes simultaneously in plant cells which have been transformed with them.
Zur Vorbereitung der Einführung fremder Gene in höhere Pflanzen stehen eine große Anzahl von Klonierungsvektoren zur Verfügung, die ein Replikationssignal für E.coli und ein Markergen zur Selektion transformierter Bakterienzellen enthalten. Beispiele für derartige Vektoren sind pBR322, pUC-Serien, M 1 3mp- Serien, pACYC1 84 usw.. Die gewünschte Sequenz kann an einer passenden Restriktionsschnittstelle in den Vektor eingeführt werden. Das erhaltene Plasmid wird für die Transformation von E.coli-Zellen verwendet. Transformierte E.coli- Zellen werden in einem geeigneten Medium gezüchtet, anschließend geerntet und lysiert. Das Plasmid wird wiedergewonnen. Als Analysemethode zur Charakterisierung der gewonnenen Plasmid-DNA werden im allgemeinen Restriktionsanalysen, Gelelektrophoresen und weitere biochemisch- molekularbiologische Methoden eingesetzt. Nach jeder Manipulation kann die Plasmid-DNA gespalten und gewonnene DNA-Fragmente mit anderen DNA- Sequenzen verknüpft werden. Jede Plasmid-DNA-Sequenz kann in den gleichen oder anderen Plasmiden cloniert werden.A large number of cloning vectors are available to prepare the introduction of foreign genes into higher plants, which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells. Examples of such vectors are pBR322, pUC series, M 1 3mp series, pACYC1 84 etc. The desired sequence can be introduced into the vector at a suitable restriction site. The plasmid obtained is used for the transformation of E. coli cells. Transformed E.coli cells are grown in a suitable medium, then harvested and lysed. The plasmid is recovered. Restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are generally used as the analysis method for characterizing the plasmid DNA obtained. After each manipulation, the plasmid DNA can be cleaved and DNA fragments obtained can be linked to other DNA sequences. Each plasmid DNA sequence can be cloned into the same or different plasmids.
Für die Einführung von DNA in eine pflanzliche Wirtszelle stehen eine Vielzahl von Techniken zur Verfügung. Diese Techniken umfassen die Transformation pflanzlicher Zellen mit T-DNA unter Verwendung von Agrobacterium tumefaciens oder Agrobacterium rhizogenes als Transformationsmittel, die Fusion von Protoplasten, die Injektion, die Elektroporation von DNA, die Einbringung von DNA mittels der biolistischen Methode sowie weitere Möglichkeiten.A variety of techniques are available for introducing DNA into a plant host cell. These techniques include transformation plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agents, the fusion of protoplasts, the injection, the electroporation of DNA, the introduction of DNA using the biolistic method and other possibilities.
Bei der Injektion und Elektroporation von DNA in Pflanzenzellen werden an sich keine speziellen Anforderungen an die verwendeten Plasmide gestellt. Es können einfache Plasmide wie z.B. pUC-Derivate verwendet werden. Sollen aber aus derartig transformierten Zellen ganze Pflanzen regeneriert werden, ist in der Regel die Anwesenheit eines selektierbaren Markergens notwendig.When injecting and electroporation of DNA into plant cells, there are no special requirements for the plasmids used. Simple plasmids such as e.g. pUC derivatives can be used. However, if whole plants are to be regenerated from such transformed cells, the presence of a selectable marker gene is generally necessary.
Je nach Einführungsmethode gewünschter Gene in die Pflanzenzelle können weitere DNA-Sequenzen erforderlich sein. Werden z.B. für die Transformation der Pflanzenzelle das Ti- oder Ri-Plasmid verwendet, so muß mindestens die rechte Begrenzung, häufig jedoch die rechte und linke Begrenzung der Ti- und Ri- Plasmid T-DNA als Flankenbereich mit den einzuführenden Genen verbunden werden.Depending on the method of introducing desired genes into the plant cell, additional DNA sequences may be required. E.g. If the Ti or Ri plasmid is used for the transformation of the plant cell, at least the right boundary, but frequently the right and left boundary of the Ti and Ri plasmid T-DNA as the flank region, must be linked to the genes to be introduced.
Werden für die Transformation Agrobakterien verwendet, muß die einzuführende DNA in spezielle Plasmide cloniert werden, und zwar entweder in einen intermediären Vektor oder in einen binären Vektor. Die intermediären Vektoren können aufgrund von Sequenzen, die homolog zu Sequenzen in der T-DNA sind, durch homologe Rekombination in das Ti- oder Ri-Plasmid der Agrobakterien integriert werden. Dieses enthält außerdem die für den Transfer der T-DNA notwendige vir-Region. Intermediäre Vektoren können nicht in Agrobakterien replizieren. Mittels eines Helferplasmids kann der intermediäre Vektor auf Agrobacterium tumefaciens übertragen werden (Konjugation). Binäre Vektoren können sowohl in E.coli als auch in Agrobakterien replizieren. Sie enthalten ein Selektionsmarker-Gen und einen Linker oder Polylinker, welche von der rechten und linken T-DNA Grenzregion eingerahmt werden. Sie können direkt in die Agrobakterien transformiert werden (Holsters et al. Mol. Gen. Genet. 1 63 (1 978), 1 81 -1 87) . Das als Wirtszelle dienende Agrobakterium soll ein Plasmid, das eine vir-Region trägt, enthalten. Die vir-Region ist für den Transfer der T- DNA in die Pflanzenzelle notwendig. Zusätzliche T-DNA kann vorhanden sein. Das derartig transformierte Agrobakterium läßt sich zur Transformation von Pflanzenzellen verwenden.If agrobacteria are used for the transformation, the DNA to be introduced must be cloned into special plasmids, either in an intermediate vector or in a binary vector. The intermediate vectors can be integrated into the Ti or Ri plasmid of the agrobacteria on the basis of sequences which are homologous to sequences in the T-DNA by homologous recombination. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria. Using a helper plasmid, the intermediate vector can be transferred to Agrobacterium tumefaciens (conjugation). Binary vectors can replicate in both E. coli and agrobacteria. They contain a selection marker gene and a linker or polylinker, which is from the right and left T-DNA border region are framed. They can be transformed directly into the agrobacteria (Holsters et al. Mol. Gen. Genet. 1 63 (1 978), 1 81 -1 87). The agrobacterium serving as the host cell is said to contain a plasmid which carries a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present. The agrobacterium transformed in this way can be used to transform plant cells.
Die Verwendung von T-DNA für die Transformation von Pflanzenzellen ist intensiv untersucht und ausreichend in EP 1 20 51 6; Hoekema, In: The Binary Plant Vector System Offsetdrukkerij Kanters B.V., Alblasserdam (1 985), Chapter V; Fraley et al., Crit. Rev. Plant. Sei., 4, 1 -46 und An et al. EMBO J. 4 (1 985), 277-287 beschrieben worden.The use of T-DNA for the transformation of plant cells has been intensively investigated and is sufficient in EP 1 20 51 6; Hoekema, In: The Binary Plant Vector System Offsetdrukkerij Kanters B.V., Alblasserdam (1 985), Chapter V; Fraley et al., Crit. Rev. Plant. Sci., 4, 1-46 and An et al. EMBO J. 4 (1 985), 277-287.
Für den Transfer der DNA in die Pflanzenzelle können Pflanzen-Explantate zweckmäßigerweise mit Agrobacterium tumefaciens oder Agrobacterium rhizogenes kokultiviert werden. Aus dem infizierten Pflanzenmaterial (z.B. Blattstücke, Stengelsegmente, Wurzeln, aber auch Protoplasten oder Suspensions-kultivierte Pflanzenzellen) können dann in einem geeigneten Medium, welches u.a. bestimmte Zucker, Aminosäuren, Antibiotika oder Biozide zur Selektion transformierter Zellen enthalten kann, wieder ganze Pflanzen regeneriert werden. Die so erhaltenen Pflanzen können dann auf Anwesenheit der eingeführten DNA untersucht werden. Andere Möglichkeiten der Einführung fremder DNA unter Verwendung des biolistischen Verfahrens oder durch Protoplastentransformation sind bekannt (vgl. z.B. Willmitzer, L., 1 993 Transgenic plants. In: Biotechnology, A Multi-Volume Comprehensive Treatise (HJ. Rehm, G. Reed, A. Pühler, P. Stadler, eds.), Vol. 2, 627-659, VCH Weinheim-New York-Basel-Cambridge) .For the transfer of the DNA into the plant cell, plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes. The infected plant material (e.g. leaf pieces, stem segments, roots, but also protoplasts or suspension-cultivated plant cells) can then be removed in a suitable medium, which, among other things. certain sugars, amino acids, antibiotics or biocides for the selection of transformed cells can contain, whole plants can be regenerated again. The plants thus obtained can then be examined for the presence of the introduced DNA. Other possibilities of introducing foreign DNA using the biolistic method or by protoplast transformation are known (cf. for example Willmitzer, L., 1 993 Transgenic plants. In: Biotechnology, A Multi-Volume Comprehensive Treatise (HJ. Rehm, G. Reed, A Pühler, P. Stadler, eds.), Vol. 2, 627-659, VCH Weinheim-New York-Basel-Cambridge).
Während die Transformation dikotyler Pflanzen über Ti-Plasmid-Vektorsysteme mit Hilfe von Agrobacterium tumefaciens wohl etabliert ist, weisen neuere Arbeiten darauf hin, daß auch monokotyle Pflanzen der Transformation mittels Agrobacterium basierender Vektoren sehr wohl zugänglich sind (Chan et al., Plant Mol. Biol. 22 (1 993), 491 -506; Hiei et al., Plant J. 6 (1 994), 271 -282).While the transformation of dicotyledonous plants via Ti plasmid vector systems with the help of Agrobacterium tumefaciens is well established, more recent ones Work on the fact that monocotyledonous plants can also be transformed using Agrobacterium-based vectors (Chan et al., Plant Mol. Biol. 22 (1 993), 491-506; Hiei et al., Plant J. 6 (1 994), 271-282).
Alternative Verfahren zur Transformation von monokotylen Pflanzen bestehen mittels des biolistischen Ansatzes, der Protoplastentransformation oder der physikalisch oder chemisch induzierten DNA-Aufnahme in Protoplasten, z.B. durch Elektroporation von partiell permeabilisierten Zellen, Transfer von DNA mittels Glasfasern, Makroinjektion von DNA in Blütenstände, die Mikroinjektion von DNA in Mikrosporen oder Pro-Embryonen, die DNA-Aufnahme durch keimenden Pollen und die DNA-Aufnahme in Embryonen durch Quellung (zur Übersicht: Potrykus, Physiol. Plant (1 990), 269 - 273).Alternative methods for the transformation of monocotyledonous plants exist by means of the biolistic approach, the protoplast transformation or the physically or chemically induced DNA uptake in protoplasts, e.g. by electroporation of partially permeabilized cells, transfer of DNA using glass fibers, macro-injection of DNA into inflorescences, micro-injection of DNA into microspores or pro-embryos, DNA uptake by germinating pollen and DNA uptake in embryos by swelling (for an overview: Potrykus, Physiol. Plant (1 990), 269-273).
Drei der oben genannten Transformationssysteme konnten in der Vergangenheit für verschiedene Getreide etabliert werden: die Elektroporation von Gewebe, die Transformation von Protoplasten und der DNA-Transfer durch Partikel-Beschüß in regenerierbare Gewebe und Zellen (zur Übersicht: Jahne et al., Euphytica 85 (1 995), 35 - 44).In the past, three of the above-mentioned transformation systems could be established for different cereals: the electroporation of tissue, the transformation of protoplasts and the DNA transfer by particle bombardment into regenerable tissue and cells (for an overview: Jahne et al., Euphytica 85 ( 1 995), 35-44).
Die Transformation von Weizen wird in der Literatur verschiedentlich beschrieben (zur Übersicht: Maheshwari et al., Critical Reviews in Plant Science 1 4 (2) (1 995), 149 bis 1 78): Hess et al. (Plant Sei. 72 (1 990), 233) benutzten das Verfahren der Makroinjektion, um Pollen und Agrobakterien in unmittelbare Nähe zu bringen. Die Mobilisierung des Plasmids, das das nptll Gen als selektierbaren Marker enthielt, wurde mittels Southern Blot Analyse und NPTII Test nachgewiesen. Die Transformanten zeigten einen normalen Phänotyp und waren fertil. Die Kanamycin-Resistenz konnte in zwei aufeinanderfolgende Generationen nachgewiesen werden.The transformation of wheat is described variously in the literature (for overview: Maheshwari et al., Critical Reviews in Plant Science 1 4 (2) (1 995), 149 to 1 78): Hess et al. (Plant Sei. 72 (1 990), 233) used the macro-injection method to bring pollen and agrobacteria in close proximity. The mobilization of the plasmid, which contained the nptll gene as a selectable marker, was demonstrated by Southern blot analysis and NPTII test. The transformants showed a normal phenotype and were fertile. Kanamycin resistance has been demonstrated in two successive generations.
Die erste transgene, fertile Weizenpflanze, die nach Beschüß mit Mikroprojektil- gebundener DNA regeneriert werden konnte, wurde von Vasil et al. (Bio/Technology 10 (1 992), 667 - 674) beschrieben. Das Zielgewebe für den Beschüß war eine embryogene Kalluskultur (Typ C Kallus). Als Selektionsmarker wurde das bar Gen eingesetzt, das eine Phosphinothricin Acetyltransferase codiert und somit eine Resistenz gegen das Herbizid Phosphinothricin vermittelt. Ein weiteres System wurde von Weeks et al. (Plant Physiol. 102 (1 993), 1077 - 1084), sowie Becker et al. (Plant J. 5(2) (1 994), 299 - 307) beschrieben. Hier ist das Zielgewebe für die DNA-Transformation das Skutellum unreifer Embryonen, das in einer einleitenden in vitro Phase zur Induktion somatischer Embryonen angeregt wurde. Die Effizienz der Transformation liegt bei dem von Becker et al. (loc cit.) entwickelten System mit 1 transgene Pflanze pro 83 Embryonen der Sorte "Florida" deutlich höher als bei dem von Weeks et al. etablierten System mit 1 bis 2 transgenen Pflanzen pro 1000 Embryonen der Sorte "Bohwhite".The first transgenic, fertile wheat plant, which after bombardment with microprojectile bound DNA could be regenerated by Vasil et al. (Bio / Technology 10 (1,992), 667-674). The target tissue for the bombardment was an embryogenic callus culture (type C callus). The bar gene which encodes a phosphinothricin acetyltransferase and thus imparts resistance to the herbicide phosphinothricin was used as the selection marker. Another system was developed by Weeks et al. (Plant Physiol. 102 (1,993), 1077-1084), and Becker et al. (Plant J. 5 (2) (1 994), 299-307). The target tissue for DNA transformation here is the scutellum of immature embryos, which was stimulated in an introductory in vitro phase to induce somatic embryos. The efficiency of the transformation lies with that of Becker et al. (loc cit.) developed system with 1 transgenic plant per 83 embryos of the "Florida" variety significantly higher than that of Weeks et al. established system with 1 to 2 transgenic plants per 1000 "Bohwhite" embryos.
Das von Becker et al. (loc. Cit) entwickelte System bildet die Basis für die in den Beispielen beschriebenen Transformationsexperimente.The Becker et al. (loc. Cit) developed system forms the basis for the transformation experiments described in the examples.
Ist die eingeführte DNA einmal im Genom der Pflanzenzelle integriert, so ist sie dort in der Regel stabil und bleibt auch in den Nachkommen der ursprünglich transformierten Zelle erhalten. Sie enthält normalerweise einender oben erwähnten Selektionsmarker, der den transformierten Pflanzenzellen z.B. Resistenz gegenüber einem Biozid wie Phosphinothricin oder einem Antibiotikum wie Kanamycin, G 41 8, Bleomycin oder Hygromycin vermittelt oder die Selektion über die An- oder Abwesenheit bestimmter Zucker oder Aminosäuren gestattet. Der individuell gewählte Marker sollte daher die Selektion transformierter Zellen gegenüber Zellen gestatten, denen die eingeführte DNA fehlt.Once the introduced DNA is integrated in the genome of the plant cell, it is generally stable there and is also retained in the progeny of the originally transformed cell. It normally contains one of the selection markers mentioned above, which e.g. Resistance to a biocide such as phosphinothricin or an antibiotic such as Kanamycin, G 41 8, bleomycin or hygromycin mediated or the selection of the presence or absence of certain sugars or amino acids allowed. The individually selected marker should therefore allow the selection of transformed cells over cells that lack the inserted DNA.
Die transformierten Zellen wachsen innerhalb der Pflanze in der üblichen Weise (siehe auch McCormick et al., Plant Cell Reports 5 (1 986), 81 -84). Die resultierenden Pflanzen können normal angezogen werden und mit Pflanzen, die die gleiche transformierte Erbanlage oder andere Erbanlagen besitzen, gekreuzt werden. Die daraus entstehenden hybriden Individuen haben die entsprechenden phänotypischen Eigenschaften. Von den Pflanzenzellen können Samen gewonnen werden.The transformed cells grow within the plant in the usual way (see also McCormick et al., Plant Cell Reports 5 (1 986), 81-84). The resulting plants can be grown normally and with plants that have the same transformed genetic makeup or other genetic makeup, are crossed. The resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plant cells.
Es sollten zwei oder mehrere Generationen angezogen werden, um sicherzustellen, daß das phänotypische Merkmal stabil beibehalten und vererbt wird. Auch sollten Samen geerntet werden, um sicherzustellen, daß der entsprechende Phänotyp oder andere Eigenarten erhalten geblieben sind.Two or more generations should be grown to ensure that the phenotypic trait is stably maintained and inherited. Seeds should also be harvested to ensure that the appropriate phenotype or other characteristics have been preserved.
Die nachfolgenden Beispiele sollen die Erfindung illustrieren und stellen keinerlei Beschränkung dar.The following examples are intended to illustrate the invention and do not represent any limitation.
1 . Clonierungsverfahren1 . Cloning process
Zur Clonierung in E. coli wurde der Vektor pBluescript II SK (Stratagene) verwendet.The vector pBluescript II SK (Stratagene) was used for cloning in E. coli.
2. Bakterienstämme2. Bacterial strains
Für den Bluescript-Vektor und für die antisense-Konstrukte wurde der E. coli Stamm DH5α (Bethesda Research Laboratories, Gaithersburg, USA) verwendet. Für die in vivo Excision wurde der E. coli-Stamm XL1 -Blue verwendet.The E. coli strain DH5α (Bethesda Research Laboratories, Gaithersburg, USA) was used for the Bluescript vector and for the antisense constructs. The E. coli strain XL1-Blue was used for the in vivo excision.
3. Transformation unreifer Weizenembryonen3. Transformation of immature wheat embryos
Medienmedia
MS: 100 ml/l Makrosalz (D.Becker und H. Lörz, 1 ml/l Mikrosalz Plant Tissue CultureMS: 100 ml / l macro salt (D.Becker and H. Lörz, 1 ml / l micro salt Plant Tissue Culture
2 ml/l Fe/NaEDTA Manual (1 996), B 1 2: 1 -20) 30 g/l Saccharose2 ml / l Fe / NaEDTA Manual (1 996), B 1 2: 1 -20) 30 g / l sucrose
#30: MS + 2,4-D (2 mg/l)# 30: MS + 2,4-D (2 mg / l)
#31 MS + 2,4-D (2 mg/l) + Phosphinothricin (PPT, aktive Komponente des Herbizids BASTA (2 mg/l))# 31 MS + 2,4-D (2 mg / l) + phosphinothricin (PPT, active component of the herbicide BASTA (2 mg / l))
#32: MS + 2,4-D (0, 1 mg/l) + PPT (2 mg/l)# 32: MS + 2,4-D (0.1 mg / l) + PPT (2 mg / l)
#39: MS + 2,4-D (2 mg/ml) + je 0,5 N Mannit/Sorbit# 39: MS + 2,4-D (2 mg / ml) + 0.5 N mannitol / sorbitol each
Die angegebenen Medien wurden auf den pH-Wert 5,6 mit KOH eingestellt und mit 0,3 % Gelrite verfestigt.The specified media were adjusted to pH 5.6 with KOH and solidified with 0.3% Gelrite.
Die Methode zur Transformation unreifer Embryonen aus Weizen wurde von Becker und Lörz (D. Becker und H. Lörz, Plant Tissue Culture Manual (1 996), B1 2: 1 bis 20) entwickelt und optimiert.The method for transforming immature embryos from wheat was developed and optimized by Becker and Lörz (D. Becker and H. Lörz, Plant Tissue Culture Manual (1 996), B1 2: 1 to 20).
In den nachfolgend beschriebenen Experimenten wurde sich an das von Becker und Lörz (loc. Cit) ausgearbeitete Protokoll gehalten.In the experiments described below, the protocol developed by Becker and Lörz (loc. Cit) was followed.
Zur Transformation werden Ähren mit Karyopsen der Entwicklungstufe 1 2 bis 14 Tage nach Anthesis geerntet und oberflächensterilisiert. Die isolierten Skutella werden mit der dem Medium zugewandten Embryoachse auf Induktionsmedium # 30 plattiert.For transformation, ears with caryopses of developmental level 1 are harvested 2 to 14 days after anthesis and surface sterilized. The isolated scutella are plated with the embryo axis facing the medium on induction medium # 30.
Nach 2 bis 4 tägiger Vorkultur (26 °C, dunkel) werden die Explantate auf Medium # 39 zur osmotischen Vorkultur (2 bis 4 h, 26 °C, dunkel) umgesetzt.After 2 to 4 days of preculture (26 ° C, dark), the explants are placed on medium # 39 converted to the osmotic preculture (2 to 4 h, 26 ° C, dark).
Zur biolistischen Transformation werden pro Schuß ca. 29 μg Goldpartikel, auf die zuvor wenige μg der Ziel-DNA gefällt wurde, eingesetzt. Da es sich bei den durchgeführten Experimenten um Co-Transformanten handelt, wird die Ziel-DNA in einem Verhältnis von 1 :1 , bestehend aus dem Zielgen und einem Resistenzmarkergen (bar-Gen) dem Fällungsansatz zugegeben.Approximately 29 μg gold particles, onto which a few μg of the target DNA had previously been precipitated, are used for the biolistic transformation. Since the experiments carried out are co-transformants, the target DNA is added to the precipitation mixture in a ratio of 1: 1, consisting of the target gene and a resistance marker gene (bar gene).
4. DIG-Markierung von DNA-Fragmenten4. DIG labeling of DNA fragments
Die Markierung von DNA-Fragmenten, die als Screeningsonden eingesetzt wurden, erfolgte über eine spezifische PCR unter Einbau von DIG-markiertem dUTP (Boehringer Mannheim, Deutschland).The DNA fragments that were used as screening probes were labeled using a specific PCR with the incorporation of DIG-labeled dUTP (Boehringer Mannheim, Germany).
In den Beispielen verwendete Medien und Lösungen:Media and solutions used in the examples:
20 x SSC 1 75,3 g NaCI20 x SSC 1 75.3 g NaCl
88,2 g Natrium-Citrat ad 1000 ml mit ddH2O pH 7,0 mit 10 N NaOH88.2 g sodium citrate ad 1000 ml with ddH 2 O pH 7.0 with 10 N NaOH
Bei der DSMZ in Braunschweig, Bundesrepublik Deutschland, erfolgte die Hinterlegung des Plasmids pTaSSI 8/1 gemäß Budapester Vertrag unter der Nummer DSM 1 2794.The plasmid pTaSSI 8/1 was deposited at the DSMZ in Braunschweig, Federal Republic of Germany in accordance with the Budapest Treaty under number DSM 1 2794.
Beispiel 1 : Identifizierung, Isolierung und Charakterisierung einer cDNA, die eine lösliche Stärkesynthase (SS I) aus Weizen (Triticum aestivum L., cv. Florida) codiertExample 1: Identification, isolation and characterization of a cDNA encoding a soluble starch synthase (SS I) from wheat (Triticum aestivum L., cv. Florida)
Zur Identifizierung der vollständigen cDNA, die eine Isoform einer löslichen Stärkesynthase (SS I) aus Weizen codiert, wurde die Strategie des homologen Screening verfolgt. Hierfür wurde eine cDNA-Bank aus Weizen mit geeigneten Oligonucleotiden durchmustert (gescreent). Das SS I spezifische Oligonucleotid, das zum Screening eingesetzt wurde, war mittels des 5'RACE-Verfahren (Rapid Amplification of cDNA Ends) wie nachfolgend beschrieben isoliert worden.To identify the complete cDNA, which is an isoform of a soluble Starch synthase (SS I) encoded from wheat, the strategy of homologous screening was pursued. For this, a wheat cDNA library was screened with suitable oligonucleotides (screened). The SS I specific oligonucleotide used for screening was isolated using the 5'RACE method (Rapid Amplification of cDNA Ends) as described below.
Die Synthese der Weizen cDNA Bank erfolgte aus poly(A) + RNA von ca. 20 Tage alten Karyopsen (Endosperm) in einem Lambda Zap II Vektor analog den Angaben des Herstellers (Lambda ZAP 11-cDNA Synthesis Kit, Stratagene GmbH, Heidelberg, Deutschland). Nach Titerbestimmung der cDNA-Bank konnte ein Primärtiter von 1 ,26x106 pfu/ml ermittelt werden.The wheat cDNA bank was synthesized from poly (A) + RNA from approx. 20 day old caryopses (endosperm) in a Lambda Zap II vector analogous to the manufacturer's instructions (Lambda ZAP 11-cDNA Synthesis Kit, Stratagene GmbH, Heidelberg, Germany ). After determining the titer of the cDNA bank, a primary titer of 1.26 × 10 6 pfu / ml could be determined.
Das Durchmustern der cDNA Bank wurde mit einer SS I Sonde aus Weizen durchgeführt. Es wurde mittels 5'-RACE ein DNA Fragment isoliert und die Amplifizierung des 5'Endes mit einem 5'RACE-Kit (nachfolgend "Kit") der Firma Boehringer (Mannheim, Deutschland) durchgeführt. Alle Schritte wurden analog den Angaben des Herstellers durchgeführt. Es wurden ausschließlich Reagenzien und Enzyme aus dem Kit verwendet, wenn nicht anders beschrieben.Screening of the cDNA library was carried out with an SS I probe from wheat. A DNA fragment was isolated using 5'-RACE and the amplification of the 5'end was carried out using a 5'RACE kit (hereinafter "kit") from Boehringer (Mannheim, Germany). All steps were carried out in accordance with the manufacturer's instructions. Only reagents and enzymes from the kit were used, unless otherwise described.
Zunächst wurde poly(A) + RNA ca. 20 Tage alter Karyopsen in einzelsträngige cDNA transkribiert und in eine Tailing-Reaktion eingesetzt. Die daraus resultierende, im 5'-Bereich mit dem Oligo(dA)Anker#9 (Kit) versehene cDNA wurde in einer ersten Reaktion mit den Primern Oligo(dT)#8 (Kit) und B2F5 nach einem modifizierten Protokoll wie folgt amplifiziert: In einem 50 μl Ansatz wurden 5 μl getaute cDNA, 5 μl 10x Reaktionspuffer (Life Technologies), 0,25 μM B2F5-Primer, 0,75 μM Oligo(dT)#8, 0,2 mM dNTP's und 5U Taq Polymerase (rekombinant, Life Technologies) eingesetzt. Das PCR-Profil war: 94°C 3794°C 45" /56°C 1 772°C 1 '30", 29 Cyclen/72°C 5'. Daran anschließend wurde eine weitere PCR mit den Primern Oligo(dT)#8 (Kit),First, poly (A) + RNA of approximately 20 days old caryopses was transcribed into single-stranded cDNA and used in a tailing reaction. The resulting cDNA provided in the 5 'region with the oligo (dA) anchor # 9 (kit) was amplified in a first reaction with the primers oligo (dT) # 8 (kit) and B2F5 according to a modified protocol as follows: 5 μl of thawed cDNA, 5 μl of 10 × reaction buffer (Life Technologies), 0.25 μM B2F5 primer, 0.75 μM oligo (dT) # 8, 0.2 mM dNTP's and 5U Taq polymerase (recombinant , Life Technologies). The PCR profile was: 94 ° C 3794 ° C 45 "/ 56 ° C 1 772 ° C 1 '30", 29 cycles / 72 ° C 5'. This was followed by a further PCR with the primers Oligo (dT) # 8 (kit),
B2F5 und dem 5'-gelegenen Primer B2F6 durchgeführt. In einem 50μl Ansatz wurden 1 μl PCR-Produkt, 5μl 10x Reaktionspuffer (Life Technologies), 0,25 μMB2F5 and the 5'-located primer B2F6. In a 50 μl mixture, 1 μl PCR product, 5 μl 10 × reaction buffer (Life Technologies), 0.25 μM
B2F5-Primer, 0,25 μM B2F6-Primer, 0,75 μM Oligo(dT)#8, 0,2mM dNTP's undB2F5 primer, 0.25 µM B2F6 primer, 0.75 µM oligo (dT) # 8, 0.2mM dNTP's and
5U Taq Polymerase (rekombinant, Life Technologies) eingesetzt. Das PCR-Profil war:5U Taq polymerase (recombinant, Life Technologies) used. The PCR profile was:
94°C 3794°C 45"/60°C 1 '/72°C 1 '30"; 29 Cyclen/72°C 5'94 ° C 3794 ° C 45 "/ 60 ° C 1 '/ 72 ° C 1 '30"; 29 cycles / 72 ° C 5 '
B2F5: 5'CCTCCCAATTCAAGGATTAGTG 3' (Seq ID No. 3)B2F5: 5'CCTCCCAATTCAAGGATTAGTG 3 '(Seq ID No. 3)
B2F6: 5'CCTCGCATGCAGCATAGCAA 3' (Seq. ID No. 4)B2F6: 5'CCTCGCATGCAGCATAGCAA 3 '(Seq. ID No. 4)
Die nach vorstehenden Verfahren erhaltenen PCR-Produkte wurden in einem Agarosegel aufgetrennt und die DNA-Fragmente mit einer Größe über 800bp isoliert. Die Klonierung der PCR-Fragmente erfolgte mit dem pCR-Script SK( + ) Cloning Kit der Firma Stratagene (Heidelberg). Durch Sequenzanalyse der clonierten Subfragmente wurden ca. 1 50 bp bisher unbekannte Sequenz des SS I Clons identifiziert.The PCR products obtained by the above methods were separated in an agarose gel and the DNA fragments with a size greater than 800 bp were isolated. The PCR fragments were cloned using the pCR-Script SK (+) cloning kit from Stratagene (Heidelberg). Sequence analysis of the cloned subfragments identified approximately 1 50 bp previously unknown sequence of the SS I clone.
Aus dem 5'-Bereich dieser neuen Sequenz wurden die Oligonucleotide B2R00 und B2F6.2 zur Amplifikation eines DNA-Fragmentes (SS I-Sonde) ausgewählt, das anschließend mit Digoxygenin-1 1 -dUTP wie beschrieben markiert und als Sonde zum Screenen der Weizen cDNA Bank eingesetzt wurde. Die Markierung der SS I-Sonde erfolgte mittels einer PCR-Reaktion mit den Primern B2R00 und B2F6.2 analog den Angaben in "The DIG System Users's Guide for Filter Hybridisation" (Boehringer Mannheim).From the 5 'region of this new sequence, the oligonucleotides B2R00 and B2F6.2 were selected for the amplification of a DNA fragment (SS I probe), which was then labeled with digoxygenin-1 1 -UTP as described and as a probe for screening the wheat cDNA bank was used. The SS I probe was labeled by means of a PCR reaction with the primers B2R00 and B2F6.2 analogously to the information in "The DIG System Users Guide for Filter Hybridization" (Boehringer Mannheim).
B2R00: 5'TGTGGCTGCAAGTGAGGAGG 3' (Seq. ID No.5)B2R00: 5'TGTGGCTGCAAGTGAGGAGG 3 '(Seq. ID No.5)
B2F6.2 5'CCAGTCACAAACACGTAGCTACG 3' (Seq. ID No.6) Zum Durchmustern der Weizen cDNA Bank wurden ca. 700.000 Phagen ausplattiert. Ausplattieren der Phagen und Abziehen der Platten erfolgte nach Standardprotokollen. Die Prähybridisierung und Hybridisierung der Filter wurde in 5X SSC, 3 % Blocking (Boehringer Mannheim), 0,2 % Na-dodecylsulfat (SDS), 0.1 % Natrium Laurylsarcosin und 50 μg/ml Heringssperma DNA bei 65 °C durchgeführt. Der Hybridisierungslösung wurde 1 ,3 ng/ml der DIG-markierten SS I-Sonde zugesetzt und die Hybridisierung über Nacht inkubiert. Gewaschen wurden die Filter gemäß dem Protokoll wie beschrieben in "The DIG System User's Guide for Filter Hybridisation" (Boehringer Mannheim) bei 65 °C. Positive Clone wurden durch 2 weitere Screening Runden vereinzelt. Über in vivo Excision wurden vereinzelte Clone als pBluescript SK Phagemide erhalten (Durchführung analog den Angaben des Herstellers; Stratagene, Heidelberg).B2F6.2 5'CCAGTCACAAACACGTAGCTACG 3 '(Seq. ID No.6) Approx. 700,000 phages were plated out to screen the wheat cDNA bank. The phages were plated out and the plates were stripped off according to standard protocols. The prehybridization and hybridization of the filters was carried out in 5X SSC, 3% blocking (Boehringer Mannheim), 0.2% Na dodecyl sulfate (SDS), 0.1% sodium lauryl sarcosine and 50 μg / ml herring sperm DNA at 65 ° C. 1.3 ng / ml of the DIG-labeled SS I probe was added to the hybridization solution and the hybridization was incubated overnight. The filters were washed according to the protocol as described in "The DIG System User's Guide for Filter Hybridization" (Boehringer Mannheim) at 65 ° C. Positive clones were isolated by two more rounds of screening. Individual clones were obtained as in vivo excision as pBluescript SK phagemids (carried out analogously to the manufacturer's instructions; Stratagene, Heidelberg).
Nach Analyse der Clone über Minipräparierung und Restringierung der Plasmid- DNA wurde der Clon TaSSI 8/1 weiter analysiert.After analysis of the clones via mini-preparation and restriction of the plasmid DNA, the clone TaSSI 8/1 was further analyzed.
Beispiel 2: Sequenzanalyse der cDNA-lnsertionen des Plasmids pTaSSI 8/1Example 2: Sequence analysis of the cDNA inserts of the plasmid pTaSSI 8/1
Aus dem Clon TaSSI 8/1 wurd die Plasmid-DNA isoliert und die Sequenz der cDNA-lnsertionen mittels der Didesoxynukleotidmethode (Sanger et al., Proc. Natl. Acad. Sei. USA 74 (1 977), 5463-5467) bestimmt. Die Insertion des Clons TaSSI 8/1 ist 2805 bp lang und stellt eine vollständige cDNA dar. Die Nucleotidsequenz ist unter Seq ID No. 1 angegeben. Die entsprechende Aminosäuresequenz ist unter Seq ID No. 2 angegeben. Ein Vergleich mit bereits publizierten Sequenzen zeigte, daß die unter Seq ID No. 1 dargestellte Sequenz neu ist und eine vollständige codierende Region beinhaltet.The plasmid DNA was isolated from the clone TaSSI 8/1 and the sequence of the cDNA insertions was determined using the dideoxynucleotide method (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1 977), 5463-5467). The insertion of the clone TaSSI 8/1 is 2805 bp long and represents a complete cDNA. The nucleotide sequence is shown under Seq ID No. 1 specified. The corresponding amino acid sequence can be found under Seq ID No. 2 specified. A comparison with previously published sequences showed that the under Seq ID No. 1 sequence is new and includes a complete coding region.
Beispiel 3: Herstellung des Pflanzentransformationsvektors pTa-gamma-SSI-8/1Example 3: Preparation of the plant transformation vector pTa-gamma-SSI-8/1
Zur Expression der unter Beispiel 1 isolierten cDNA wurden auf der Grundlage von pUC1 9 als Basisplasmid der Pflanzentransformationsvektor pTa-gamma-SSI- 8/1 konstruiert. Zur Konstruktion des Vektors wird die cDNA-lnsertion des Plasmids TaSSI 8/1 vollständig in sense-Orientierung mit dem 3'Ende des Ubiquitin-Promotors verbunden. Dieser Promotor besteht aus dem ersten untranslatierten Exon und dem ersten Intron des ubiquitinl Gens aus Mais (Christensen A.H. et al., Plant Molecular Biology 1 8 (1 992), 675-689) . Teile des Polylinkers und der NOS-Terminator stammen aus dem Plasmid pACT1 .cas (CAMBIA, TG 0063; Cambia, GPO Box 3200, Canberra ACT 2601 , Australia). Vektorkonstrukte mit diesem Terminator und Konstruktionen, die auf pActl .cas basieren, sind in MCElroy et al. (Molecular Breeding 1 (1 995), 27-37) beschrieben. Der so entstandene Vektor wurde pUbi.cas genannt.The expression of the cDNA isolated under Example 1 was based on constructed from pUC1 9 as the base plasmid the plant transformation vector pTa-gamma-SSI-8/1. To construct the vector, the cDNA insertion of the plasmid TaSSI 8/1 is connected completely in sense orientation to the 3 'end of the ubiquitin promoter. This promoter consists of the first untranslated exon and the first intron of the ubiquitinl gene from maize (Christensen AH et al., Plant Molecular Biology 1 8 (1 992), 675-689). Parts of the polylinker and the NOS terminator originate from the plasmid pACT1 .cas (CAMBIA, TG 0063; Cambia, GPO Box 3200, Canberra ACT 2601, Australia). Vector constructs with this terminator and constructions based on pActl .cas are described in MCElroy et al. (Molecular Breeding 1 (1 995), 27-37). The resulting vector was called pUbi.cas.
Die Klonierung des Expressionsvektors erfolgte durch Restriktion eines Fragmentes aus dem Klon TaSSI 8/1 mit den Restriktionsenzymen Xba I und Ssp. I. Das Fragment wurde an den Enden mittels einer Klenow Reaktion aufgefüllt und anschließend in die Sma I Klonierungsstelle des Expressionsvektors pUbi.cas ligiert. Der entstandene Expressionsvektor wurde pTA-gamma-SSI 8/1 bezeichnet. In einem zweiten Konstrukt wurde der 5'- untranslatierte Leader des Klons TaSSI-8/1 zunächst durch eine Behandlung mit Exonnuklease entfernt. Sodann erfolgte die Klonierung in den Expressionsvektor pUbi.cas. Dieses Konstrukt wurde Ta-gamma-SSI-8/1 -2 bezeichnet.The expression vector was cloned by restricting a fragment from the clone TaSSI 8/1 with the restriction enzymes Xba I and Ssp. I. The fragment was filled in at the ends using a Klenow reaction and then ligated into the Sma I cloning site of the expression vector pUbi.cas. The resulting expression vector was called pTA-gamma-SSI 8/1. In a second construct, the 5'-untranslated leader of the clone TaSSI-8/1 was first removed by treatment with exonnuclease. The cloning into the expression vector pUbi.cas was then carried out. This construct was called Ta-gamma-SSI-8/1 -2.
Der Vektoren pTa-gamma-SSI-8/1 und pTa-gamma-SSI-8/1 -2 werden anschließend zur Transformation von Weizen verwendet. INTERNATIONALES FORMBLATTThe vectors pTa-gamma-SSI-8/1 and pTa-gamma-SSI-8/1 -2 are then used to transform wheat. INTERNATIONAL FORM
Hoechst Schering AgrEvo GmbH 55926 Frankfurt/MainHoechst Schering AgrEvo GmbH 55926 Frankfurt / Main
EMPFANGSBESTÄTIGUNG BEI ERSTHINTERLEGUNG, ausgestellt gemäß Regel 7 1 von der unten angegebenen INTERNATIONALEN HINTERLEGUNGSSTELLEFIRST DEPOSIT RECEIPT CONFIRMATION, issued in accordance with Rule 7 1 by the INTERNATIONAL DEPOSITOR below
I. KENNZEICHNUNG DES MIKROORGANISMUSI. LABELING OF THE MICROORGANISM
Vom HINTERLEGER zugeteiltes Bezugszeichen Von der INTERNATIONALEN HINTERLEGUNGSSTELLE zugeteilte EINGANGSNUMMER. pTa SSI 8/1REFERENCE NUMBER ALLOCATED BY THE DEPOSIT INPUT NUMBER ALLOCATED BY THE INTERNATIONAL DEPOSIT. pTa SSI 8/1
DSM 12794DSM 12794
II WISSENSCHAFTUCHE BESCHREIBUNG UND/ODER VORGESCHLAGENE TAXONOM1SCHE BEZEICHNUNGII SCIENCE TOWEL DESCRIPTION AND / OR PROPOSED TAXONOMIC NAME
Mit dem unter I. bezeichneten Mikroorganismus wurdeWith the microorganism designated under I.
(X ) eine wissenschaftliche Beschreibung(X) a scientific description
( ) eine vorgeschlagene taxonomische Bezeichnung eingereicht. (Zutreffendes ankreuzen).() submitted a proposed taxonomic name. (Tick the appropriate).
III EINGANG UND ANNAHMEIII INPUT AND ACCEPTANCE
Diese internationale Hinterlegungsstelle nimmt den unter 1 bezeichneten Mikroorganismus an, der bei ihr am 1999 - 04 - 2 8 (Datum der Ersthinterlegung)1 eingegangen istThis international depository accepts the microorganism designated under 1, which it received on 1999 - 04 - 2 8 (date of first deposit) 1
IV. EINGANG DES ANTRAGS AUF UMWANDLUNGIV. RECEIPT FOR CONVERSION
Der unter I bezeichnete Mikroorganismus ist bei dieser Internationalen Hinterlegungsstelle am eingegangen (Datum der Ersthinterlegung) und ein Antrag auf Umwandlung dieser Ersthinterlegung in eine Hinterlegung gemäß Budapester Vertrag ist am eingegangen (Datum des Eingangs des Antrags auf Umwandlung)The microorganism referred to under I has been received by this international depository on (date of first deposit) and an application for conversion of this first deposit into a deposit under the Budapest Treaty has been received on (date of receipt of the application for conversion)
V INTERNATIONALE HINTERLEGUNGSSTELLEV INTERNATIONAL DEPOSIT
Name. DSMZ-DEUTSCHE SAMMLUNG VON Unterschrιft(en) der zur Vertretung der internationalen HinterlegungsSurname. DSMZ-GERMAN COLLECTION OF Signature (s) to represent the international deposit
MIKROORGANISMEN UND ZELLKULTUREN GmbH befugten Person(en) oder des (der) von ihr ermächtigten BediensteteMIKROORGANISMEN UND ZELLKULTUREN GmbH authorized person (s) or the employee (s) authorized by them
Anschrift Mascheroder Weg lb D-38124 BraunschweigAddress Mascheroder Weg lb D-38124 Braunschweig
Datum 1999 - 05 - 03 Date 1999 - 05 - 03

Claims

Patentansprüche: Claims:
1 . Nucleinsäuremolekül, codierend ein Protein mit der Funktion einer Stärkesynthase aus Weizen, ausgewählt aus der Gruppe bestehend aus1 . Nucleic acid molecule encoding a protein having the function of a wheat starch synthase selected from the group consisting of
(a) einem Nucleinsäuremolekül, das ein Protein codiert, das die unter Seq ID NO. 2 angegebene Aminosäuresequenz umfaßt,(a) a nucleic acid molecule which encodes a protein which has the sequence shown in Seq ID NO. 2 includes the given amino acid sequence,
(b) einem Nucleinsäuremolekül, das die unter Seq ID No. 1 dargestellte Nucleotidsequenz oder einen Teil davon umfasst oder eine hierzu korrespondierende Ribonucleotidsequenz;(b) a nucleic acid molecule which has the properties listed under Seq ID No. 1 comprises a nucleotide sequence shown or a part thereof or a corresponding ribonucleotide sequence;
(c) einem Nucleinsäuremolekül, das mit einem der unter (a) oder (b) genannten Nucleinsäuremoleküle hybridisiert oder komplementär dazu ist, und(c) a nucleic acid molecule which hybridizes with or is complementary to one of the nucleic acid molecules mentioned under (a) or (b), and
(d) einem Nucleinsäuremolekül, dessen Nucleotidsequenz aufgrund der Degeneration des genetischen Codes von der Sequenz eines unter (a), (b) oder (c) genannten Nucleinsäuremoleküls abweicht.(d) a nucleic acid molecule whose nucleotide sequence deviates from the sequence of a nucleic acid molecule mentioned under (a), (b) or (c) due to the degeneration of the genetic code.
2. Nucleinsäuremolekül nach Anspruch 1 , dadurch gekennzeichnet, daß es ein DNA-Molekül ist.2. Nucleic acid molecule according to claim 1, characterized in that it is a DNA molecule.
3. DNA-Molekül nach Anspruch 2, dadurch gekennzeichnet, daß es ein cDNA-Molekül ist.3. DNA molecule according to claim 2, characterized in that it is a cDNA molecule.
4. Nucleinsäuremolekül nacheinem oder mehreren der Ansprüche 1 bis 3, das regulatorische Elemente enthält.A nucleic acid molecule according to one or more of claims 1 to 3, which contains regulatory elements.
5. Nucleinsäuremolekül nach Anspruch 1 , dadurch gekennzeichnet, daß es ein RNA-Molekül ist.5. Nucleic acid molecule according to claim 1, characterized in that it is an RNA molecule.
6. Nucleinsäuremolekül, das spezifisch mit einem Nucleinsäuremolekül nach einem der Ansprüche 1 bis 5 hybridisiert. 6. A nucleic acid molecule that hybridizes specifically with a nucleic acid molecule according to any one of claims 1 to 5.
7. Nucleinsäuremolekül nach Anspruch 6, das ein Oligonucleotid mit einer Länge von mindestens 1 5 Nucleotiden ist.7. The nucleic acid molecule of claim 6, which is an oligonucleotide at least 15 nucleotides in length.
8. Vektor, enthaltend ein DNA-Molekül nach einem der Ansprüche 1 bis 5.8. vector containing a DNA molecule according to any one of claims 1 to 5.
9. Vektor nach Anspruch 8, worin besagtes Nucleinsäuremolekül in sense- Orientierung mit regulatorischen Elementen verknüpft ist, die die Transkription und Synthese einer translatierbaren RNA in pro- oder eukaryontischen Zellen gewährleisten.9. Vector according to claim 8, wherein said nucleic acid molecule is linked in sense orientation to regulatory elements which ensure the transcription and synthesis of a translatable RNA in pro- or eukaryotic cells.
10. Vektor nach Anspruch 8, worin besagtes Nucleinsäuremolekül in sense- Orientierung mit regulatorischen Elementen verknüpft ist, die die Synthese einer nicht-translatierbaren RNA in pro- oder eukaryontischen Zellen gewährleisten.10. The vector of claim 8, wherein said nucleic acid molecule is linked in sense orientation to regulatory elements which ensure the synthesis of a non-translatable RNA in pro- or eukaryotic cells.
1 1 . Vektor nach Anspruch 8, worin besagtes Nucleinsäuremolekül in antisense-Orientierung mit regulatorischen Elementen verknüpft ist, die die Synthese einer nicht-translatierbaren RNA in pro- oder eukaryontischen Zellen gewährleisten.1 1. A vector according to claim 8, wherein said nucleic acid molecule is linked in antisense orientation to regulatory elements which ensure the synthesis of a non-translatable RNA in pro- or eukaryotic cells.
1 2. Wirtszelle, die mit einem Nucleinsäuremolekül nach einem oder mehreren der Ansprüche 1 bis 5 oder einem Vektor nach einem oder mehreren der Ansprüche 8 bis 1 1 transformiert ist oderdie von einer solchen Zelle abstammt.A host cell transformed with a nucleic acid molecule according to one or more of claims 1 to 5 or a vector according to one or more of claims 8 to 1 1 or which is derived from such a cell.
1 3. Protein, codiert durch ein Nucleinsäuremolekül nach einem oder mehreren der Ansprüche 1 bis 4.3. Protein encoded by a nucleic acid molecule according to one or more of claims 1 to 4.
14. Verfahren zur Herstellung eines Proteins nach Anspruch 1 3, worin eine Wirtszelle nach Anspruch 1 2 unter Bedingungen kultiviert wird, die die Synthese das besagten Proteins erlauben und besagtes Protein aus den kultivierten Zellen und/oder dem Kulturmedium isoliert wird.14. A method for producing a protein according to claim 1 3, wherein a host cell according to claim 1 2 is cultivated under conditions which the Allow synthesis of said protein and said protein is isolated from the cultured cells and / or the culture medium.
1 5. Verfahren zur Herstellung einer transgenen Pflanzenzelle, worin a) ein Nucleinsäuremolekül nach einem oder mehreren der Ansprüche 1 bis 5 oder b) ein Vektor nach einem oder mehreren der Ansprüche 8 bis 1 1 in das Genom einer pflanzlichen Zelle integriert wird.1 5. A method for producing a transgenic plant cell, wherein a) a nucleic acid molecule according to one or more of claims 1 to 5 or b) a vector according to one or more of claims 8 to 1 1 is integrated into the genome of a plant cell.
1 6. Transgene Pflanzenzelle, die mit einem Nucleinsäuremolekül nach einem oder mehreren der Ansprüche 1 bis 5 oder einem Vektor nach einem oder mehreren der Ansprüche 8 bis 1 1 transformiert wurde oder die von einer solchen Zelle abstammt.1 6. Transgenic plant cell which has been transformed with a nucleic acid molecule according to one or more of claims 1 to 5 or a vector according to one or more of claims 8 to 1 1 or which is derived from such a cell.
1 7. Verfahren zur Herstellung einer transgenen Pflanzenzelle, worin a1 ) ein Nucleinsäuremolekül nach einem oder mehreren der Ansprüche 1 bis 5 oder a2) ein Vektor nach einem oder mehreren der Ansprüche 8 bis 1 1 in das Genom einer pflanzlichen Zelle integriert wird und b) eine vollständige Pflanze aus besagter Pflanzenzelle regeneriert wird.1 7. A method for producing a transgenic plant cell, wherein a1) a nucleic acid molecule according to one or more of claims 1 to 5 or a2) a vector according to one or more of claims 8 to 1 1 is integrated into the genome of a plant cell and b) a whole plant is regenerated from said plant cell.
18. Pflanze, enthaltend eine Pflanzenzelle nach Anspruch 1 6.18. Plant containing a plant cell according to claim 1 6.
1 9. Pflanze nach Anspruch 1 9, die eine monokotyle oder dikotyle Pflanze ist.1 9. Plant according to claim 1 9, which is a monocot or dicot plant.
20. Pflanze nach Anspruch 1 9, die eine Nutzpflanze ist.20. Plant according to claim 1 9, which is a useful plant.
21 . Pflanze nach Anspruch 20, die eine stärkespeichernde Pflanze ist.21. A plant according to claim 20 which is a starch storing plant.
22. Pflanze nach Anspruch 21 , die eine Mais, Reis, Kartoffel oder Weizenpflanze ist. 22. The plant of claim 21 which is a corn, rice, potato or wheat plant.
23. Vermehrungsmaterial einer Pflanze nach einem oder mehreren der Ansprüche 1 8 bis 22.23. Plant propagation material according to one or more of claims 1 8 to 22.
24. Stärke, erhätlich aus einer Pflanzenzelle gemäß Anspruch 1 6, einer Pflanze nach einem oder mehreren der Ansprüche 1 8 bis 22 oder aus Vermehrungsmaterial nach Anspruch 23.24. Starch, obtainable from a plant cell according to claim 1 6, a plant according to one or more of claims 1 8 to 22 or from propagation material according to claim 23.
25. Verwendung der Stärke nach Anspruch 24 zur Herstellung von Lebensmitteln oder Lebensmittelvorprodukten, vorzugsweise von Backoder Teigwaren.25. Use of the starch according to claim 24 for the production of foods or food precursors, preferably baked or pasta.
26. Verwendung der Stärke nach Anspruch 24 zur Herstellung von Verpackungsmaterialien oder Einwegartikeln. 26. Use of the starch according to claim 24 for the production of packaging materials or disposable items.
EP99923557A 1998-05-08 1999-05-07 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch Withdrawn EP1095152A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19820607A DE19820607A1 (en) 1998-05-08 1998-05-08 New enzyme with starch synthase activity, useful for producing starch for foods and packaging materials
DE19820607 1998-05-08
PCT/EP1999/003156 WO1999058688A2 (en) 1998-05-08 1999-05-07 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch

Publications (1)

Publication Number Publication Date
EP1095152A2 true EP1095152A2 (en) 2001-05-02

Family

ID=7867091

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99923557A Withdrawn EP1095152A2 (en) 1998-05-08 1999-05-07 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch

Country Status (14)

Country Link
US (1) US6890732B1 (en)
EP (1) EP1095152A2 (en)
JP (1) JP2002514427A (en)
KR (1) KR20010043457A (en)
CN (1) CN1299415A (en)
AU (1) AU4039199A (en)
BR (1) BR9910307A (en)
CA (1) CA2328508A1 (en)
DE (1) DE19820607A1 (en)
HU (1) HUP0101833A2 (en)
NO (1) NO20005614L (en)
PL (1) PL345092A1 (en)
SK (1) SK15772000A3 (en)
WO (1) WO1999058688A2 (en)

Families Citing this family (183)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070246683A1 (en) * 2006-04-24 2007-10-25 David Paul Miller Reduced dusting gypsum composites and method of making them
CL2007003743A1 (en) * 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
CL2007003744A1 (en) * 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES A 2-PYRIDILMETILBENZAMIDE DERIVATIVE AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
EP1969934A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides
EP1969929A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG Substituted phenylamidines and their use as fungicides
WO2008110279A1 (en) 2007-03-12 2008-09-18 Bayer Cropscience Ag Dihalophenoxyphenylamidines and use thereof as fungicides
EP1969931A1 (en) * 2007-03-12 2008-09-17 Bayer CropScience Aktiengesellschaft Fluoroalkyl phenylamidines and their use as fungicides
JP2010520900A (en) 2007-03-12 2010-06-17 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト Phenoxy-substituted phenylamidine derivatives and their use as fungicides
WO2008110281A2 (en) * 2007-03-12 2008-09-18 Bayer Cropscience Ag 3,4-disubstituted phenoxyphenylamidines and use thereof as fungicides
EP2146975B1 (en) * 2007-04-19 2015-06-17 Bayer Intellectual Property GmbH Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
DE102007045956A1 (en) 2007-09-26 2009-04-09 Bayer Cropscience Ag Combination of active ingredients with insecticidal and acaricidal properties
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
DE102007045922A1 (en) * 2007-09-26 2009-04-02 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
CA2701290A1 (en) * 2007-10-02 2009-04-16 Bayer Cropscience Ag Methods of improving plant growth
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2113172A1 (en) * 2008-04-28 2009-11-04 Bayer CropScience AG Method for improved utilisation of the production potential of transgene plants
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
BRPI0918430A2 (en) 2008-08-14 2015-11-24 Bayer Cropscience Ag 4-phenyl-1h-pyrazols insecticides.
DE102008041695A1 (en) * 2008-08-29 2010-03-04 Bayer Cropscience Ag Methods for improving plant growth
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
WO2010075966A1 (en) 2008-12-29 2010-07-08 Bayer Cropscience Ag Method for improved use of the production potential of genetically modified plants
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2387309A2 (en) 2009-01-19 2011-11-23 Bayer CropScience AG Cyclic diones and their use as insecticides, acaricides and/or fungicides
EP2227951A1 (en) 2009-01-23 2010-09-15 Bayer CropScience AG Application of enaminocarbonyl compounds for combating viruses transmitted by insects
ES2406131T3 (en) 2009-01-28 2013-06-05 Bayer Intellectual Property Gmbh Fungicidal derivatives of N-cycloalkyl-N-bicyclomethylene-carboxamine
AR075126A1 (en) * 2009-01-29 2011-03-09 Bayer Cropscience Ag METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL
CN102317259B (en) 2009-02-17 2015-12-02 拜尔农科股份公司 Fungicidal N-(phenylcycloalkyl) carboxylic acid amides, N-(benzylic cycloalkyl group) carboxylic acid amides and thiocarboxamide derivative
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
TW201031331A (en) 2009-02-19 2010-09-01 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
DE102009001469A1 (en) 2009-03-11 2009-09-24 Bayer Cropscience Ag Improving utilization of productive potential of transgenic plant by controlling e.g. animal pest, and/or by improving plant health, comprises treating the transgenic plant with active agent composition comprising prothioconazole
DE102009001681A1 (en) 2009-03-20 2010-09-23 Bayer Cropscience Ag Improving utilization of production potential of a transgenic plant by controlling animal pests, phytopathogenic fungi, microorganisms and/or improving plant health, comprises treating plant with a drug composition comprising iprovalicarb
DE102009001730A1 (en) 2009-03-23 2010-09-30 Bayer Cropscience Ag Improving utilization of production potential of a transgenic plant by controlling animal pests, phytopathogenic fungi and/or microorganisms and/or the plant health, comprises treating plant with a drug composition comprising spiroxamine
DE102009001732A1 (en) 2009-03-23 2010-09-30 Bayer Cropscience Ag Improving the production potential of transgenic plant, by combating e.g. animal pests and/or microorganism, and/or increasing plant health, comprises treating the plants with active agent composition comprising trifloxystrobin
DE102009001728A1 (en) 2009-03-23 2010-09-30 Bayer Cropscience Ag Improving the production potential of transgenic plant, by combating e.g. animal pests and/or microorganism, and/or increasing plant health, comprises treating the plants with active agent composition comprising fluoxastrobin
CN102365018B (en) 2009-03-25 2014-10-29 拜尔农作物科学股份公司 Synergistic combinations of active ingredients
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
CN102361555B (en) 2009-03-25 2014-05-28 拜尔农作物科学股份公司 Active ingredient combinations with insecticidal and acaricidal properties
CN102448304B (en) 2009-03-25 2015-03-11 拜尔农作物科学股份公司 Active ingredient combinations having insecticidal and acaricidal properties
CN102395271A (en) 2009-03-25 2012-03-28 拜尔农作物科学股份公司 Active ingredient combinations having insecticidal and acaricidal properties
CN102448305B (en) 2009-03-25 2015-04-01 拜尔农作物科学股份公司 Active ingredient combinations having insecticidal and acaricidal properties
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
CN102458125B (en) 2009-05-06 2015-04-29 拜尔农作物科学股份公司 Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides
AR076839A1 (en) 2009-05-15 2011-07-13 Bayer Cropscience Ag FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
EA023833B1 (en) * 2009-06-02 2016-07-29 Байер Интеллектуэль Проперти Гмбх Use of succinate dehydrogenase inhibitors for controlling sclerotinia ssp.
BR112012001080A2 (en) * 2009-07-16 2015-09-01 Bayer Cropscience Ag Combinations of synergistic active substances containing phenyltriazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
MX2012007540A (en) 2009-12-28 2012-07-23 Bayer Cropscience Ag Fungicidal hydroximoyl - tetrazole derivatives.
US9000012B2 (en) 2009-12-28 2015-04-07 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
EP2519103B1 (en) 2009-12-28 2014-08-13 Bayer Intellectual Property GmbH Fungicide hydroximoyl-tetrazole derivatives
BR112012018108A2 (en) 2010-01-22 2015-10-20 Bayer Ip Gmbh acaricidal and / or insecticidal combinations of active ingredients
WO2011107504A1 (en) 2010-03-04 2011-09-09 Bayer Cropscience Ag Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants
JP2013523795A (en) 2010-04-06 2013-06-17 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Use of 4-phenylbutyric acid and / or salt thereof to enhance stress tolerance of plants
JP6046604B2 (en) 2010-04-09 2016-12-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH Use of derivatives of (1-cyanocyclopropyl) phenylphosphinic acid, their esters and / or their salts to enhance plant tolerance to abiotic stress
BR112012027558A2 (en) 2010-04-28 2015-09-15 Bayer Cropscience Ag '' Compound of formula (I), fungicidal composition and method for the control of crop phytogenic fungi ''
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011134913A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
UA110703C2 (en) 2010-06-03 2016-02-10 Байєр Кропсайнс Аг Fungicidal n-[(trisubstitutedsilyl)methyl]carboxamide
US8999956B2 (en) 2010-06-03 2015-04-07 Bayer Intellectual Property Gmbh N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
EP2576516B1 (en) 2010-06-03 2014-12-17 Bayer Intellectual Property GmbH N-[(het)arylethyl)]pyrazole(thio)carboxamides and their heterosubstituted analogues
CA2801834A1 (en) 2010-06-09 2011-12-15 Kathleen D'halluin Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
CN109504700A (en) 2010-06-09 2019-03-22 拜尔作物科学公司 Plant Genome transformation in commonly on nucleotide sequence modified plant genome Method and kit for
US9173399B2 (en) 2010-07-20 2015-11-03 Bayer Intellectual Property Gmbh Benzocycloalkenes as antifungal agents
EP2611300B1 (en) 2010-09-03 2016-04-06 Bayer Intellectual Property GmbH Substituted annelated dihydropyrimidinone compounds
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
MX2013003159A (en) 2010-09-22 2013-05-01 Bayer Ip Gmbh Use of biological or chemical control agents for controlling insects and nematodes in resistant crops.
MX346667B (en) 2010-10-07 2017-03-28 Bayer Cropscience Ag * Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative.
BR112013009590B8 (en) 2010-10-21 2019-03-19 Bayer Ip Gmbh compound, fungicidal composition and method
EP2630125B1 (en) 2010-10-21 2016-08-24 Bayer Intellectual Property GmbH N-benzyl heterocyclic carboxamides
CA2815117A1 (en) 2010-11-02 2012-05-10 Bayer Intellectual Property Gmbh N-hetarylmethyl pyrazolylcarboxamides
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
JP2013543858A (en) 2010-11-15 2013-12-09 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー 5-halogenopyrazole (thio) carboxamides
US9206137B2 (en) 2010-11-15 2015-12-08 Bayer Intellectual Property Gmbh N-Aryl pyrazole(thio)carboxamides
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
JP6412311B2 (en) 2010-12-01 2018-10-24 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH Use of fluopyram to control nematodes in crops and to increase yield
JP2014502611A (en) 2010-12-29 2014-02-03 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Fungicide hydroxymoyl-tetrazole derivative
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
EP2471363A1 (en) 2010-12-30 2012-07-04 Bayer CropScience AG Use of aryl-, heteroaryl- and benzylsulfonamide carboxylic acids, -carboxylic acid esters, -carboxylic acid amides and -carbonitriles and/or its salts for increasing stress tolerance in plants
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
CA2823999C (en) 2011-03-10 2020-03-24 Bayer Intellectual Property Gmbh Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
US20140005230A1 (en) 2011-03-14 2014-01-02 Juergen Benting Fungicide hydroximoyl-tetrazole derivatives
US20140051575A1 (en) 2011-04-08 2014-02-20 Juergen Benting Fungicide hydroximoyl-tetrazole derivatives
AR085568A1 (en) 2011-04-15 2013-10-09 Bayer Cropscience Ag 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENTA-2,4-DIENOS AND 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENT- 2-IN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST ABIOTIC STRESS OF PLANTS
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
AR085585A1 (en) 2011-04-15 2013-10-09 Bayer Cropscience Ag VINIL- AND ALQUINILCICLOHEXANOLES SUBSTITUTED AS ACTIVE PRINCIPLES AGAINST STRIPS ABIOTIQUE OF PLANTS
AR090010A1 (en) 2011-04-15 2014-10-15 Bayer Cropscience Ag 5- (CICLOHEX-2-EN-1-IL) -PENTA-2,4-DIENOS AND 5- (CICLOHEX-2-EN-1-IL) -PENT-2-EN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST THE ABIOTIC STRESS OF PLANTS, USES AND TREATMENT METHODS
CA2833749C (en) 2011-04-22 2019-06-04 Bayer Intellectual Property Gmbh Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
EP2718443B1 (en) 2011-06-06 2017-11-29 Bayer CropScience NV Methods and means to modify a plant genome at a preselected site
JP2014520776A (en) 2011-07-04 2014-08-25 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Use of substituted isoquinolinones, isoquinoline diones, isoquinoline triones and dihydroisoquinolinones or their salts in each case as active agents against abiotic stresses in plants
CN103717076B (en) 2011-08-10 2016-04-13 拜耳知识产权股份有限公司 Active compound combinations containing specific tetramic acid derivatives
CN103890181A (en) 2011-08-22 2014-06-25 拜尔作物科学公司 Methods and means to modify a plant genome
WO2013026836A1 (en) 2011-08-22 2013-02-28 Bayer Intellectual Property Gmbh Fungicide hydroximoyl-tetrazole derivatives
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
BR112014005262A2 (en) 2011-09-09 2017-04-04 Bayer Ip Gmbh method for enhancing a vegetable and using a compound of formula (i) or (ii)
CN103874681B (en) 2011-09-12 2017-01-18 拜耳知识产权有限责任公司 Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4H)-one derivatives
US10301257B2 (en) 2011-09-16 2019-05-28 Bayer Intellectual Property Gmbh Use of acylsulfonamides for improving plant yield
US20140378306A1 (en) 2011-09-16 2014-12-25 Bayer Intellectual Property Gmbh Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield
MX362112B (en) 2011-09-16 2019-01-07 Bayer Ip Gmbh Use of phenylpyrazolin-3-carboxylates for improving plant yield.
BR112014006940A2 (en) 2011-09-23 2017-04-04 Bayer Ip Gmbh use of 4-substituted 1-phenylpyrazol-3-carboxylic acid derivatives as abiotic stress agents in plants
AR088113A1 (en) 2011-10-04 2014-05-07 Bayer Ip Gmbh INTERFERENCE RNA (RNAi) FOR THE CONTROL OF FUNGES AND OOMYCES BY THE INHIBITION OF THE SACAROPINE DEHYDROGENASE GENE
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
RU2014125077A (en) 2011-11-21 2015-12-27 Байер Интеллекчуал Проперти Гмбх FUNGICIDAL N - [(TRISubstituted SILYL) ETHYL] -CARBOXAMIDE DERIVATIVES
JP2015504442A (en) 2011-11-30 2015-02-12 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Bactericidal N-bicycloalkyl and N-tricycloalkyl (thio) carboxamide derivatives
CA2859467C (en) 2011-12-19 2019-10-01 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
TWI557120B (en) 2011-12-29 2016-11-11 拜耳知識產權公司 Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
CN104039769B (en) 2011-12-29 2016-10-19 拜耳知识产权有限责任公司 3-[(1,3-thiazole-4-yl methoxyimino) (phenyl) methyl]-2-substituted-1,2,4-diazole-5 (2H) the-one derivant of antifungal
NZ722692A (en) 2012-02-22 2018-02-23 Bayer Ip Gmbh Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape
BR112014020898B1 (en) 2012-02-27 2020-08-11 Bayer Intellectual Property Gmbh COMBINATION, METHOD FOR THE CONTROL OF HARMFUL PHYTOPATHOGENIC FUNGI UNDERSTANDING THE REFERRED COMBINATION AND ITS USE
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
WO2013153143A1 (en) 2012-04-12 2013-10-17 Bayer Cropscience Ag N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides
JP6109295B2 (en) 2012-04-20 2017-04-05 バイエル・クロップサイエンス・アクチェンゲゼルシャフト N-cycloalkyl-N-[(heterocyclylphenyl) methylene]-(thio) carboxamide derivatives
WO2013156560A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
CA2871008C (en) 2012-04-23 2022-11-22 Bayer Cropscience Nv Targeted genome engineering in plants
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
BR112014027644A2 (en) 2012-05-09 2017-06-27 Bayer Cropscience Ag 5-halopyrazole indanyl carboxamides
MX2014013497A (en) 2012-05-09 2015-02-10 Bayer Cropscience Ag Pyrazole indanyl carboxamides.
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
AR091104A1 (en) 2012-05-22 2015-01-14 Bayer Cropscience Ag COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A LIPO-CHYTOOLIGOSACARIDE DERIVATIVE AND A NEMATICIDE, INSECTICIDE OR FUNGICIDE COMPOUND
EP2871958A1 (en) 2012-07-11 2015-05-20 Bayer CropScience AG Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
CN104780764A (en) 2012-09-05 2015-07-15 拜尔农作物科学股份公司 Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
US9801374B2 (en) 2012-10-19 2017-10-31 Bayer Cropscience Ag Active compound combinations comprising carboxamide derivatives
PL2908640T3 (en) 2012-10-19 2020-06-29 Bayer Cropscience Ag Method of plant growth promotion using carboxamide derivatives
DK2908641T3 (en) 2012-10-19 2018-04-23 Bayer Cropscience Ag PROCEDURE FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES
CA2888559C (en) 2012-10-19 2021-03-02 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
EP2925137A1 (en) 2012-11-30 2015-10-07 Bayer CropScience AG Binary fungicidal or pesticidal mixture
EP2925136A2 (en) 2012-11-30 2015-10-07 Bayer CropScience AG Binary fungicidal mixtures
JP6359551B2 (en) 2012-11-30 2018-07-18 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Three-way disinfectant mixture
EA201890495A3 (en) 2012-11-30 2019-01-31 Байер Кропсайенс Акциенгезельшафт TRIPLE FUNGICIDAL AND PESTICIDAL MIXTURES
UA117819C2 (en) 2012-11-30 2018-10-10 Байєр Кропсайєнс Акцієнгезелльшафт Binary pesticidal and fungicidal mixtures
WO2014086751A1 (en) 2012-12-05 2014-06-12 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
AR093909A1 (en) 2012-12-12 2015-06-24 Bayer Cropscience Ag USE OF ACTIVE INGREDIENTS TO CONTROL NEMATODES IN CULTURES RESISTANT TO NEMATODES
AR093996A1 (en) 2012-12-18 2015-07-01 Bayer Cropscience Ag BACTERICIDAL COMBINATIONS AND BINARY FUNGICIDES
EP2935218A1 (en) 2012-12-19 2015-10-28 Bayer CropScience AG Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides
JP2016515100A (en) 2013-03-07 2016-05-26 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Bactericidal 3- {phenyl [(heterocyclylmethoxy) imino] methyl} -heterocyclic derivatives
WO2014161821A1 (en) 2013-04-02 2014-10-09 Bayer Cropscience Nv Targeted genome engineering in eukaryotes
EP2984080B1 (en) 2013-04-12 2017-08-30 Bayer CropScience Aktiengesellschaft Novel triazolinthione derivatives
MX2015014365A (en) 2013-04-12 2015-12-07 Bayer Cropscience Ag Novel triazole derivatives.
JP2016519687A (en) 2013-04-19 2016-07-07 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Binary insecticide or pesticide mixture
CA2909725A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Aktiengesellschaft Method for improved utilization of the production potential of transgenic plants
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
TW201507722A (en) 2013-04-30 2015-03-01 Bayer Cropscience Ag N-(2-halogen-2-phenethyl)carboxamides as nematicides and endoparasiticides
EP3013802B1 (en) 2013-06-26 2019-08-14 Bayer Cropscience AG N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2015004040A1 (en) 2013-07-09 2015-01-15 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2015082587A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
AU2014359208B2 (en) 2013-12-05 2018-10-04 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
AR101214A1 (en) 2014-07-22 2016-11-30 Bayer Cropscience Ag CIANO-CICLOALQUILPENTA-2,4-DIENOS, CIANO-CICLOALQUILPENT-2-EN-4-INAS, CIANO-HETEROCICLILPENTA-2,4-DIENOS AND CYANO-HETEROCICLILPENT-2-EN-4-INAS REPLACED AS ACTIVE PRINCIPLES PLANTS ABIOTIC
AR103024A1 (en) 2014-12-18 2017-04-12 Bayer Cropscience Ag SELECTED PYRIDONCARBOXAMIDS OR ITS SALTS AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANTS STRESS
CN104673923B (en) * 2015-02-15 2016-10-05 中国农业科学院作物科学研究所 Primer SSIV-1b and detection method thereof for the detection of wheaten starch synthase gene TaSSIV allelic variation
WO2016166077A1 (en) 2015-04-13 2016-10-20 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives
WO2016205749A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
WO2018019676A1 (en) 2016-07-29 2018-02-01 Bayer Cropscience Aktiengesellschaft Active compound combinations and methods to protect the propagation material of plants
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
CN109715622A (en) 2016-09-22 2019-05-03 拜耳作物科学股份公司 New triazole derivative and its purposes as fungicide
US20190225974A1 (en) 2016-09-23 2019-07-25 BASF Agricultural Solutions Seed US LLC Targeted genome optimization in plants
CA3041351A1 (en) 2016-10-26 2018-05-03 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
BR112019011616A2 (en) 2016-12-08 2019-10-22 Bayer Ag use of insecticides to control larvae
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
US11591601B2 (en) 2017-05-05 2023-02-28 The Broad Institute, Inc. Methods for identification and modification of lncRNA associated with target genotypes and phenotypes
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
CA3073848A1 (en) 2017-09-21 2019-03-28 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
CN112513033A (en) 2018-06-04 2021-03-16 拜耳公司 Herbicidally active bicyclic benzoylpyrazoles
EP3898958A1 (en) 2018-12-17 2021-10-27 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524938D0 (en) * 1995-12-06 1996-02-07 Zeneca Ltd Modification of starch synthesis in plants
DE19619918A1 (en) 1996-05-17 1997-11-20 Planttec Biotechnologie Gmbh Nucleic acid molecules encoding soluble starch synthases from maize
DE19636917A1 (en) * 1996-09-11 1998-03-12 Hoechst Schering Agrevo Gmbh Nucleic acid encoding starch synthase enzymes from wheat
CA2256461C (en) * 1996-05-29 2012-07-24 Hoechst Schering Agrevo Gmbh Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
DE19621588A1 (en) * 1996-05-29 1997-12-04 Hoechst Schering Agrevo Gmbh Nucleic acid encoding starch synthase enzymes from wheat
DE69738587T2 (en) * 1996-09-30 2009-04-30 Basf Plant Science Gmbh Encapsulation of Polypepidines in the Stem Matrix
EP1012250B1 (en) * 1997-09-12 2008-12-17 Commonwealth Scientific And Industrial Research Organisation Regulation of gene expression in plants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9958688A2 *

Also Published As

Publication number Publication date
CA2328508A1 (en) 1999-11-18
NO20005614D0 (en) 2000-11-07
US6890732B1 (en) 2005-05-10
BR9910307A (en) 2001-01-09
WO1999058688A3 (en) 2000-01-13
AU4039199A (en) 1999-11-29
HUP0101833A2 (en) 2001-10-28
PL345092A1 (en) 2001-12-03
SK15772000A3 (en) 2001-06-11
WO1999058688A2 (en) 1999-11-18
JP2002514427A (en) 2002-05-21
DE19820607A1 (en) 1999-11-11
CN1299415A (en) 2001-06-13
NO20005614L (en) 2001-01-04
KR20010043457A (en) 2001-05-25

Similar Documents

Publication Publication Date Title
EP1088082B1 (en) Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
EP1095152A2 (en) Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
EP1200615B8 (en) Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch
DE69737448T2 (en) NUCLEIC ACID MOLECULES CODING FOR ENZYMES FROM WHEAT INVOLVED IN STARCH SYNTHESIS
EP1203087B1 (en) Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
EP0874908B1 (en) Nucleic acid molecules from plants encoding enzymes which participate in the starch synthesis
EP0791066B1 (en) Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
EP0904389A1 (en) Nucleic acid molecules coding soluble maize starch synthases
WO2000008175A2 (en) Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
WO2000008185A1 (en) Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
WO2000008184A1 (en) Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
WO1997042328A1 (en) Nucleic acid molecules which code the potato debranching enzyme
WO1997032985A1 (en) Nucleic acid molecules coding for debranching enzymes from maize
DE19709775A1 (en) Nucleic acid molecules encoding corn starch phosphorylase
DE102004029763A1 (en) Plants that produce amylopectin starch with new properties
DE19636917A1 (en) Nucleic acid encoding starch synthase enzymes from wheat
DE19621588A1 (en) Nucleic acid encoding starch synthase enzymes from wheat
MXPA00010987A (en) Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
CZ20004154A3 (en) Molecules of nucleic acids encoding enzymes from wheat and which take part in starch synthesis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001208

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER CROPSCIENCE GMBH

17Q First examination report despatched

Effective date: 20030710

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031121